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List of abbreviations 
 
The following abbreviations are used throughout this thesis. In addition, amino acids are 
referred to by their common 3 letter codes. 
 
Metabolites 
3PG 3-phosphoglycerate 
AcCoA acetyl-coenzyme A 
AKG α-ketoglutarate 
ATP/ADP/AMP  adenosine tri/di/monophosphate 
DHAP dihydroxyacetone phosphate 
E4P erythrose 4-phosphate 
F16BP fructose 1,6-bisphosphate 
F6P fructose 6-phosphate 
FAD+/FADH2  flavin adenine dinucleotide; (ox/red) 
Fum  fumarate 
G6P  glucose 6-phosphate 
GAP glyceraldehyde 3-phosphate 
gCDW  cell dry weight [g] 
glc  glucose 
GTP/GDP/GMP  guanosine tri/di/monophosphate 
IMP inosine 5-monophosphate 
Iso isocitrate 
Km  michaelis constant 
Mal malate 
NAD+/NADH  nicotinamide adenine dinucleotide; (ox/red) 
NADP+/NADPH  nicotinamide adenine dinucleotide phosphate; (ox/red) 
OAA oxaloacetate 
P5P  pentose 5-phosphate 
PEP phosphoenolpyruvate 
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Pi   inorganic phosphate 
PPi   pyrophosphate 
PRPP 5-phosphoribosyl 1-pyrophosphate 
Pyr pyruvate 
S7P sedoheptulose 7-phosphate 
Suc succinate 
THF  tetrahydrofolate 
Tre trehalose 
Vmax  maximal enzymatic activity 
XMP xanthosine 5-monophosphate 
 
 
Enzymes, reactions and pathways 
6PGDH 6-phosphogluconate dehydrogenase  
G6PDH  glucose 6-phosphate dehydrogenase 
GuaB2/guaB2 IMP dehydrogenase (enzyme/gene) 
ICD  isocitrate dehydrogenase  
MalE/malE  malic enzyme (enzyme/gene) 
Pck  PEP carboxykinase 
pgi glucose 6-phosphate isomerase (gene) 
PPP  pentose phosphate pathway 
PTS  phosphotransferase system 
PurA/purA adenylosuccinate synthase (enzyme/gene) 
PurF/purF amidophosphoribosyltranferase (enzyme/gene) 
PurFK348Q/purFK348Q  amidophosphoribosyltranferase with point  
 mutation K348Q (enzyme/gene) 
Pyk  pyruvate kinase 
rpm  rounds per minute 
SacB/sacB levansucrase (enzyme/gene) 
TCA cycle  tricarboxylic acid cycle 
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Others 
µ   specific growth rate [h-1] 
AMM   atom mapping matrix 
ATCC American Type Culture Collection 
BM  biomass 
BSTFA N,O-bis-(trimethylsilyl)trifluoroacetamide 
CE  collision energy 
CE-MS capillary electrophoresis-mass spectrometry 
CID  collision-induced dissociation 
CPR   CO2 production rate [mmol L-1 h-1] 
DNA   desoxynucleic acid 
DP  declustering potential 
DSMZ Deutsche Sammlung von Mikroorganismen  
 und Zellkulturen 
DTT   dithiothreitol 
et al.   and others (et alii) 
GC  gas chromatography 
HPLC  high performance liquid chromatography 
IDV  isotopomer distribution vector 
IEC  ion-exchange chromatography 
IMM  isotopomer mapping matrix 
IPC  ion-pairing chromatography 
IS  internal standard 
Kan   kanamycin 
LC  liquid chromatography 
LLOQ  lower limit of quantification 
m/z   mass to charge ratio [-] 
MBDSTFA   N-methyl-N-t-butyldimethylsilyl- 
  trifluoroacetamide 
MCS multiple cloning site 
MDV  mass distribution vector 
MFA  metabolic flux analysis 
MRM  multiple reaction monitoring 
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MS  mass spectrometry 
NMR   nuclear magnetic resonance 
OD   optical density 
ori   origin of replication 
OUR   oxygen uptake rate [mmol L-1 h-1]  
PCA  perchloric acid 
PCR  polymerase chain reaction 
pH   negative decimal logarithm of the proton activity 
QC  quality control 
qCO2   specific CO2 production rate [mmol g-1 h-1] 
qO2   specific O2 consumption rate [mmol g-1 h-1] 
qp   specific product formation rate [mmol g-1 h-1] 
qs   specific substrate consumption rate [mmol g-1 h-1] 
SAX  strong anion-exchange chromatography 
t   time [h] 
TOF  time of flight 
U   units 
v   metabolic flux 
YP/S   product yield [mol mol-1] 
YX/S   biomass yield [g mmol-1] 
ε   molar extinction coefficient [mM-1] 
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Abstract 
 
 
This thesis focused on the purine biosynthetic pathway of C. glutamicum in order to 
increase the general understanding of this essential pathway. 
In a first step, a suitable approach for the reliable quantitation of intracellular purine pools 
was established and validated, thus allowing targeted metabolite profiling of genetically 
engineered C. glutamicum strains. Based on a metabolic engineering strategy, site-directed 
mutants were generated and comprised modifications of the purine precursor supply (pgi), 
deletions of degrading reactions (purA and guaB2) and a point mutation (purFK348Q) 
targeting at a deregulation of the feedback inhibitory control. 
The individual modifications were combined in C. glutamicum ΔpurA ΔguaB2 purFK348Q 
Δpgi. Conducting a systems-level approach, a metabolic shift of the purine intermediate 
distribution was revealed, promoting a tremendous increase of the intracellular 
concentration of the degradation product hypoxanthine at the expense of IMP. 
Furthermore, a global phenotypic adaptation, expressed in transient growth stagnation, was 
observed. These adverse effects were attributed to a decline in the ATP generating capacity 
and imbalances of the NADPH metabolism caused by the deletion of the first glycolytic 
enzyme, glucose 6-phosphate isomerase (pgi). Cultivations applied on complex substrates 
showed a release of these adverse effects, temporarily delaying the growth stagnation 
phenomenon. 
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Zusammenfassung 
 
 
Im Mittelpunkt der Arbeit stand die Untersuchung des Purinbiosynthesewegs in 
C. glutamicum, welche auf eine Erweiterung des vorliegenden Kenntnisstandes über diesen 
essentiellen Stoffwechselweg abzielte. 
Zunächst wurde ein geeignetes Verfahren zur Quantifizierung intrazellulärer Purinpools 
etabliert und validiert. Dies bildete die Grundlage zur Erstellung gezielter metabolischer 
Profile genetisch veränderter C. glutamicum Stämme. Die eingebrachten genetischen 
Veränderungen umfassten die Modifizierung der Purin-Vorläuferbereitstellung (pgi), die 
Deletion beteiligter Abbauwege (purA und guaB2), sowie die Einführung einer 
Punktmutation (purFK348Q). Letztere hatte die Deregulation der Feedback-Inhibierung zum 
Ziel.  
Eine system-orientierte Analyse der Mutante C. glutamicum ΔpurA ΔguaB2 purFK348Q 
Δpgi wies eine ausgeprägte Verschiebung der intrazellulären Purinpools auf, die zu einem 
drastischen Konzentrationsanstieg des Abbauproduktes Hypoxanthin führte. Desweiteren 
resultierten die genetischen Veränderungen in einer phänotypisch-globalen Adaption, die 
sich durch einen vorübergehenden Wachstumsstillstand auszeichnete. Die nachteiligen 
Effekte – die sich sowohl lokal im Hinblick auf den Purinweg, aber auch global mit 
Auswirkungen auf den gesamten Phänotyp – zeigten, wurden auf ein verringertes Potential 
zur Energiegewinnung, sowie auf ein Ungleichgewicht im NADPH-Metabolismus 
zurückgeführt. Diese Effekte wurden durch den Einsatz komplexer Medienbestandteile 
teilweise eliminiert.  
 7 
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Microorganisms 
- 
Tailor-made cell factories in the scope of  
systems biotechnology 
 
 
The exploitation of microorganisms, representing the most diverse group on earth and the 
basis of life itself (Schaechter et al., 2004), has been performed for thousands of years. 
Possessing a tremendous repertoire of biochemical capabilities, those “conversion agents” 
emerged as irreplaceable instruments in the era of biotechnological manufacturing, e.g. for 
product synthesis or degradation of undesired and harmful compounds.  
Whereas trial and error-driven advancements characterized traditional bioprocess 
improvements over the last century, thereby primarily relying on classical breeding 
(Becker and Wittmann, 2012; Nakayama et al., 1978; Vallino and Stephanopoulos, 1993), 
the focus nowadays is more and more shifting towards targeted approaches, e.g. genetic 
and metabolic engineering. The creation of microorganisms with modified cellular 
properties, so called designer microbes (Cameron and Tong, 1993) requires knowledge on 
how these cellular systems operate, ultimately targeting a global and comprehensive 
picture of the dynamic properties and especially the interconnectivity of the diverse 
cellular components. Therefore various platforms, allowing quantitative analyses i.e. 
genomics, proteomics, transcriptomics, metabolomics and fluxomics are being combined.  
Recent developments in the fields of molecular biology, biochemistry, biophysics, 
microbiology, analytical chemistry and computational modeling and the increasing ability 
to understand and utilize the vast amount of data, drastically promoted this field. One of 
the microbial milestones within the scope of industrial manufacturing was the discovery 
and following exploitation of the Gram-positive microbe Corynebacterium glutamicum. 
This organism, exhibiting an outstanding significance in the biotechnological industry, 
represents a model system within the field of systems biotechnology. This integrative field, 
composed by the joined terms of systemsbiology and biotechnology, aims at uncovering 
emerging system properties and the refinement of cellular properties to the point of the 
General introduction   -   Chapter I 
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redefinition of whole cellular systems, always based on a profound basis of research 
knowledge, ideally in the form of predictive mathematical models. 
The purine biosynthetic pathway and corresponding intermediates are in this context of 
special interest, as these metabolites exhibit various functions within the cellular system, 
ranging from carrying the genetic information to signal mediation and energy supply 
(Cordell et al., 2008; Guimaraes and Londesborough, 2008; Pang et al., 2011; Traut, 1994). 
In addition imbalances in their pool sizes are reported to be directly linked to increased 
mutation rates (Bebenek et al., 1992; Pang et al., 2011). Enzymatic defects, perturbing the 
purine metabolism further cause a large number of human diseases by metabolic 
dysfunctions (van Gennip et al., 2006). Furthermore some of those compounds exhibit 
additional functions as flavor-enhancing agents (inosine monophosphate (IMP) and 
guanosine monophosphate (GMP) (Halpern, 2002; Shimaoka et al., 2005)), putting them 
into focus of biotechnological manufacturing. Particularly the biotechnological production 
using Corynebacteria (e.g. Corynebacterium ammoniagenes) has been successfully 
performed over the past decades (Abbouni et al., 2004; Furuya et al., 1968; Furuya et al., 
1969; Furuya et al., 1970). Flavor-enhancing agents are defined as compounds not 
possessing a taste on their own but amplifying that of other substances. Thereby, the purine 
5-ribonucleotides IMP and GMP synergistically increase the savory taste associated with 
meat, cheese or seafood (umami taste), generated by small amounts of L-glutamate added 
to food (Abbouni et al., 2004; Halpern, 2002).  
In sharp contrast to the development of amino acid producing strains – for example for 
lysine or glutamate biosynthesis – which have been derived mostly by (targeted) metabolic 
engineering (Wendisch et al., 2006a), the microbial production of IMP and GMP has been 
(and still is) relying on classical strain optimization applying random mutagenesis and 
screening (Mori et al., 1997; Shimaoka et al., 2007; Teshiba and Furuya, 1989). Thus, 
genetic perturbations allowing increased secretion of those compounds and hence 
regulation and linkage of this essential pathway branch with the central metabolism are not 
known in detail, promoting this subject into focus of systems biotechnological research.  
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Aim and outline of the thesis 
 
 
The objective of this research project aimed towards an in-depth analysis of the purine 
biosynthetic pathway of the Gram-positive soil bacterium Corynebacterium glutamicum. 
This microorganism, exhibiting an extraordinary significance within the field of 
biotechnology, provides on one side a powerful and complex platform for industrial 
processes (Becker and Wittmann, 2012); on the other side, due to its close scientific study 
and increasing elucidation of global regulatory structures and interactions within the cell, it 
serves as a model organism in systems biotechnology targeting the ultimate understanding 
of its metabolic and regulatory potential (Burkovski, 2008; Eggeling and Bott, 2005).  
While one section of this thesis focused on global understanding of the essential pathway 
of the purine metabolites, another section studied the requirements and consequences of 
increased intracellular concentrations of the industrially relevant purine intermediate 
inosine 5-monophosphate (IMP), investigating regulatory parameters and the 
interconnection of this pathway with the central metabolism. Thereby, far-reaching 
connection of terminal and central pathways via mutual precursor molecules like ATP, 
NADH or NADPH – system multiplayers – but also the unique complexity of this pathway 
within the whole metabolic network should be outlined, employing metabolomic and 
fluxomic analyses.  
Each chapter thereby tackles a particular problem or challenge. In addition, result parts of 
this thesis are summarized in two separate parts (Part I and II), particularly depicting 
utilization of alternate carbon sources: whereas cultivations performed on glucose as sole 
carbon source were studied in Part I, metabolization of complex medium supplements, i.e. 
peptone was investigated in Part II. 
A general introduction is outlined in Chapter I. 
In Chapter II the organism Corynebacterim glutamicum, its physiological principles – 
especially focusing on the purine biosynthetic pathway and its interconnection to the 
central carbon metabolism – and analytical approaches for the investigation of the 
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metabolome and fluxome are described. Furthermore, fundamentals for targeted genetic 
engineering of this bacterium are outlined. 
In the initial chapter of Part I (Chapter III), the challenge of an adequate, reproducible, 
sensitive and selective analytical platform for quantitative determination of purine 
intermediates, i.e. targeted metabolite profiling, was addressed. In particular, the question 
for a suitable extraction procedure, ensuring maintenance of unchanged, intracellular in 
vivo concentrations was raised. Usage of a high-sensitive and selective detection system, 
ESI-MS/MS, set the basis for further in-depth analyses of different C. glutamicum mutant 
strains performed in Chapter IV. In this chapter, a metabolic engineering strategy was 
realized, focusing on the rigidity analysis of the pathway branch of the purine 
intermediates. Furthermore, influences arising from readjustment processes of the central 
metabolism, i.e. increased activity of the pentose phosphate pathway due to genetic 
perturbations were addressed and studied based on physiological analyses, targeted 
metabolite profiling and fluxomics. This allowed the identification of basic regulatory 
patterns, e.g. impacts emanating from a perturb ATP generation capacity.  
Chapter V addressed the problem of deleting the key enzyme glucose 6-phosphate 
isomerase, targeting an increased precursor availability of ribose 5-phosphate, 
simultaneously detracting the flexibility and adaptation capabilities of the metabolic 
network. Effects on the intracellular purine distributions determined and analyzed in 
Chapter IV, were addressed in Chapter V with respect to the overall growth 
performance, especially focusing on the specific growth rates, and redox state of different 
deletion mutants of C. glutamicum. The focus thereby was the elucidation of the impact on 
the central metabolism emerging from targeted improvements of the purine precursor 
supply of ribose 5-phosphate, pursued by the deletion of the pgi gene. 
In Part II, glucose-decoupled growth and intracellular purine accumulation of a site-
directed C. glutamicum mutant strain (C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi) were 
investigated (Chapter VII), a response to the observations obtained in previous chapters, 
especially Chapters III and IV. The objective was to investigate the intracellular 
alteration of metabolite concentrations and their distributions as well as that of carbon 
fluxes of the purine accumulating strain C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi. 
The corresponding wild type strain served as reference and was used to implement a 
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suitable method to study dynamic metabolic flux redistributions on complex media 
(Chapter VI).  
Finally reflections, summarizing the results obtained in this thesis, and prospects for future 
analyses are presented and discussed in Chapter VIII, illustrating that new insights had 
been gained but also new questions have been raised. 
 13 
Chapter II 
 
Theoretical principles 
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C. glutamicum and its significance within the field 
of systems biotechnology 
 
 
The Gram-positive microorganism Corynebacterium glutamicum belongs to the family of 
the Corynebacteriaceae, a heterogeneous group within the actinomycetes subphylum 
(Liebl, 2005; Stackebrandt et al., 1997). Besides the human pathogenic species 
Mycobacterium tuberculosis, Mycobacterium leprea and Corynebacterium diphteriae 
(Tauch et al., 2002), the family of Corynebacteriaceae comprises commercially relevant 
species e.g. C. glutamicum and C. ammoniagenes (Hirasawa et al., 2000). 
 
 
 
 
Figure II-1. Electron microscopical image of the soil bacterium Corynebacterium glutamicum 
(source: DBU (Deutsche Bundesstiftung Umwelt; http://www.dbu.de/533bild14952__1959.html).  
 
 
 
The rod-shaped, non-sporulating, aerobic, non-motile soil bacterium C. glutamicum 
(Figure II-1) characterized by a high GC content (Pfefferle et al., 2003) and the “GRAS” 
status (generally regarded as safe) has first been discovered in Japan in 1957 as natural 
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producer of the amino acid L-glutamate (Kinoshita et al., 1957; Udaka, 1960). It requires 
biotin for growth (Schneider et al., 2012) and can be isolated from various ecological 
niches (Liebl, 2005). Since then this microorganism started its advancement within 
systems biotechnology, writing a remarkable success story (Becker and Wittmann, 2012) 
as one of today’s most important bacterial species for biotechnological production 
(Burkovski, 2008). Its product portfolio comprises various compounds e.g. amino acids, 
flavors, diamines, polymers but also biofuels, further driven by systems metabolic 
engineering concepts (Becker and Wittmann, 2012). In addition to its conversion 
capabilities, this organism is characterized by low nutritional requirements.  
Since its discovery numerous production strains have been created empirically by random 
mutagenesis and selection (Sahm et al., 2000; Vallino and Stephanopoulos, 1994). 
Although being successful in the past, these approaches have the huge disadvantages of 
high labor and resource intensities due to the associated trial and error principle, and the 
fact that the phenotype-modifying alterations of the genome remain unknown. 
Furthermore, the pronounced accumulation of undesired mutations leads to weak and 
slowly growing strains (Ohnishi et al., 2002). 
The determination of the genome sequence in 2003 (Ikeda and Nakagawa; Kalinowski et 
al.), marked an essential advancement and allowed the transition from so-far untargeted 
approaches towards rational strain optimization by metabolic engineering, driven by global 
analytical techniques – the omic platforms – promoting a fundamental understanding of the 
underlying cellular concepts.  
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Fundamentals of metabolic physiology 
 
 
The metabolism of cellular systems is a complex, highly intertwined network of 
interactions, linking central and terminal metabolic branches while maintaining 
comprehensive and selective regulation mechanisms. Thus, in order to understand the 
concept behind proper and improper functioning, extensive in-depth analyses are required. 
The metabolic branch of the purine biosynthesis involves several pathway branches, 
supplying the essential precursor molecules i.e. ribose 5-phosphate, glutamine, glycine, C1 
groups derived from tetrahydrofolate derivates, aspartate, as well as energy and reduction 
power. In addition, the synthesis of these compounds can be accomplished by two distinct 
biosynthetic routes: the de novo pathway – assembly of the corresponding purine bases 
directly onto the carbon skeleton of the precursor ribose 5-phosphate – and the salvage 
pathway – recycling of intact purine bases, either obtained by degradation of nucleotides or 
by extracellular supplementation, and attachment to 5-phosphoribosyl 1-pyrophosphate 
(PRPP). 
 
 
 
Purine biosynthetic pathway 
 
De novo nucleotide synthesis starts with the activation of the PPP intermediate and direct 
precursor ribose 5-phosphate (R5P) to 5-phosphoribosyl 1-pyrophosphate (PRPP) 
(Messenger and Zalkin, 1979), which is further converted to IMP in a twelve-step 
biosynthetic pathway (Figure II-2).  
This step, catalyzed by the ribose-phosphate pyrophosphokinase (PrsA, EC 2.7.6.1) is 
further accompanied with the conversion of 1 molecule ATP to AMP. The next step 
catalyzed by the amidophosphoribosyltranferase (PurF, EC 2.4.2.14) represents a 
transamination reaction with glutamine acting as amino group donor. This rate-determining 
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step of the purine biosynthesis is controlled by a synergistic feedback-inhibition of the two 
end products AMP and GMP, acting as competitive inhibitors with respect to PRPP 
(Messenger and Zalkin, 1979). Thereby, GMP exhibits the highest inhibition efficiency. 
The corresponding product 5-phosphoribosylamine (PRA) is converted to glycineamide 
ribonucleotide (GAR) by glycineamide ribonucleotide synthetase (PurD, EC 6.3.4.13) 
concomitantly consuming 1 molecule glycine and 1 molecule ATP. The transfer of a 
formyl group derived from N10 formyltetrahydrofolate by GAR transformylase (PurN, EC 
2.1.2.2) completes the successive reaction to formylglycineamide ribonucleotide (FGAR). 
FGAR is then converted to phosphoribosyl formylglycineamidine (FGAM) by FGAM 
synthetase (PurL, EC 3.6.5.3) utilizing 1 molecule ATP and 1 molecule glutamine. The 
hydrolysis of 2 molecules ATP and the incorporation of 1 molecule hydrogencarbonate 
represent the two successive reaction steps catalyzed by AIR synthetase (PurM, EC 
6.3.3.1) and N5-CAIR synthetase (PurK, EC 6.3.4.18), respectively. N5-CAIR mutase 
(PurE, EC 5.4.99.18) catalyzes the isomerisation of N5-CAIR (N5-carboxyaminoimidazole 
ribonucleotide) into carboxyaminoimidazole ribonucleotide (CAIR). The conversion of 
CAIR into SAICAR (phosphoribosylaminoimidazole succinocarboxamide) is catalyzed by 
SAICAR synthetase (HemH, EC 6.3.2.6) consuming 1 molecule aspartate and 1 molecule 
ATP. Adenylosuccinate lyase (PurB, EC 4.3.2.2) catalyzes the reaction to AICAR 
(phosphoribosylaminoimidazole carboxamide) releasing fumarate. The final carbon atom 
is added from formyltetrahydrofolate by AICAR formyltransferase/ IMP cyclohydrolase 
(PurH, EC 2.1.2.3) generating formamido phosphoribosylimidazole carboxamide 
(FAICAR) that is finally converted to inosine 5-monophosphate (IMP). 
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Figure II-2. Purine biosynthetic pathway in C. glutamicum comprising reactions end 
corresponding enzymes from de novo (A.) and salvage pathway (B.). Origin of base ring atoms is 
illustrated in (C.). 
 
AMP and GMP are derived from IMP via two-step biosyntheses (Pang et al., 2011; Saxild 
and Nygaard, 1991): synthesis of AMP starts via the conversion to adenylosuccinate by 
adenylosuccinate synthase (PurA, EC 6.3.4.4) in the presence of aspartate and GTP. 
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Adenylosuccinate is further converted to AMP by adenylosuccinate lyase (PurB, EC 
4.3.2.2) releasing in addition 1 molecule of fumarate. GMP is generated via the reactions 
of IMP dehydrogenase (GuaB2, EC 1.1.1.205) and GMP synthase (GuaA, EC 6.3.5.2), 
leading to XMP (in the presence of 1 molecule NAD+) and GMP and glutamate (in the 
presence of ATP and glutamine), respectively.  
Due to the complexity of the underlying biosynthetic process, the atoms contained in the 
purine ring are derived from various precursor molecules (Figure II-2) highly 
interconnecting this pathway with the central carbon metabolism and – due to the high 
demand of ATP (10 mol ATP for 1 molecule IMP starting from glucose) – with the energy 
metabolism. 
 
 
 
Central carbon metabolism 
 
The central carbon metabolism fulfills the task to constantly meet the demand for carbon 
precursors and cofactors draining the intracellular metabolite pools and supplying the 
anabolic pathways. Varying demands, e.g. caused by altered product syntheses or a 
changing availability of carbon sources, lead to flux redistributions and fine-tunings of the 
metabolic activities to assure the sufficient supply for precursor and cofactor molecules 
(NADH, NADPH and ATP). The metabolic flexibility and adaption potential to varying 
environmental conditions allows C. glutamicum to utilize several carbon sources. 
Carbohydrates as glucose, fructose and sucrose are taken up by phosphotransferase 
systems (PTS) (Dominguez et al., 1998; Moon et al., 2005; Moon et al., 2007; Mori and 
Shiio, 1987). In addition, lactate and mannose as well as organic acids e.g. acetate can be 
used as carbon sources (Gourdon et al., 2000; Neuner and Heinzle, 2011; Veit et al., 2009).  
The central metabolism of C. glutamicum comprises the metabolic pathways of glycolysis, 
pentose phosphate pathway (PPP), tricarboxylic acid (TCA) cycle and anaplerosis (Figure 
II-3).  
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Figure II-3. Central carbon metabolism of Corynebacterium glutamicum including glycolysis, 
pentose phosphate pathway (PPP), TCA cycle, C3/C4 metabolism (anaplerosis), C1 metabolism 
(simplified), purine biosynthesis and biosynthetic pathways of amino acids required for purine 
biosynthesis (glycine, glutamine and aspartate).  
 
The latter includes the two C3-carboxylating enzymes phosphoenolpyruvate carboxylase 
(Ppc, EC 4.1.1.31) and pyruvate carboxylase (Pyc, EC 6.4.1.1), replenishing the TCA 
cycle at the level of OAA (Eikmanns et al., 1989; Sauer and Eikmanns, 2005). The 
glyconeogenic C4-decarboxylating enzymes phosphoenolpyruvate carboxykinase (Pck, EC 
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4.1.1.32), OAA-decarboxylase (Oad, EC 4.1.1.3) and malic enzyme (MalE, EC 1.1.1.40) 
contribute to refill the PEP/pyruvate pools (Gourdon et al., 2000; Jetten and Sinskey, 1993; 
Jetten and Sinskey, 1995; Netzer et al., 2004a; Sauer and Eikmanns, 2005). Glucose uptake 
in C. glutamicum is generated via a PEP-dependent phosphotransferase system (PTSGlc). 
Thereby, glucose is phosphorylated and enters the glycolysis as glucose 6-phosphate (Mori 
and Shiio, 1987; Parche et al., 2001; Yokota and Lindley, 2005). The required phosphate 
group is derived from PEP. The glucose uptake is thus linked to the availability of PEP and 
glucose uptake might be constricted under PEP limitations. 
 
With ribose 5-phosphate representing the starting point for the purine biosynthesis – the 
purine ring system is assembled onto this molecule – the activity of the PPP for supply of 
this initial precursor is crucial. In addition, serine as precursor for glycine synthesis and 
also serving as linking point to the C1 (tetrahydrofolate-) metabolism, is generated during 
glycolysis. Aspartate and glutamate are synthesized in the TCA cycle. Besides the supply 
of precursors, glycolysis generates 2 mol ATP and 2 mol NADH per mol glucose; TCA 
cycle delivers 3 mol NADH, 1 mol FADH2 and 1 mol GTP. One key enzyme of the TCA 
cycle is the strictly NADP+-dependent isocitrate dehydrogenase (Icd, EC 1.1.1.42) 
controlling the flux activity of this pathway branch while supplying NADPH and α-
ketoglutarate (Eikmanns et al., 1995). In C. glutamicum NADPH supply is provided by 4 
strictly NADP+-dependent enzymes, located in the PPP – glucose 6-phosphate 
dehydrogenase (Zwf, EC 1.1.1.49) and 6-phosphogluconate dehydrogenase (Gnd, EC 
1.1.1.44) – the TCA cycle – isocitrate dehydrogenase – and anaplerosis – malic enzyme 
(Gourdon et al., 2000; Marx et al., 1996; Sugimoto and Shiio, 1987a; Sugimoto and Shiio, 
1987b). With respect to the purine biosynthesis, especially ATP generation is one of the 
key points as 1 molecule IMP – the initial purine nucleotide – consumes 10 mol ATP 
starting from glucose. Furthermore, the intracellular distribution of the purine 
intermediates is reported to be influenced by the ATP supply. Diminished ATP supply 
thereby provokes a metabolic shift towards degradation products (Noguchi et al., 2003). In 
C. glutamicum NADH generated in different pathway branches, is oxidized by oxidative 
phosphorylation and used for ATP formation. In contrast to the utilization of NADH, usage 
of NADPH in an energy-generating function has, so far, not been described for 
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C. glutamicum. A NADPH oxidizing capacity of the respiratory chain, i.e. the NADH-
ubiquinone-1 oxidoreductase, however has been suggested by Matsushita et al. (2001). 
 
 
 
 
 
 
Metabolic engineering toolbox 
 
 
Recent developments of novel molecular biology tools (genetic engineering) provide the 
capability to control but also to understand and link cellular properties with corresponding 
genetic perturbations. In addition, while entering the post genome era, high throughput 
sequencing techniques and improvements of bioinformatic tools in data mining allow the 
elucidation of genetic repertoires of diverse biological systems (Wendisch et al., 2006b) 
leading from local pathway identification towards global phenotype analysis (Ikeda and 
Nakagawa, 2003). Techniques of proteomics and transcriptomics are undergoing rapid 
developments and facilitate the determination of regulatory function mechanisms. In 
combination with quantitative metabolomics and fluxomics, these techniques depict a 
global approach to perform in-depth system profiling (Dunn, 2008; Ikeda and Nakagawa, 
2003; Nielsen et al., 2003; Niklas and Heinzle, 2011; Niklas et al., 2010) (Figure II-4).  
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Figure II-4. Schematic illustration of the metabolic engineering toolbox comprising the different 
omic platforms: Targeting the understanding of complex metabolic networks and their regulatory 
pattern, systems bio(techno)logy represents a global and integrative approach. 
 
 
 
Quantitative metabolomics  
Linking genotypes and phenotypes 
 
While focusing on the study of different hierarchical levels, which comprise 
comprehensive regulatory actions (Nielsen and Oliver, 2005), especially the metabolome 
exhibits distinct advantages for investigating phenotypes (Dunn, 2008; Klein and Heinzle, 
2012). As final downstream product of the genome, the metabolome – next to the fluxome 
– is seen to be closest to describing the actual phenotype. The study of metabolites and 
their concentration changes due to altered physiological states, e.g. caused by genetic 
perturbations or varied environmental conditions, provides valuable insights into 
regulatory principles as well as the interconnectivity of biological systems.  
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With the development of MS-based analytical platforms e.g. LC-MS, LC-MS/MS, CE-MS, 
GC-MS or GC-TOF, which provide the capabilities for high-sensitive multi-analyte 
determination, metabolomics progressed into a mainstream science (Dunn, 2008; Shulaev, 
2006; Sumner et al., 2003). The high accuracy and selectivity of the applied analytical 
platforms allow the quantitative determination of molecules even in complex biological 
matrices such as cell extracts. 
 
Due to the complexity and size of the metabolome, analytical procedures might be 
restricted to a defined metabolic “section”. The investigation of an isolated pathway is 
thereby described as targeted metabolite profiling. Metabolite target analysis (Fiehn, 
2002) solely describes the analysis of a small number of predefined metabolites e.g. 
exclusive analysis of the corresponding substrates and products of a targeted reaction 
(Figure II-5). Such punctual investigations drastically reduce the analytical requirements in 
contrast to a whole metabolome analysis (metabolomics) (Dunn, 2008) but still elucidate 
limiting and inhibiting effects or simply provide metabolite concentrations, that can be 
optimized in an iterative strain improvement process (Buchholz et al., 2002). The field of 
metabolomic analyses finds important applications in bioscience, e.g. profiling whole 
metabolomes, performing profile comparisons or analyzing dynamic cell behavior. 
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Figure II-5. Targeted metabolite profiling of a biological system representing two distinct 
physiological states with differential metabolite concentrations and metabolic fluxes (based on 
Sauer and Zamboni (2008)). 
 
In order to actually represent physiological states of biological systems, the extraction of 
metabolites has to maintain the in vivo conditions. Thus extraction-based degradation, 
insufficient extraction efficiency and enzymatic conversions due to an inadequate arrest of 
metabolic activity have to be prevented (for further references see Chapter III). 
Based on the interconnectivity of the various reactions within metabolic systems, small – 
sometimes not even detectable – perturbations of the fluxome can cause significant 
changes of the metabolome (de Koning and van Dam, 1992; Nielsen and Oliver, 2005). 
Thus metabolome data represent the ultimate, integrative response to genetic or 
environmental alterations (Villas-Boas et al., 2005), but concomitantly are themselves 
functions of metabolic fluxes and participating enzymes representing a crucial feedback 
regulation imposed on the system (Nielsen, 2003) (Figure II-5). 
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Fluxomics 
Principles of metabolic flux analysis 
 
Metabolic flux analysis (MFA) is a generally applicable characterization method in the 
field of metabolic engineering, targeting the quantitative analysis of intracellular carbon 
fluxes of a predefined metabolic network (Wittmann and de Graaf, 2005). While 
metabolome analyses provide data about various reactants (metabolites) and their pool 
sizes present in biological systems, fluxome analyses (fluxomics) describe the reactions 
interconnecting these molecules with each other. Thus, in vivo quantitation of intracellular 
fluxes further improves the in-depth analysis of physiological systems and in combination 
with metabolite data, represents a powerful tool to determine kinetic regulatory principles. 
Over the past years, MFA greatly contributed to identifying novel pathways or metabolic 
bottlenecks, improving strain optimizing processes and to the analysis of regulation and 
structural design of metabolic systems (Beste et al., 2011; Bonarius et al., 1996; Fong et 
al., 2006; Tang et al., 2008). Due to the presence of common metabolites as ATP, NADH 
or NADPH, the various metabolic pathways exhibit a high degree of interconnectivity. As 
a result, flux alterations affecting one distinct pathway branch disseminate to other parts, 
provoking a global network response (Nielsen, 2003). 
 
Quantitation of intracellular flux rates, which represent time-dependent conversing 
reactions and are thus not directly measureable (Noh and Wiechert, 2011), can be 
performed using two approaches: metabolite balancing or 13C MFA (Stephanopoulos, 
1998; Stephanopoulos et al., 1998; Wittmann and de Graaf, 2005).  
A detailed description of approach-specific advantages and disadvantages is given in 
Chapter VI, also covering basic principles. The following section only addresses the 
fundamental and analytical principles for the usage of isotope-labeled substrates. A 
detailed description of computational modeling and mathematical optimization algorithms 
is given by Yang et al., 2008 and 2009.  
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As explained in Chapter VI, metabolization of isotope-labeled substrates, e.g. 13C labeled 
glucose, leads to the distribution of the labeled carbon atoms throughout the entire 
metabolic network, resulting in stable (fluxome-) specific isotopic enrichment of cellular 
components – macromolecules as well as free intermediates (Wittmann, 2002). In the field 
of isotope-base MFA, usage of 13C labeling is the most prominent, as carbon transfer 
reactions within a biological network are exactly defined by the enzyme specificities and 
are in addition very well studied (Wittmann, 2002; Yang et al., 2009). The specific labeling 
patterns can be analyzed by NMR (nuclear magnetic resonance) or MS (mass 
spectrometry) (Wittmann, 2002). The combination of measured extracellular fluxes, i.e. 
biomass and by-product formation, and determined labeling pattern of metabolites, allows 
the computational estimation of intracellular carbon fluxes overcoming the limitations 
representative for sole metabolite balancing (Wittmann and de Graaf, 2005). Based on the 
isotopomer distributions of the individual metabolites and the corresponding metabolic 
network, the relative reaction activities generating those distributions can be calculated 
(Wittmann and Heinzle, 1999). This includes important physiological parameters e.g. the 
flux partitioning at the glucose 6-phosphate node (de Graaf et al., 2001). In order to 
determine proper flux distributions, the existence of other stable isotopes other than 13C has 
to be corrected for (Fernandez et al., 1996; van Winden et al., 2002; Wittmann and 
Heinzle, 1999). 
The term isotopomer – composed of the two terms isotope and isomer (Schmidt et al., 
1997) – thereby describes the labeling state of a metabolite (Malloy et al., 1988; Wiechert, 
2001). Isotope enrichment analysis carried out by mass spectrometry can resolve single 
mass isotopomers, while NMR allows for the differentiation between positional 
isotopomers (Wittmann and de Graaf, 2005). Positional isotopomers are thereby described 
by uniquely determined labeling patterns of the molecule (Christensen and Nielsen, 1999) 
i.e. the specific number of the labeled carbon atoms (13C atoms) at specific positions within 
the molecule is defined (Wittmann and de Graaf, 2005). Mass isotopomers however, solely 
describe the number of 13C atoms within the molecule but not their exact positions. In 
conclusion, a positional isotopomer distribution precisely determines the corresponding 
mass isotopomer distribution while the mass isotopomer distribution only impose certain 
constraints but does not deliver a unique solution for the corresponding positional 
isotopomer distribution (Christensen and Nielsen, 1999). This principle has to be 
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considered during the parameter estimation process i.e. it has to be specified if either mass 
(MDVs) or isotopomer distribution vectors (IDVs) are used (Figure II-6) or an IDV has to 
be converted into a MDV (Wittmann, 2002). 
 
 
 
Figure II-6. Positional and mass isotopomers with corresponding IDV and MDV exemplarily for 
a molecule comprising 3 carbon atoms (white circles illustrate 12C, black circles illustrate 13C; 
based on Wittmann (2002)). Arrows represent conversion (grouping) of different positional 
isotopomers into mass isotopomers. Fractions of individual mass and positional isotopomers add up 
to 1.  
 
 
The carbon transition network, in form of an atom mapping matrix (AMM), precisely 
defines the transfer of the individual carbon atoms from reactants to products (Zupke and 
Stephanopoulos, 1994). AMMs thereby depict m x n matrices with m representing the 
carbon atoms of the product and n those of the substrate. The reaction catalyzed by 
pyruvate carboxylase, converting pyruvate and CO2 to OAA is highlighted as illustrative 
example (equation 1, [1]). A carbon transfer from the educt to the corresponding position 
of the product is indicated by the element 1. In 1997, isotopomer mapping matrices (IMM) 
were introduced by Schmidt et al. (1997). IMMs define the precise transfer of the 
positional isotopomers of a substrate to the corresponding product and can be deduced 
from the corresponding AMM (Wittmann, 2002). The m x n AMM is thereby converted 
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into a 2m x 2n IMM with m corresponding to the number of carbon atoms of the product 
and n to those of the substrates. 
 
 
 
 
The combination of the isotopomer distribution vectors (IDV) – comprising information 
about the experimentally determined labeling pattern – and the isotopomer mapping 
matrices (IMMs) – comprising information about the carbon transfer based on the 
underlying enzymatic reactions – are further used to solve the complex equation system 
(Schmidt et al., 1997). For a description of the parameter estimation and the mathematical 
modeling see Yang et al., 2008 and 2009.  
 
The experimental principle of 13C MFA is depicted in Figure II-7. Incorporation of the 
stable 13C carbon isotope into cellular components e.g. into cellular protein, is 
accomplished by cultivations performed on 13C labeled glucose. The corresponding MDVs 
are determined by e.g. GC-MS after isotopic steady state of the corresponding metabolites 
was reached (stationary MFA (Noack et al., 2011)). In combination with additionally 
determined physiological parameters, i.e. biomass and by-product formations, flux 
calculations are performed. The unknown flux activities are estimated, fitting simulated 
isotopomer distributions to those experimentally determined via an optimizing algorithm 
(Wittmann, 2007; Yang et al., 2008).  
 
[1]
Chapter II   -   Theoretical principles
 
30 
 
 
Figure II-7. Schematic representation of the strategy for 13C metabolic flux analysis: the 
experimental part comprises tracer experiment(s) and the determination of the corresponding 
labeling pattern by GC-MS; the computational part comprises the simulation of the labeling pattern 
(based on Wittmann (2007)). 
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Genetic engineering 
Principles of strain construction 
 
Traditional strain optimizing processes of the last century were primarily based upon 
classical mutagenesis and selection (Rowlands, 1984). One of the most crucial 
disadvantages of these processes is the fact that genetic alterations triggering the “superior 
qualities” remained unknown (Sahm et al., 2000). This depicted a huge challenge for 
further optimizations as neither identified beneficial properties could be combined, nor 
“unwanted” – often harmful – modifications could be eliminated. Decryption of the 
C. glutamicum genome sequence in 2003 (Kalinowski et al.) and development of methods 
for recombinant DNA technology marked the advent of targeted mutagenesis approaches 
(Eggeling et al., 1997; Ikeda, 2003; Sahm et al., 1995). Targeted genetic perturbations 
further provide the basis for the elucidation of genotype-phenotype relationships (Dunn, 
2008) and are therefore an indispensable tool within the field of metabolic engineering. 
The portfolio of genetic engineering tools i.e. amplification and over expression (Neuner 
and Heinzle, 2011), deletion (Mascarenhas et al., 1991), introduction of point mutations 
(Becker et al., 2007; Kim et al., 2006) or foreign DNA (heterologous gene expression) as 
well as codon optimization (Kind et al., 2010), offered new opportunities for targeted strain 
optimization (Sahm et al., 1995). The introduction of stable genetic modifications of the 
chromosome, which are maintained and passed on without the need for selective pressure, 
can be accomplished by homologous recombination employing integrative plasmids 
(Tauch et al., 2002). Theses plasmids are characterized by an origin of replication (ori) for 
E. coli but not for the organism to be modified e.g. C. glutamicum. Two selection markers 
– additionally encoded within the plasmid DNA sequence – allow the identification of two 
(separate) recombination events: the KanR selection marker, conferring resistance to 
kanamycin, is employed for the selection of the first recombination event which leads to 
the integration of the whole plasmid DNA into the genome. The second selection marker, 
the sacB positive selection system introduced by Jager et al. (1992) facilitates the 
identification of the second recombination event. Thereby, the sacB gene sequence 
encoding for the exoenzyme levansucrase from Bacillus subtilis catalyzes the conversion 
of sucrose into levan that is lethal to C. glutamicum. The presence of sucrose in the 
corresponding media will lead to the cell death of transformants still containing the 
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plasmid DNA and expressing the sacB gene. Thus, solely cells that performed the double 
crossover event i.e. the second recombination randomly initiated without selective 
pressure, and eliminated the plasmid DNA from the genome, are selected (Nesvera and 
Patek, 2011). 
The first step comprises the design of the targeted genetic modification: performing a 
SOE-PCR (splicing by overlapping extension, (Ho et al., 1989)) hybrid-DNA molecules 
are constructed (Figure II-8).  
 
 
Figure II-8. Fusion (SOE) PCR: connection of two separate DNA molecules. Primer 2 and primer 
3 exhibit complementary DNA sequences to each other, while primer 1 und 4 are complementary 
to the corresponding 3’ and 5’ ends of the gene(s) additionally comprising specific restriction sites. 
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Therefore specific primers (1 and 4) – complementary to the 3’ and 5’ ends of the gene(s) 
– and in addition fusion primers (2 and 3) – exhibiting complementary DNA sequences to 
each other – are used. In the first two PCR reactions (primer pairs 1-2 and 3-4) overlapping 
complementary extensions are created. These overlaps are used in the third PCR reaction 
to fuse the two single PCR segments. Existence of differential restriction sites, contained 
and attached by primers 1 and 4, allows a targeted ligation into the integrative vector. This 
vector is then amplified in E. coli employing the selection marker KanR. After isolation 
from E. coli, the plasmid is transferred into the recipient C. glutamicum by electroporation 
(Kirchner and Tauch, 2003; Tauch et al., 2002) where the two recombination events take 
place (Figure II-9).  
 
 
 
Figure II-9. Implementation of stable genetic modifications by homologous recombination in 
C. glutamicum.
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In order to avoid degradation of the introduced (foreign) DNA and to increase the 
transformation efficiency (Bonamy et al., 2003; Bonnassie et al., 1990; Tzvetkov et al., 
2003) the plasmid is methylated in E. coli using an additional plasmid (pTC) carrying the 
corynespecific methyltransferase gene. After the second recombination event – the 
complete removal of the plasmid DNA from the genome of C. glutamicum – either the 
native (wild type) or the manipulated gene sequence are eliminated, yielding either wild 
type cells or site-directed mutants. 
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PART I 
 
Phenotype characterization on 
minimal medium 
 
 
 
 
The following chapters of Part I present results obtained from cultivations on a defined, 
fully synthetic medium with glucose as the sole carbon source. Metabolic behavior of 
different genetically engineered Corynebacterium glutamicum strains was investigated, 
starting with the implementation of a suitable analytical procedure for quantitative 
metabolite profiling of the purine biosynthetic pathway. Modifying the genetic background 
of this organism resulted in a complete metabolic shift and uncovered essential regulatory 
processes, that monitor and control the distribution patterns of the purine intermediates.  
Furthermore, adverse effects on the overall growth performance were determined, which 
were related to the deletion of the glucose 6-phosphate isomerase (pgi), interrelating the 
terminal pathway branch of the purine metabolites with the central metabolism. These 
topics are described in the following chapters: 
 
 Quantitation of intracellular purine intermediates in different Corynebacteria using 
electrospray LC-MS/MS (Chapter III). 
 Metabolic engineering of the purine biosynthetic pathway in Corynebacterium glutamicum 
results in increased intracellular pool sizes of IMP and hypoxanthine (Chapter IV). 
 Restriction of the metabolic flexibility due to pgi gene deletion triggers a unique adaptation 
process in C. glutamicum involving increased oxygen uptake (Chapter V). 
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Chapter III 
 
It is all about numbers 
Quantitation of intracellular purine intermediates in different 
Corynebacteria using electrospray LC-MS/MS 
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Abstract* 
 
 
Intermediates of the purine biosynthesis pathway play key roles in cellular metabolism 
including nucleic acid synthesis and signal mediation. In addition, they are of major 
interest to the biotechnological industry as several intermediates either possess flavor-
enhancing characteristics or are applied in medical therapy. In this study, we have 
developed an analytical method for quantitation of 12 intermediates from the purine 
biosynthesis pathway including important nucleotides and their corresponding nucleosides 
and nucleobases. The approach comprised a single-step acidic extraction/quenching 
procedure, followed by quantitative electrospray LC-MS/MS analysis. The assay was 
validated in terms of accuracy, precision, reproducibility and applicability for complex 
biological matrices. The method was subsequently applied for determination of free 
intracellular pool sizes of purine biosynthetic pathway intermediates in the two Gram-
positive bacteria Corynebacterium glutamicum and Corynebacterium ammoniagenes. 
Importantly, no ion pair reagents were applied in this approach as usually required for 
liquid chromatography analysis of large classes of diverse metabolites. 
 
 
 
 
 
 
 
 
 
* In press: 
Peifer S, Schneider K, Nürenberg G, Volmer DA, Heinzle E.  
Quantitation of intracellular purine intermediates in different Corynebacteria using electrospray LC-MS/MS. 
Anal Bioanal Chem DOI: 10.1007/s00216-012-6388-6.  
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Introduction 
 
 
Nucleotides and their corresponding nucleosides and nucleobases are essential 
biomolecules and fulfill various functions in the living cell. In addition to being central 
building blocks for DNA and RNA (Traut, 1994), they also act as co-substrates in 
enzymatic reactions, play crucial roles in activating metabolites and serve as signal 
mediators (Cordell et al., 2008). Furthermore, several intermediates of the purine 
biosynthesis pathway exhibit additional characteristics – ranging from flavor-enhancing 
qualities (inosine monophosphate (IMP) and guanosine monophosphate (GMP) (Halpern, 
2002; Shimaoka et al., 2005)) to drug-assisted therapy (e.g. inosine and purine analogues 
(Cohen et al., 2010; Hofmann et al., 2012)). These properties make them attractive targets 
for the pharmaceutical and biotechnological industries. Particularly the fermentative 
production using Corynebacteria (e.g. Corynebacterium ammoniagenes) has been 
successfully performed over the past decades (Abbouni et al., 2004; Furuya et al., 1968; 
Furuya et al., 1969; Furuya et al., 1970). Corynebacterium glutamicum, a most relevant 
industrial producer of amino acids and other metabolites, may serve as a starting organism 
to develop a new, powerful producer strain for purine pathway intermediates. As a result, 
quantifying these substances from biological matrices such as bacteria is crucial to assess 
the potential of the underlying cellular systems.  
The quantitative determination of these compounds, however, is very challenging due to 
their diverse chemical properties (Cordell et al., 2008), the possibility for chemical and 
biological degradation during extraction and sample treatment, and the wide concentration 
range observed in biological systems (Carlucci et al., 1992; Traut, 1994). Over the past 
several decades, quantitation of nucleotide concentrations has been performed by liquid 
chromatography and UV detection. The poor retention of phosphorylated polar substances 
on conventional reversed-phase HPLC columns using mixtures of water and organic 
solvents as mobile phases led to the frequent application of ion-exchange chromatography 
(IEC). IEC using high salt concentrations was first described in the 1950s (Cohn). Long 
run times (Carlucci et al., 1992; Faletto et al., 1997) and incompatibility with mass 
spectrometry however, have limited its application for nucleotide quantification mostly to 
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in vitro studies (Qian et al., 2004). Alternatives are ion suppression HPLC (Witters et al., 
1996) and ion-pairing chromatography (IPC). The latter has been used for many years with 
a broad application range in nucleotide analysis (Buziol et al., 2002; Cai et al., 2002; 
Carlucci et al., 1992; Cohen et al., 2010; Cordell et al., 2008; Gayden et al., 1991; 
Naydenova et al., 2008). The addition of cationic reagents such as alkylamines leads to 
formation of adducts between negatively-charged nucleotides and positively-charged ion 
pair reagent, increasing the retention factors for these compounds and thus improving 
retention. In addition to this classical ion-pairing model, which describes ion formation 
solely as a mobile phase phenomenon, an alternate dynamic ion-exchange model has been 
proposed (Kissinger, 1977) utilizing stationary phase modification processes. Here, 
modification of the stationary phase is attributed to active adsorption of the ion-pairing 
reagent to the stationary phase, in turn modifying its surface charge and providing ion-
exchange sites for analyte ions (Hoffman and Liao, 1977). The extent to which these two 
alternate mechanisms are contributing to analyte retention has been shown to depend on 
experimental conditions (Bidlingmeyer et al., 1979). 
Although HPLC/UV systems have been successfully applied (de Abreu et al., 1982; Gill 
and Indyk, 2007; Werner et al., 1989), the increasing need for higher sensitivity and 
improved selectivity has prompted the use of LC-MS approaches in this field.  
High salt conditions required for strong anion-exchange chromatography (SAX) and the 
non-volatile nature of ion-pairing reagents such as tetraalkylamines and ammonium 
phosphates, are not readily compatible with LC-MS detection systems (Luo et al., 2007; 
Seifar et al., 2009). Thus, new alternative separation methods have been developed 
including HPLC coupled to electrochemical detection (Deng et al., 2003) or CE-MS 
(Auriola et al., 1997).  
Nevertheless, LC-MS remains the method of choice for quantification of nucleotides in 
complex biological matrices. Since even low concentrations of non-volatile ion-pairing 
reagents such as trialkylamines and dialkylamines lead to a contamination of the ion source 
(Witters et al., 1997), careful choice of the ion-pairing reagent is crucial for hyphenation 
ion pair separations to MS (Cordell et al., 2008). Considerable efforts have been made to 
improve the compatibility of ion-pairing reagents for LC-MS over the recent years, usually 
based on volatile ion-pair reagents. This led to simplified routines with significantly 
reduced operator intervention. Even though reduced ion-pair concentrations have been 
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reported by several groups (Cordell et al., 2008; Crauste et al., 2009; Klawitter et al., 2007; 
Yamaoka et al., 2010), developing a method for quantitative determination of nucleotides, 
nucleosides and nucleobases from complex biological samples without any ion-pairing 
reagent has, to our knowledge, not been reported yet. 
The aim of the present study therefore was the development of a LC-MS method for 
targeted metabolite profiling of the purine biosynthesis pathway in bacteria, without the 
need for any ion-pairing reagents in the mobile phase. The assay allowed the quantitative 
determination of 12 intermediates of this pathway in complex biological samples in less 
than 15 min run time. 
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Materials and methods 
 
 
Chemicals and reagents 
99% 13C enriched [U-13C6] glucose was purchased from Cambridge Isotope Laboratories 
(Andover, Mass., USA). Ultrapure water was obtained from a Milli-Q purifier (Millipore, 
Eschborn, Germany) and HPLC-grade acetonitrile was purchased from Sigma-Aldrich 
(Taufkirchen, Germany). All other chemicals and reagents of analytical grade were 
obtained from Sigma-Aldrich (Taufkirchen, Germany). 
 
Standard mixtures, quality control (QC) and biological samples 
Standard mixtures and QC samples 
Standards were prepared for guanosine 5’-monophosphate (GMP), adenosine 5’-
monophosphate (AMP), inosine 5’-monophosphate (IMP), xanthosine 5’-monophosphate 
(XMP), adenosine, guanosine, inosine, xanthosine, adenine, guanine, hypoxanthine and 
xanthine in ultrapure water (1 mM each). Subsequently all compounds were mixed and 
diluted with perchloric acid (PCA, final concentration 500 mM) to give a final 
concentration of 100 µM of each compound. A series of working standard solutions for 
external calibration and a set of quality control (QC) samples were prepared by adding 
increasing amounts of the standard mixture to the 13C-labeled cell extract reaching 
concentration ranges from 0.001 µM to 5 µM. 
 
Biological samples 
Wild type strain Corynebacterium glutamicum (ATCC 13032) and 
Corynebacterium ammoniagenes (DSM 20306) were purchased from the American Type 
Culture Collection (Manassas, VA, USA) and the Deutsche Sammlung von 
Mikroorganismen und Zellkulturen (Braunschweig, Germany). 
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Precultures and main cultures were performed using an orbital shaker (Multitron 2, Infors 
AG, Bottmingen, Switzerland) at 230 rpm and 30°C on minimal medium (pH 7.2) 
containing (per liter): 15 g glucose, 4 g KH2PO4, 16 g Na2HPO4, 500 mg MgCl2 · 6 H2O, 
300 mg 3,4-dihydroxybenzoic acid, 100 mg CaCl2 · 2 H2O, 100 µg cyanocobalamin, 
750 µg thiamine, 4 µg pyridoxal phosphate, 100 µg biotin, 400 µg calcium pantothenate, 
2 µg folic acid, 400 µg nicotinic acid, 200 µg 4-aminobenzoic acid, 400 µg 
pyridoxine · HCl, 2 mg inositol, 10 mg FeCl2 · 4 H2O, 1 mg ZnCl2, 100 µg CuCl2, 20 µg 
NiCl2 · 6 H2O, 20 µg Na2MoO4 · 2 H2O, 500 µg boric acid, 100 µg KI, 100 µg 
CoCl2 · 6 H2O, 10 mg MnCl2 · 4 H2O. Cultures of C. ammoniagenes DSM 20306 were 
supplied additionally with 300 mg L-1 methionine. C. glutamicum and C. ammoniagenes 
main cultures were inoculated from overnight precultures with initial optical densities of 
0.5 and 0.8, respectively (660 nm, Novospec II, Parmacia Biotech, Uppsala, Sweden). 
Cultivations were carried out in 500 mL baffled shake flasks using 10% liquid volume. 
Cells were grown until an optical density of 6.5 and 11.8 for C. glutamicum, and 4.0 and 
8.0 for C. ammoniagenes. During this period cells grew exponentially under balanced 
growth conditions (Provost and Bastin, 2004) and concentrations of internal metabolites 
were expected to be constant assuming a quasi-steady-state.  
 
13C-labeled biomass extract 
Wild type C. glutamicum ATCC 13032 precultures were performed under the same 
conditions as mentioned above, except using [U-13C6] glucose. Cells were grown on [U-
13C6] glucose to an optical density of 4.0 and used as inoculum for the main culture. Main 
cultivations were carried out in a 500 mL stirred tank bioreactor (Meredos, Bovenden, 
Germany) containing 75 mL minimal medium and [U-13C6] glucose at 30°C and 1,000 rpm 
maintaining dissolved oxygen concentrations above 60% air duration throughout the 
cultivation. The gas flow was controlled at 1 vvm (vessel volume per minute) (WMR 
Compact4, Brooks Instruments, Veenedaal, Netherlands) using a nitrogen/oxygen gas 
mixture to avoid CO2 derived 12C incorporation into biomass. Temperature, pH and 
agitation were collected using the Lucullus process control system (Lucullus PIMS 2.1, 
Biospectra, Schlieren, Switzerland). Cells were cultivated until mid-exponential growth 
phase (OD660nm 6.7). 
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Sample preparation and extraction procedure 
Extraction was performed by mixing preheated PCA (55°C, final concentration 500 mM) 
with the sample followed by incubation at 55°C. Exact sample volumes were determined 
gravimetrically. Sampling setups and incubation times varied according to validation 
parameters and nature of samples. 
 
Stability of standard compounds under extraction conditions 
1 mL standard mixture containing all 12 compounds (initial concentration 3 µM each) was 
mixed with 1 mL preheated extraction solution (1 M PCA). Incubation at 55°C was carried 
out for 3, 5, 10 and 30 min, followed by incubation on ice (10 min). Supernatants were 
obtained by centrifugation (10 min, 4°C, 6,000 g), and stored at -20°C until further 
analysis. 
 
Extraction of biological samples  
Biological samples for metabolite profiling were taken at balanced growth during the mid-
exponential growth phase. To ensure instantaneous mixing 2 mL sample were drawn into a 
syringe filled with 2 mL preheated extraction solution. Generated turbulence guaranteed 
instantaneous mixing of sample and extraction solution as verified by colored test solutions 
(phenolphthalein). Incubation at 55°C (3 min) was followed by 10 min incubation on ice. 
Cell debris and insoluble macromolecules were precipitated by centrifugation (10 min, 
4°C, 6,000 g). Prior to the LC-ESI-MS/MS analysis, the naturally labeled cell extracts of 
C. glutamicum and C. ammoniagenes were mixed with uniformly 13C-labeled cell extract 
of C. glutamicum treated under the same conditions (see “13C-labeled biomass extract – 
Materials and Methods”). As a result, the 13C-labeled cell extract served a dual function: 
firstly, by acting as internal standard (IS) providing isotope standard analytes (Wu et al., 
2005) at relevant concentration levels, i.e. at levels of the analytes to be determined. The IS 
corrects for influences of precipitation and degradation on metabolite levels during 
extraction as well as for variabilities during LC-MS injection. Secondly, addition of 
labeled cell extract provided a suitable biological matrix with identical properties to the 
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samples to be analyzed, while still allowing discrimination between the added analytes and 
those naturally present due to isotopic m/z differences. As a result, 13C-labeled cell extract 
was chosen as internal standard and was mixed with standard and sample solutions in all 
experiments, except when the biological matrix was interrogated for matrix effects (see 
below). 
To prevent matrix effects during extraction stability studies, no cell extract was added to 
the samples. 
 
LC-MS/MS conditions 
Liquid chromatography 
Chromatographic separation was carried out using a Phenomenex (Torrance, CA, USA) 
Kinetex reversed-phase PFP core-shell column (2.6 µm pore size, 100 Å particle size, 
100 x 2.1 mm). All separations were performed at 25°C with a constant flow rate of 
200 µL min-1 using a Shimadzu (Duisburg, Germany) UFLC Prominence system. The 
autosampler (SIL20AC) temperature was set to 4°C. Separation of single purine 
intermediates was performed isocratically as proposed by Nichthauser and Stepnowski 
(2009) using 0.1% formic acid in water (eluent A). Solely elution of xanthosine required an 
organic mobile phase (0.1% formic acid in acetonitrile) of the following elution profile: 
after an initial isocratic step at 0% B for 5.5 min, B was increased to 30% within 10 min, 
followed by a flushing step at 100% B for a further 5 min. The column was reconditioned 
at 0% B (initial concentration) for 5 min. The standard injection volume was 1 µL, but was 
increased to 10 µL in some experiments when needed.  
 
Mass spectrometry 
LC-MS/MS analysis was carried out on a API5500 QTRAP quadrupole linear ion trap (AB 
Sciex, Concord, Ontario, Canada) equipped with a Turbo-V electrospray ionization source. 
Nitrogen was used as curtain (20 psi), nebulizer (GS1; 60 psi) and auxiliary gas (GS2; 
60 psi). The ESI voltage was set to 5500 V and a source temperature of 200°C was used. 
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Multiple reaction monitoring (MRM) was performed in positive mode with the following 
parameters: collision gas (nitrogen), medium; dwell time, 250 ms. The declustering 
potentials (DP) and collision energies (CE) were optimized for each MRM transition by 
direct injection of 5 µM standard solution in ACN/water (50/50, v/v) using a syringe pump 
at a constant flow rate of 10 µL min-1 for each metabolite.  
 
Data analysis/ quantitative analysis 
Calibration curves were created by plotting the peak area ratios of analytes and IS, i.e. the 
biological 13C-labeled cell extract, (areacompound/areainternal standard) against the nominal 
concentration of each analyte (µM) in the cell extract and assessed by linear least square 
regression analysis. Analyte concentrations in unknown samples were interpolated using 
the calculated calibration curves. 
 
Validation procedure 
The impact of extraction was validated for metabolite stability and recovery using standard 
solutions. In this procedure, the values of standard concentrations were compared with 
experimentally determined concentrations after the extraction. Time-dependent stability of 
metabolites was assessed at different incubation times at 55°C (3, 5, 10, 30 min). In 
addition, the impact of varying freeze-thaw cycles on compound stability was assessed. In 
these experiments, up to 10 freeze-thaw cycles of standard solutions mixed with 13C-
labeled cell extract to mimic the presence of biological matrix were performed and 
resulting degradation determined.  
The validation procedure for MS quantification included linearity, accuracy, precision, 
lower limit of quantification (LLOQ) and influence of matrix effects.  
For all MS validation procedures, standard solutions at a concentration range between 
1 nM to 5 µM were spiked with biological matrix (13C-labeled cell extract). Precision and 
lower limits of quantification were calculated by determining coefficients of variation    
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(CV %) of standard deviation and measured concentrations of spiked QC samples. 
Accuracy was assessed by comparing the determined concentrations of the spiked QC 
samples with calculated values obtained from standard calibration curves. In this study, 
LLOQ was defined as the lowest concentration for which precision values of 15% or better 
and an accuracy bias of 20% or better were observed. All calibrations were performed in 
the presence of a biological matrix. To investigate long term reproducibility, analysis of 
precision and accuracy was performed over a period of 4 weeks.  
Matrix effects were determined by a post-extraction addition approach (Taylor, 2005). 
Peak areas from extracted standards spiked post-extraction with an extracted biological 
sample (13C-labeled) were compared to extracted standards spiked with diluted extraction 
solution (1:1 dilution in water, v/v). Comparison was carried out for all compounds at two 
different concentration levels, similar to observed concentration levels in biological 
samples analyzed in this study.  
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Results and discussion 
 
 
The present work describes the development of an assay aimed at the quantitation of 12 
important metabolites from the purine biosynthesis pathway of bacteria, namely 5’-
nucleoside monophosphates as well as their corresponding nucleosides and nucleobases.  
Although several reports have investigated quantification of nucleotides and nucleosides in 
mammalian cells, tissues or fluids (Carlucci et al., 1992; Giannattasio et al., 2003; Gill and 
Indyk, 2007; Naydenova et al., 2008; Traut, 1994; Werner et al., 1989), this is, to the best 
of our knowledge, the first assay combining an extraction procedure for Gram-positive 
bacteria with simultaneous quantification of compounds from all three compound classes, 
including IMP, its nucleoside and nucleobase. Turnover rates for intracellular metabolites 
are reported to be within milliseconds (Moritz et al., 2000) and pool sizes are considerably 
small (Wittmann et al., 2004c). Therefore, the first essential step was the quenching of 
cellular metabolism maintaining actual in vivo concentrations and thereby yielding a 
representative metabolic snapshot of the current growth phase of the organism. 
 
Validation of the extraction method 
Metabolic freeze-frame by acidic extraction 
Since Corynebacterium glutamicum belongs to bacteria affected by the unspecific cold 
shock phenomenon (Wittmann et al., 2004c), quenching using cold methanol or other low 
temperature-based quenching methods should not be applied for absolute quantification of 
intracellular metabolite pool sizes. We have therefore developed a one-step 
quenching/extraction method for quantitative metabolite extraction suited to the 
subsequent LC-ESI-MS/MS analysis.  
In this procedure, it was important to assess the acidic extraction method for intermediates 
with respect to their stability and recovery after incubation at 55°C. Results clearly indicate 
that temperature or acid-dependent decomposition was not observed except for XMP, 
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xanthosine and xanthine (Table III-1). Recoveries for AMP, GMP, IMP, adenosine, 
guanosine, inosine, adenine, guanine and hypoxanthine were > 90%. Only intermediates of 
the xanthine family (XMP, xanthosine and xanthine) exhibited time-dependent 
decomposition of up to 50% (Table III-1) in 30 min.  
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The degradation of the xanthine family intermediates was therefore studied in greater 
detail, to assess the impact on the determination of the other compounds. Fortunately, no 
negative effects were observed.  
Unspecific metabolite leakage and secretion during the cultivation were also investigated 
for the purine intermediates studied in this work. Sole intracellular localization of the 
quantified metabolites is a prerequisite for application of a whole culture quenching 
procedure as performed in this work and neglecting this fact may otherwise result in 
significant errors. Therefore, medium supernatants were analyzed at different time points 
throughout the entire cultivation process. However, no detectable amounts were observed 
for the minimal medium used for cultivation. Thus, the described extraction procedure was 
well suited for the extraction and quantitation of in vivo free intracellular concentrations of 
the metabolites analyzed in this work. Importantly, unspecific leakages or secretions have 
to be considered when medium compositions are changed or different organisms are 
analyzed.  
Application of PCA as quenching/extraction solution resulted in precipitation of cell debris 
and insoluble macromolecules. The obtained sample solution was of sufficient purity for 
direct LC-ESI-MS/MS analysis. However, extraction with PCA has to be validated for 
each substance due to varying chemical stabilities. Thus, PCA extraction is only suitable 
for analytes stable during acidic extraction. 
To assess the extent of degradation of the individual purine intermediates caused by 
multiple freeze-thaw cycles, up to 10 freeze-thaw cycles using a standard solution were 
consistently performed on ice (concentrations: 1 µM each in PCA as described in 
“Materials and Methods”). The recovery rate (as percentage normalized to the relative 
initial concentrations) was then determined. As matrix effects from the complex biological 
samples might interfere with stability properties, the standard solution was mixed with IS 
(i.e. the 13C-labeled cell extract, 1/1; v/v).  
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As is clearly seen in Table III-2, the freeze-thaw procedure was found to trigger a 
significant reduction in the concentration levels, particularly for AMP, GMP, IMP and 
XMP. The recovery rates for AMP were found to exhibit the greatest loss at 12% after 10 
cycles, while even after 2 cycles a significant reduction was determined. 
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The susceptibility of the individual analytes to degradation was determined to be highly 
variable, as neither nucleosides nor nucleobases showed any freeze-thaw-related 
degradation (Table III-2). An extended extraction procedure at 55°C (Table III-1) for 
30 min, however, yielded increased degradation mainly of xanthine, xanthosine and XMP. 
Therefore, to obtain reproducible and quantitative results, unnecessary freeze-thaw cycles 
should be avoided, and extreme care should be taken in terms of unnecessary extraction 
cycles. 
 
Validation of the LC-ESI-MS/MS method 
Separation and MS-MS optimization 
Several studies have attempted the simultaneous quantification of nucleosides and 
nucleotides (Cordell et al., 2008; Czarnecka et al., 2005; Meyer and Wagner, 1985; Werner 
et al., 1989; Yamaoka et al., 2010). No method for all purine nucleoside monophosphates, 
nucleosides and nucleobases without the necessity for ion-pairing reagents, however, has 
yet been reported in the literature. 
The MRM chromatograms for the 12 purine intermediates are shown in Figure III-1, which 
demonstrates the simultaneous analysis by LC-ESI-MS/MS.  
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Figure III-1. MRM chromatograms for the 12 investigated purine intermediates. 1 = guanine, 2 = 
adenine, 3 = AMP, 4 = GMP, 5 = hypoxanthine, 6 = xanthine, 7 = IMP, 8 = XMP, 9 = adenosine, 
10 = inosine, 11 = guanosine, 12 = xanthosine. 
 
 
To describe active adsorption processes and retention effects for the different analytes, 
retention factors (k), were calculated (k = (ta-t0)/t0). The net analyte retentions (ta) were 
corrected using the void volume (t0 = 0.95) of the column and k values were determined as 
shown in Table III-3.  
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Table III-3. Retention factors (k) of the purine analytes. 
 
compound k 
   
 AMP 1.6 
 adenosine 4.0 
 adenine 1.4 
 
  
 GMP 2.0 
 guanosine 5.1 
 guanine 1.3 
 
  
 IMP 2.6 
 inosine 4.2 
 hypoxanthine 2.3 
 
  
 XMP 2.7 
 xanthosine 6.6 
 xanthine 2.4 
 
These values were found to be the lowest for guanine (1.3), adenine (1.4) and AMP (1.6), 
whereas all other analytes exhibited retention factors k > 2.0, indicating active adsorption 
by the stationary phase. 
Fragmentation of protonated molecules of the investigated nucleotides and nucleosides by 
collision-induced dissociation (CID) resulted in the highly-specific protonated nucleobase 
as major product ions, allowing selection of specific product ions for quantitation by MRM 
(Table III-4). The CID spectra, fragmentation patterns as well as specific product ions for 
quantification of IMP, inosine and hypoxanthine are shown in Figure III-2 as illustrative 
examples.  
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Table III-4. MRM transitions and settings for LC-ESI-MS/MSa. 
 
ID monoisotopic mass(amu) 
Q1 
(amu) 
Q3 
(amu) DP CE 
  
adenine 
 
135.0545 
 
136 
 
119 
 
234 
 
42 
  
adenosine 
 
267.0968 
 
268 
 
136 
 
16 
 
25 
  
AMP 
 
347.0631 
 
348 
 
136 
 
72 
 
25 
  
GMP 
 
363.0580 
 
364 
 
152 
 
26 
 
19 
  
guanine 
 
151.0494 
 
152 
 
135 
 
18 
 
27 
  
guanosine 
 
283.0917 
 
284 
 
152 
 
42 
 
17 
  
hypoxanthine 
 
136.0385 
 
137 
 
110 
 
147 
 
29 
  
IMP 
 
348.0471 
 
349 
 
137 
 
64 
 
19 
  
inosine 
 
268.0808 
 
269 
 
137 
 
42 
 
32 
  
xanthine 
 
152.0334 
 
153 
 
136 
 
50 
 
21 
  
xanthosine 
 
284.0757 
 
285 
 
153 
 
32 
 
19 
  
XMP 
 
364.0420 
 
365 
 
153 
 
21 
 
23 
       
 
a  for each compound the following parameters are indicated: compound name (ID), monoisotopic mass, 
selected ions on quadrupoles Q1 and Q3 (Q1 mass and Q3 mass, respectively), declustering potential [V] 
(DP), collision energy [V] (CE). 
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Figure III-2. CID spectra, fragmentation patterns and product ions of the [M+H]+ ions of IMP 
(A.), inosine (B.) and hypoxanthine (C.). Chemical structures shown in gray represent the parent 
ions, and chemical structures shown in black the corresponding product ions.  
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Linearity, sensitivity and long term reproducibility 
Calibration curves were obtained from a series of working standard solutions over a wide 
concentration range, using 13C-labeled cell extract as internal standards (IS). To ensure 
thorough incorporation of 13C-labeled carbon (derived from the sole carbon source [U-
13C6] glucose) into cellular components and intermediates, the mass isotopomer 
distributions of the nucleotide IMP were determined (Figure III-3).  
 
          
 
Figure III-3. Mass isotopomer distributions of the intracellular purine metabolite IMP, unlabeled 
(extracted from unlabeled cell extract) and uniformly labeled (extracted from 13C-labeled cell 
extract). The theoretical distributions were corrected for the natural abundance of 13C with 1.1% 
(unlabeled cell extract) and for the 99% enrichment of [U-13C6] glucose (labeled cell extract). 
 
 
The 13C-labeled cell extract was shown to exhibit the uniformly labeled isotopomer at 
90%, whereas the remaining 10% comprised incorporation of 1 molecule of 12C carbon 
(m+9) due to the 99% enrichment of [U-13C6] glucose. The non-labeled cell extract was 
found to exhibit the natural distribution of the corresponding isotopes from the natural 
presence of 13C (1.1% (Boehlke et al., 2005)) (Figure III-3). In addition to utilizing glucose 
as carbon source, the purine biosynthesis comprises incorporation of 1 molecule of CO2 
from hydrogencarbonate. Thus, to preclude any 12C assimilation, carbon dioxide free 
synthetic air was used. This was validated by mass spectrometric analysis of the CO2 
m0 m+1 m+2 m+9m+8 m+10
0
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released during the whole fermentation process. This released CO2 was found to consist 
exclusively of 13CO2. Therefore, the mass isotopomer distribution, as exemplarily 
determined for IMP, did not posses any detectable amounts of naturally-occurring mass 
isotopomers (i.e. m0, m+1 and m+2). This allowed non-interfered analyte quantitation using 
13C-labeled cell extract as internal standard. Peak area ratios of each analyte relative to the 
IS, i.e. the biological matrix, were plotted against the standard concentrations and linear 
regression was applied. The correlation coefficients (r2) were consistently >0.99 for 
concentration levels >0.001 µM for GMP and IMP and 0.0075 µM for AMP, adenosine, 
inosine and guanosine. The highest LLOQ of 0.015 µM were observed for XMP, 
xanthosine, adenine, hypoxanthine, guanine and xanthine. Applying QC samples at the 
lower limit of quantification (LLOQ), precision was always better than 15% and accuracy 
deviated less than 20% (Table III-5) for all analytes.  
 
 
Table III-5. Lower limits of quantification (LLOQ), accuracy and precision of QC samplesa. 
 
compound LLOQ mean [nM] 
 accuracy 
[%]  
precision 
[CV %] 
  
AMP 
 
9.4 
  
106.0 
  
13.7 
 adenosine 8.2  108.5  13.6 
 adenine 16.1  97.2  10.0 
  
GMP 
 
0.8 
  
103.8 
  
13.2 
 guanosine 7.2  109.3  12.4 
 guanine 17.5  101.8  7.9 
  
IMP 
 
0.8 
  
107.4 
  
7.6 
 inosine 7.0  99.4  6.2 
 hypoxanthine 15.2  90.6  7.3 
  
XMP 
 
18.8 
  
94.8 
  
5.9 
 xanthosine 16.1  93.0  5.1 
 xanthine 19.0  98.3  10.9 
       
 
a  LLOQ corresponds to lower limits of quantification; acceptance criteria for LLOQs were 15 CV % or 
better for precision and a bias of 20% or better for accuracy. Results derived from n = 4 and determined 
in the presence of a biological matrix.  
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This was also true for all concentrations above LLOQ. To accurately quantify in vivo 
concentrations in biological samples, all validation steps, including linearity, precision and 
accuracy, were performed in the presence of a biological matrix. Standard working 
solutions containing 13C-labeled cell extract were used for the calibration, which allowed 
for compensation of matrix effects. Matrix effects, which are specified as any interference 
of ionization efficiency caused by co-eluting substances (Taylor, 2005), usually result in a 
signal attenuation. To analyze the influence of possible matrix effects on the 12 analytes, a 
post-extraction-addition experiment was performed and the recovery for all analytes was 
determined. The resulting recoveries are summarized in Table III-4 and did not show any 
significant matrix effects for all analytes. This recovery study not only evaluated possible 
matrix effects, it also illustrated quantitative determination of purine intermediate pool 
concentrations in Corynebacteria, since the concentration range (Table III-6) covered the 
observed biological concentration levels (Table III-7) except for guanosine.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter III   -   It is all about numbers
 
60 
Table III-6. Recovery for standard solutionsa. 
compound conc [µM] 
 recovery 
[%] 
    
 AMP 3.1 
 102.0 ± 3.5 
0.2 102.1 ± 5.1 
 adenosine 2.7  102.8 ± 4.7 0.1 106.7 ± 3.9 
 adenine 2.2  105.0 ± 1.1 0.1 101.7 ± 6.6 
       
 GMP 2.7 
 98.1 ± 6.9 
0.1 95.1 ± 2.5 
 guanosine 2.4  104.0 ± 1.1 0.1 105.7 ± 1.8 
 guanine 2.4  100.1 ± 4.1 0.1 103.6 ± 3.3 
       
 IMP 2.9 
 99.8 ± 1.7 
0.1 97.9 ± 0.4 
 inosine 2.3  101.8 ± 1.7 0.1 104.4 ± 0.2 
 hypoxanthine 2.1  99.0 ± 3.7 0.1 92.3 ± 4.6 
       
 XMP 2.6 
 100.2 ± 1.5 
0.1 98.8 ± 0.1 
 xanthosine 2.2  96.7 ± 0.5 0.1 99.6 ± 1.3 
 xanthine 2.6  101.0 ± 2.0 0.1 98.8 ± 2.4 
       
 
a  determined recoveries for standard solutions in two different concentrations in order to estimate matrix 
effects.  
 
 
To ensure accurate and precise quantitation of guanosine and other low level analytes or of 
those exhibiting lower detection sensitivities, the injection volume was adapted 
accordingly (see “LC-MS/MS conditions - Materials and Methods”). 
All compounds exhibited a linear dynamic range of at least two orders of magnitude, 
which was considered sufficient for quantitation in this study. 
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Application to pathway analysis 
Samples from two Gram-positive Corynebacterium species, C. glutamicum and 
C. ammoniagenes, were extracted and quantitation of intracellular purine pools was 
performed. Multiple reaction monitoring (MRM) chromatograms of purine biosynthetic 
pathway intermediates in biological samples are shown in Figure III-4. The corresponding 
concentration levels for detected nucleotides, nucleosides and nucleobases normalized to 
the cell volume (Gutmann et al., 1992) are summarized in Table III-7.  
 
 
Figure III-4. MRM chromatogram of a C. glutamicum extract. 1 = guanine, 2 = adenine, 3 = 
AMP, 4 = GMP, 5 = hypoxanthine, 6 = xanthine, 7 = IMP, 8 = adenosine, 9 = inosine and 10 = 
guanosine. Isotope peaks (exemplary for 1, 2, 4 and 8) are marked with an asterisk.  
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Table III-7. Concentrations of purine intermediates (µmol mL-1cell volume) in Corynebacterium 
glutamicum and Corynebacterium ammoniagenesa. 
compound C. glutamicum 
 
C. ammoniagenes 
  b.   b. 
 AMP 4.09 ± 0.20 (4.33)  1.19 ± 0.12 (1.41) 
 GMP 1.35 ± 0.08 (1.40)  0.15 ± 0.01 (0.20) 
 IMP 0.23 ± 0.02 (0.26)  0.06 ± 0.00 (0.08) 
 XMP c.  c.    
       
 adenosine 0.05 ± 0.00 (0.06)  0.17 ± 0.01 (0.20) 
 guanosine 0.02 ± 0.00 (0.02) c.    
 inosine 0.05 ± 0.00 (0.07) c.    
 xanthosine c.  c.    
           
 adenine 1.47 ± 0.08 (1.40)  0.78 ± 0.05 (1.05) 
 guanine 1.67 ± 0.11 (1.74)  1.16 ± 0.05 (1.50) 
 hypoxanthine 0.13 ± 0.01 (0.15)  0.07 ± 0.01 (0.09) 
 xanthine 0.06 ± 0.00 (0.06)  0.05 ± 0.00 (0.06) 
           
 
a  concentrations and corresponding standard deviations were determined using 4 biological and 2 technical 
replicates for each compound and standardized to the cell volume (Gutmann et al., 1992). 
b concentrations in µM from LC-MS quantitation, not related to biomass.  
c below detection limit. 
 
Concentrations in µM, obtained from LC-MS quantitations are additionally provided, to 
allow evaluation of an adequate and suitable concentration range. For C. glutamicum, all 
compounds except for XMP and xanthosine (which were below the detection limit) were 
quantified with precision values of less than 12%. AMP and GMP, central building blocks 
for DNA and RNA and co-substrates for activation of metabolites, exhibited the highest 
intracellular nucleotide concentrations of 4.1 µmol mL-1 and 1.3 µmol mL-1, respectively. 
Other purine pathway intermediates showed a broad range of concentration levels varying 
between 0.02 µmol mL-1 and 1.7 µmol mL-1. However, nucleosides exhibited the lowest 
levels of all analyzed metabolites at 0.02 µmol mL-1. The observed concentrations for all 
quantified analytes were 1 to 3 orders of magnitude above the determined quantification 
limits, indicating that the investigated sample volumes could be further reduced if required.  
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Analysis of C. ammoniagenes revealed the same distribution pattern of intracellular 
concentrations of purine pathway intermediates, however, all quantified compounds 
(except for adenosine) exhibited significantly reduced intracellular concentration levels 
compared to C. glutamicum. Furthermore, no free intracellular nucleosides were detected, 
except for adenosine. The relatively decreased intracellular purine concentration levels 
detected in C. ammoniagenes could indicate differing regulatory mechanism of these 
species, eventually favoring reduced intracellular concentrations in C. ammoniagenes. This 
might be linked to the increased capability of C. ammoniagenes for nucleotide and 
nucleoside secretion (Furuya et al., 1968), resulting in decreased intracellular 
concentrations. This organism, which is characterized by its potential for extracellular 
purine accumulation, has been exploited for large-scale production of diverse compounds, 
i.e. IMP, GMP, XMP and inosine (Auriola et al., 1997), whereas 
Corynebacterium glutamicum, an outstanding model organism in the field of systems 
biotechnology and producer of various substances such as amino acids, polymers or 
biofuels (Becker and Wittmann, 2012) only possesses poor nucleotide secretion 
capabilities (Demain et al., 1965; Demain et al., 1966). A further deduction of the 
information based on the inter-species variations, however, has to be performed carefully, 
as the resulting pool sizes do not allow any interpretation of the participating enzymes; the 
alteration of intracellular metabolite pool sizes cannot directly be linked to varying enzyme 
activities and can only provide indications of differing underlying mechanisms.  
Additional investigation of extended extraction at 55°C times up to 15 min did not result in 
increased metabolite concentrations (data not shown), indicating that a temperature of 
55°C in combination with an incubation time of 3 min was sufficient for complete 
metabolite extraction. Incubating for more than 3 min caused degradation of analytes 
belonging to the xanthine family and should therefore be avoided. 
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Conclusions 
 
 
In this study, a LC-ESI-MS/MS approach in conjunction with a single-step extraction 
procedure was developed and validated for quantitation of 12 major purine biosynthetic 
pathway intermediates from biological samples. Chromatographic separation of polar 
nucleotides and non-polar nucleosides and nucleobases was achieved in less than 15 min 
using reversed-phase HPLC-MS without using any ion-pairing reagents. The method 
exhibited excellent selectivity, precision and accuracy in the presence of a biological 
matrix. As no ion-pairing reagents were used, the method was much more rugged than 
existing methodologies and required significantly less instrument maintenance and 
operator intervention. Other advantages over previous methods include the simplified 
extraction procedure, the straightforward quantitation routine and the exclusive use of 
inexpensive reagents, making this approach particular suitable for high throughput, multi-
user laboratories. Even though addition of ion-pairing reagents might sometimes have a 
positive effect on retention performance, in particular for phosphorylated compounds, the 
separations achieved in this work were found to fully meet the requirements in this study, 
without the need for troublesome ion-pairing reagents. 
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Chapter IV 
 
Let’s take a look inside 
Metabolic engineering of the purine biosynthetic pathway in 
Corynebacterium glutamicum results in increased 
intracellular pool sizes of IMP and hypoxanthine 
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Abstract* 
 
 
An in-depth analysis of the purine biosynthetic pathway was performed in 
Corynebacterium glutamicum in order to study the influence of directed rational strain 
design on intracellular IMP accumulation. The metabolic engineering strategy applied in 
this work focused on reducing metabolizing reactions towards AMP and GMP, feedback-
deregulation of the purine biosynthetic pathway itself and an enhanced precursor supply of 
ribose 5-phosphate. Blocking of the degrading reactions towards AMP and GMP lead to a 
45-fold increased intracellular IMP pool of 22 µmol gCDW-1. Deletion of the pgi gene 
encoding glucose 6-phosphate isomerase in combination with the deactivated AMP and 
GMP generating reactions, however, resulted in a significantly decreased IMP pool 
(13 µmol gCDW-1). Targeted metabolite profiling of the purine biosynthetic pathway further 
revealed a metabolite shift towards the formation of the corresponding nucleobase 
hypoxanthine (102 µmol gCDW-1) derived from IMP degradation.  
 
 
 
 
 
 
 
 
 
* Submitted as: 
Peifer S, Barduhn T, Zimmet S, Volmer DA, Ho-Dac T, Heinzle E, Schneider K.  
Metabolic engineering of the purine biosynthetic pathway in Corynebacterium glutamicum results in 
increased intracellular pool sizes of IMP and hypoxanthine. 
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Introduction 
 
 
The diverse class of purine intermediates comprises phosphorylated nucleotides, 
nucleosides and nucleobases, exhibiting multiple functions in the cellular system (Pang et 
al., 2011): for example, they serve as transmitters of the genetic information (Traut, 1994), 
as phosphate group donors, are involved in signal mediation (Cordell et al., 2008) and 
ensure the energy supply of the living cell (Guimaraes and Londesborough, 2008). Thus, 
these intermediates are involved in almost every aspect of cellular metabolism. 
Furthermore, some of these compounds possess secondary functions as flavor-enhancing 
substances, i.e. IMP and GMP (Halpern, 2002; Matsui et al., 2001b; Shimaoka et al., 
2005), and act as potential drugs in medical therapy, e.g. inosine and purine analogs 
(Cohen et al., 2010; Hofmann et al., 2012; Li et al., 2011). 
Their de novo synthesis, however, is energetically expensive and imbalances in their pool 
sizes are reported to be directly linked to increased mutation rates (Bebenek et al., 1992), 
which eventually leads to constant pool sizes (Traut, 1994). These are maintained by a 
balanced system with two compensatory operating parts: the de novo biosynthesis 
pathway, generating the purine intermediates from central carbon metabolism, and the 
salvage pathway, which can replenish corresponding pools (Figure IV-1) (Li et al., 2011; 
Matsui et al., 2001b; Shimaoka et al., 2005; Tozzi et al., 2006). 
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Figure IV-1. Metabolic map of the purine biosynthetic pathway. Dashed lines indicate multiple 
enzymatic steps; boxes denote contributing enzymes of de novo biosynthetic pathway (dark grey) 
and salvage pathway (light gray). Abbreviations: R5P, ribose 5-phosphate; PRPP, 5-
phosphoribosyl 1-pyrophosphate; IMP, inosine 5-monophosphate; AMP, adenosine 5-
monophosphate; XMP xanthosine 5-monophosphate; GMP, guanosine 5-monophosphate; purA, 
adenylosuccinate synthetase; purB, adenylosuccinate lyase; guaB2, IMP dehydrogenase; guaA, 
GMP synthase; apt, adenine phosphoribosyltransferase; hpt, hypoxanthine-guanine 
phosphoribosyltransferase. 
 
 
De novo nucleotide synthesis begins with the activation of the PPP intermediate and direct 
precursor ribose 5-phosphate (Messenger and Zalkin, 1979), which is further converted to 
IMP in a twelve-step biosynthetic process with concomitant consumption of 10 mol ATP. 
AMP and GMP are derived from IMP as depicted in Figure IV-1 (Pang et al., 2011; Saxild 
and Nygaard, 1991). The salvage pathway, however, converts extracellular nucleobases or 
degraded purine compounds into the corresponding nucleosides and nucleotides (Abbouni 
et al., 2003; Abbouni et al., 2004), thereby preventing energetically-expensive de novo 
synthesis of these compounds.  
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Since primary metabolism is designed and optimized to deliver and sustain a more or less 
consistent distribution of metabolites (described as network rigidity (Stephanopoulos and 
Vallino, 1991)), which can be used as cellular building blocks, redox equivalents, energy 
and cofactors, any kind of overproduction or accumulation basically targets the 
deregulation of the underlying metabolism. In the present study, a strategy for increased 
IMP accumulation was developed by focusing on modifying the general key factors for 
overproduction: (i) increasing the precursor availability, (ii) de-bottlenecking regulation-
restricted branch points, and (iii) deactivating the depleting reactions. The goal of this 
study was to identify essential nodes of this pathway and to uncover impacts from central 
and purine metabolism. Applying genetic engineering and in-depth metabolome analysis of 
the purine pathway intermediates, information of the extremely well-regulated purine 
pathway should be gathered (Mathews, 2006; Pang et al., 2011; Saxild and Nygaard, 1991; 
Wheeler et al., 2005). However, the underlying mechanisms and the contributions of 
different branches are not well described yet. In addition, identification of individual 
regulation factors (Fiehn, 2002; Nielsen, 2003) operating at different hierarchic levels (van 
Gulik and Heijnen, 1995) is challenging due to the comprehensive connectivity of the 
metabolic network. The interconnectivity of metabolome and fluxome therefore provides 
valuable insights into global dynamics (Fiehn, 2001; Nielsen and Oliver, 2005) resulting 
from single and multiple perturbations in the central and branch metabolism (Dunn, 2008).  
  
Chapter IV   -   Let’s take a look inside 
 
70 
Materials and methods 
 
 
Microorganisms 
Wild type C. glutamicum ATCC 13032 was obtained from the American Type Culture 
Collection (Manassas, VA, USA) and used as parent strain for further genetic 
modifications. E. coli DH5α was utilized as host strain for cloning and plasmid 
construction. E. coli NM522pTC served as host for plasmid amplification and coryne-
specific methylation. The pTC plasmid, harboring an origin of replication (ori), for E. coli 
a tetracycline resistance as selection marker and the DNA-methyltransferase gene from 
C. glutamicum, was co-expressed in E. coli NM522pTC to transfer the methylation pattern 
of C. glutamicum to the integrative plasmids. The vector pClik, used for integrative genetic 
modifications, exhibited an ori for E. coli but not for C. glutamicum, a multiple cloning site 
(MCS) and kanamycin (KanR) and sacB selection markers. The constructed pClik-
derivates were used for homologous replacement of the native gene sequences with the 
modified ones. Transformation of C. glutamicum and subsequent selection on KanR 
yielded transformants possessing genome-integrated plasmids via single crossover. The 
sacB positive selection system (Jager et al., 1992) on sucrose was applied to select clones 
from the second recombination event. KanR-sensitive and sucrose-insensitive clones were 
tested for the existence of the modified gene sequence via PCR and positive clones were 
additionally sequenced.  
The modifications constructed in this study comprised single gene deletions (ΔpurA, 
ΔguaB2 and Δpgi), an allelic replacement of the purF gene encoding 
amidophosphoribosyltranferase with a purFK348Q gene (purFK348Q) and multiple gene 
deletions (ΔpurA ΔguaB and ΔpurA ΔguaB2 purFK348Q Δpgi). The site-directed mutants 
and corresponding genetic modifications are summarized in Table IV-1. Allelic 
replacement of the modified purF gene was carried out by first deleting the native gene 
followed by a replacement step with the manipulated gene containing the point mutation. 
Primer sequences used for construction and verification are listed in Table IV-2. 
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Table IV-1. Genetically modified organisms constructed in the present study: Mutant strains of 
C. glutamicum based on the wild type strain (ATCC 13032) were constructed by site-directed 
mutagenesis. E. coli strains were employed for plasmid construction. 
 
 strain genotype 
 
reference 
 
  
C. glutamicum ATCC 13032 
 
wild type 
 
American Type Culture 
Collection 
 C. glutamicum Δpgi deletion of the pgi gene This work 
 C. glutamicum ΔpurA deletion of the purA gene This work 
 C. glutamicum ΔguaB2 deletion of the guaB2 gene This work 
 C. glutamicum purFK348Q nucleotide exchange K348Q in the purF 
gene 
This work 
 C. glutamicum ΔpurA ΔguaB2 double deletion of purA and guaB2 genes This work 
 C. glutamicum ΔpurA ΔguaB2 
purFK348Q Δpgi 
deletion of purA, guaB2 and pgi genes and 
allelic amino acid substitution K348Q in 
the purF gene 
This work 
  
E. coli DH5α 
 
F−endA1, hsdR17(rk−mk+) supE44, thi-1λ− 
recAI gyrA96 relA1 Φ80ΔlacAm15 
 
(Hanahan, 1983) 
 E. coli NM522pTC supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5 
(rK− mK+) [F′ proAB lacIqZΔM15] 
Stratagene 
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Table IV-2. Mutant genotypes and corresponding site-specific primer sequences (F, forward; R, 
reverse) used for verificationa. 
 
 mutant 
genotype 
 
primer 
 
primer sequence 
 
    
 Δpgi Δpgi-F 
Δpgi-R 
 
5′-GATCACGCGTATCCCTTCTCCGGCATC-3′ 
5′-GATCTCTAGATCCAGCGACACGAATAATC-3′ 
 ΔpurA ΔpurA-F 
ΔpurA-R 
 
5′-GATCTCTAGAATGGATCGGATGTGACG-3′ 
5′-GATCACGCGTCAATCGGTCAACCTGGT-3′ 
 ΔguaB2 ΔguaB2-F 
ΔguaB2-R 
 
5′-GATCACGCGTGAGTTTCTACCGGAGGA-3′ 
5′-GATCTCTAGATCAGACTGGAAGTAACG-3′ 
 purFK348Q purFK348Q-F 
purFK348Q-R 
K348Q-1 
K348Q-2 
 
5′-GATCACGCGTGATTGCGGACTGGTTAC-3′ 
5′-GATCTCTAGACTCCTGCTGCTGCGTATG-3′ 
5′-GGCCAAGGCATGGTCCAGAACGCCTACGTTGGC-3′ 
5′-GCCAACGTAGGCGTTCTGGACCATGCCTTGGCC-3′ 
 
 
a  for the single amino acid substitution in purFK348Q, sequences for fusion primers (K348Q-1, K348Q-2) 
containing the point mutation (underlined) are additionally denoted. 
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DNA preparation and recombinant DNA modifications 
Oligonucleotide synthesis was performed by Sigma-Aldrich (Steinheim, Germany) and 
DNA sequencing was carried out by GATC (Konstanz, Germany). Plasmid construction 
and DNA purification were performed using standard techniques. Preparation of genomic 
DNA from C. glutamicum was carried out with the MasterPureTM Gram Positive DNA 
Purification Kit (Biozym Scientific GmbH, Germany). PCR reactions were performed in a 
TGradient-Cycler (Whatman–BiometraR) with Phusion polymerase (Biozym) for insert 
construction and JumpStart REDTaq Ready Mix (Sigma-Aldrich) for strain verification. 
PCR products were purified using NucleoSpin® Extract II Kit (Macherey-Nagel, Düren, 
Germany) and plasmids using HiYield® Plasmid Mini Kit (SLG, Gauting, Germany). 
Ligations were performed with Fast-LinkTM DNA Ligation Kit (Epicentre Biotechnologies, 
Madison, WI, USA). FastDigest® restriction enzymes were obtained from Fermentas (St. 
Leon-Rot, Germany) as well as 10 mM dNTP Mix and 1-kb DNA O’GeneRulerTM. 
 
Transformation 
Precultures used for transformation of C. glutamicum, were grown on BHI++ medium 
(10 mL in 100 mL baffled shake flasks) and incubated for 12 h at 30°C. The main culture 
in BHI++ medium (80 mL in 1000 mL baffled shake flasks) was inoculated from 
exponentially growing precultures to an optical density OD660nm of 0.2. 400 mg 
isonicotinic acid hydrazide, 2.5 g glycine and 0.1 mL Tween 80 were dissolved in 20 mL 
H2O, sterilized by filtration and added to the main culture at an OD660nm of 0.6. Cells were 
further incubated until an OD660nm of 0.8 was reached and harvested by centrifugation 
(7 min, 4,000 g, 4°C, Laborfuge 400R, Heraeus, Hanau, Germany). Cells were washed 
three times with pre-cooled wash buffer (10% glycerine, 8 mM tris hydrochloride, pH 7.4) 
and once with 10% glycerine. After the second resuspension in 6 mL 10% glycerine, 
200 µL cells were subsequently used for transformation. Electroporation was performed 
using a BioRad Gene Pulser II (Hercules, California, USA) with the following parameters: 
25 µF, 600 Ω and 2.5 kV. Cells were transferred into a 2 mL Eppendorf tube, mixed with 
1 mL BHIS medium, followed by a heat shock for 5 min at 46°C. Regeneration was 
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performed for 90 min at 30°C to allow recovery of the cells, which were then spread on 
BHISKan agar plates and incubated for 4 days. 
Transformation of E. coli DH5α and NM522pTC with the integrative pClik-derivates was 
performed by heat shock. Cells were incubated on ice for 30 min, heated at 45°C for 45 s 
and again cooled on ice for 2 min. Regeneration was performed for 1 h at 37°C after 
900 µL SOC medium were added. 
 
Targeted mutant generation 
Site-directed mutations were introduced using the integrative vector pClik, which lacks an 
ori for C. glutamicum. Selection on KanR as resistance marker yielded transformed cells 
with genome-integrated plasmid DNA. The insertion of the plasmids thereby results from a 
single crossover recombination event. The second homologous recombination event, 
generated by the sacB positive selection system, causes the deletion of the sacB gene and 
therefore allows growth on corresponding selective agar plates. Due to the sacB associated 
additional deletion of the native or the modified gene sequence, transformants either 
contain the wild type gene sequence or exhibit the targeted mutation. KanR-sensitive and 
sucrose-insensitive clones were further verified by allelic-specific PCR for the presence of 
the targeted gene sequence. The corresponding gene sequence for a nucleotide exchange, 
i.e. purFK348Q, was first deleted and then replaced.  
 
Chemicals 
Yeast extract, beef extract, polypeptone, casamino acids, and brain heart infusion (BHI) 
were purchased from Difco Laboratories (Detroit, USA). 99% enriched glucose, i.e. [1-
13C] and [1,2-13C2], were obtained from Cambridge Isotope Laboratories (Andover, MA., 
USA). All other chemicals and reagents of analytical grade were purchased from Sigma-
Aldrich, Merck (Darmstadt, Germany), Fluka (Buchs, Switzerland) or Roth (Karlsruhe, 
Germany). 
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Growth Media 
The first precultures were grown on complex media (pH 6.8) containing per liter: 10.0 g 
glucose, 2.5 g NaCl, 2.0 g urea, 5.0 g yeast extract, 5.0 g beef extract, 5.0 g polypeptone 
and 20.0 g casamino acids. For agar plates, the complex medium was supplemented with 
20.0 g L-1 agar. Second precultures and main cultures were grown on minimal medium (pH 
7.2) containing per liter: 15.0 g glucose, 4.0 g KH2PO4, 16.0 g Na2HPO4, 500 mg 
MgCl2 · 6 H2O, 300 mg 3,4-dihydroxybenzoic acid, 100 mg CaCl2 · 2 H2O, 100 µg 
cyanocobalamin, 750 µg thiamine, 4 µg pyridoxal phosphate, 100 µg biotin, 400 µg 
calcium pantothenate, 2 µg folic acid, 400 µg nicotinic acid, 200 µg 4-aminobenzoic acid, 
400 µg pyridoxine · HCl, 2 mg inositol, 10 mg FeCl2 · 4 H2O, 1 mg ZnCl2, 100 µg CuCl2, 
20 µg NiCl2 · 6 H2O, 20 µg Na2MoO4 · 2 H2O, 500 µg boric acid, 100 µg KI, 100 µg 
CoCl2 · 6 H2O, 10 mg MnCl2 · 4 H2O. For tracer studies, naturally labeled glucose was 
replaced by 99% 13C enriched [1-13C] or [1,2-13C] glucose. Mutants of C. glutamicum 
exhibiting deletions of adenylosuccinate synthetase (purA) or IMP dehydrogenase (guaB2) 
were grown on minimal media additionally supplemented with 200 mg L-1 adenine sulfate 
or 80 mg L-1 guanine hydrochloride, due to the introduced auxotrophies.  
Media used for transformation experiments of C. glutamicum contained per liter: 37 g BHI, 
26.4 g (NH4)2SO4 and 40 g glucose for BHI++ and 37 g BHI and 46 g sorbitol for BHIS 
medium.  
 
Cultivations 
Cultivations were carried out in baffled shake flasks on an orbital shaker (Multitron 2, 
Infors AG, Bottmingen, Switzerland) at 230 rpm and 30°C. First precultures were grown 
on complex medium (25 mL medium in 250 mL baffled flasks) for 8 h and used for 
inoculation of the second precultures (25 mL medium in 250 mL baffled flasks). Second 
precultures and main cultures were performed in minimal medium. Main cultivations were 
performed in duplicates in minimal medium using 500 mL baffled shake flasks with 50 mL 
medium. For tracer experiments, which were conducted under the same conditions as main 
cultivations, naturally labeled glucose was replaced by [1-13C] glucose or [1,2-13C2] 
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glucose for analysis of glucose 6-phosphate isomerase (pgi) deletion mutants and the 
volume was adjusted to 5 mL in 50 mL baffled shake flasks. 
 
Substrate and product analysis 
Biomass concentration was determined by measuring the optical density of the culture at 
660 nm (OD660nm) using a photometer (Marsha Pharmacia Biotech, Freiburg, Germany) 
which was gravimetrically correlated with the cell dry weight. Extracellular substrates and 
secreted products were analyzed after 3 min centrifugation at 16,000 g. Quantification of 
glucose, α-ketoglutarate and trehalose was performed in diluted supernatants by HPLC 
(Kontron Instruments, Neufahrn, Germany). Separation was performed using an Aminex 
HPX-87H Bio-Rad column (300 x 7.8 mm; Hercules, USA), at 55°C with a constant flow 
rate of 0.8 mL min-1 (7 mM H2SO4 as mobile phase). Refraction index (RI) detection was 
used for quantification of sugars, and UV detection at 218 nm for organic acids. 
Determination of amino acids was performed as described previously (Kromer et al., 
2005). Extracellular concentrations of adenine and guanine were determined by HPLC 
(Agilent 1290 Infinity; Agilent Technologies, Waldbronn, Germany) using a Phenomenex 
(Aschaffenburg, Germany) reversed-phase C18-column (Gemini 5u 110Å, 150 x 4.6 mm). 
Separations were carried out at 10°C with a constant flow of 0.8 mL min-1. Gradient 
elution was performed using 5 mM ammonium formate solution at pH 5.8 (eluent A) and 
acetonitrile:methanol:water mixture (45:45:10, eluent B) applying the following gradient: 
an initial isocratic step with 0% B (3.5 min) was followed by an increase to 30% within 
10 min and to 100% within 1 min. The flushing step at 100% B was performed for 5 min. 
The column was reconditioned at 0% B for another 5 min. 
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Analysis of intracellular metabolites 
Extraction and quantification of intracellular purine intermediates, i.e. nucleotides, 
nucleosides and nucleobases, by LC-ESI-MS/MS was performed as described previously 
(Peifer et al., 2012; Chapter III).  
 
Mass spectrometric 13C-labeling analysis 
The mass isotopomer distributions of amino acids derived from cellular protein and of 
trehalose secreted during cultivation were determined by gas chromatography-mass 
spectrometry (GC-MS). Sample preparation and instrument settings were performed as 
described previously (Becker et al., 2005; Kiefer et al., 2004; Wittmann et al., 2004a).  
 
Fluxome analysis 
Calculation of the in vivo metabolic fluxes of the C. glutamicum strains was carried out by 
fitting simulated mass isotopomer distributions to experimentally determined labeling 
patterns of amino acids derived from cellular protein and trehalose secreted during 
cultivation. The calculations were based on the approach of Yang et al. (2008) 
implemented in Matlab (version 2008b, Mathworks Inc., Nattick, USA) using metabolite 
and isotopomer balancing. Anabolic demands for biomass synthesis and extracellular 
production rates were additionally considered and implemented in the metabolic network. 
A Monte Carlo approach with 100 independent runs was employed for the statistical 
analysis (Wittmann and Heinzle, 2002). 
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Data analysis 
Mean concentration values for purine intermediates were calculated from four biological 
replicates for each strain for two biomass concentrations and corrected using 13C-labeled 
cell extract as internal standard as described previously (Peifer et al., 2012; Chapter III). 
The metabolomics-based phenotype profiling was extended by principal component 
analysis (PCA) applying pareto scaling of the data. Data sets were compressed by 
reduction of dimension numbers and the metabolomic patterns were highlighted. PCA was 
performed using Matlab R2008b (The Math Works, Inc., Boston, USA) software. 
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Results 
 
 
Metabolic snapshots of the purine pathway in wild type C. glutamicum 
Intracellular metabolite concentrations in C. glutamicum were quantified after whole 
culture extraction using LC-ESI-MS/MS (Peifer et al., 2012; Chapter III). In order to verify 
balanced growth conditions (Provost and Bastin, 2004; Wittmann, 2007) and stable 
intracellular metabolite concentrations (Marx et al., 1996; Wiechert, 2001), respectively, 
quantification was performed for two different biomass concentrations, resulting in four 
biological replicates for each biomass concentration. The corresponding concentrations of 
nucleotides, nucleosides and nucleobases related to the cell dry weight are listed in 
Table IV-3.  
 
All compounds except xanthosine and XMP, which were below the detection limit, were 
quantified with a precision better than 12%. AMP and GMP, as central building 
constituents for DNA and RNA and co-substrates for various enzyme reactions (Cordell et 
al., 2008; Traut, 1994), showed the highest concentration ranges of 8.13 and 
2.63 µmol gCDW-1, respectively. Other intermediates varied within a broader concentration 
range from 0.04 to 3.27 µmol gCDW-1. The lowest concentrations were detected for 
nucleosides and reaching up to 0.04 µmol gCDW-1 for guanosine. 
Several genetic perturbations aiming at various metabolic key nodes were performed to 
evaluate the effects and impacts of changing activities of different metabolic branches of 
the metabolism on the intracellular purine pool sizes.  
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Manipulating the main carbon flux distribution  
The first implemented modification affected the glucose 6-phosphate branch point and 
focused on amending the availability of the immediate precursor of IMP, ribose 5-
phosphate. The carbon flux distribution was rerouted by deleting the first enzyme of the 
glycolysis, the glucose 6-phosphate isomerase encoded by the pgi gene, resulting in an 
entry block into glycolysis at that stage and thus restricting the metabolization of glucose 
6-phosphate exclusively to the PPP. Growth parameters are depicted in Table IV-4. 
Specific growth rate of C. glutamicum Δpgi was slightly reduced compared to the wild type 
strain, as was biomass formation.  
 
 
Table IV-4. Growth parameters for C. glutamicum ATCC 13032 and site-directed mutants. 
 
 strain 
parameter  ATCC 13032  Δpgi  purFK348Q ΔpurA 
     
µ 0.443 ± 0.00 0.376 ± 0.00 0.440 ± 0.01 0.455 ± 0.01 
Yx/s 0.095 ± 0.05 0.090 ± 0.00 0.091 ± 0.01 0.090 ± 0.00 
qS 4.67 ± 0.09 4.18 ± 0.02 4.82 ± 0.06 5.05 ± 0.02 
 
        ΔguaB2 ΔpurA ΔguaB2 ΔpurA ΔguaB2 purFK348Q Δpgi 
    
µ 0.320 ± 0.00 0.317 ± 0.01 0.146 ± 0.00 
Yx/s 0.073 ± 0.00 0.075 ± 0.00 0.076 ± 0.00 
qS 4.38 ± 0.03 4.24 ± 0.01 1.92 ± 0.02 
 
data represent mean values obtained from two parallel cultivations with corresponding standard deviations: 
specific growth rate (µ) [h-1]; biomass yield (YX/S) [g mmol-1] and the specific glucose consumption rate (qS) 
[mmol g-1 h-1]. 
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Phenotypic analysis was further extended towards the determination of free intracellular 
purine pool sizes and a metabolic profile based on these analyses was generated (Table IV-
3). Intracellular concentrations related to cell dry weight showed only minor changes 
compared to wild type C. glutamicum. GMP and AMP concentrations were slightly 
increased in C. glutamicum Δpgi, as were amounts of adenine, guanine and inosine. 
Adenosine and guanosine showed decreased concentrations. IMP and hypoxanthine were 
not affected significantly. 
 
Targeted perturbations of the purine biosynthetic pathway 
Further genetic manipulations were then aimed at the purine pathway itself, to estimate 
immediate effects emanating from this metabolic branch. The first target was the purF 
gene encoding the PRPP amidotransferase. This enzyme is generally regarded to act as key 
controller in the purine de novo synthesis, regulated by a feedback inhibition mainly 
caused by GMP and AMP (Matsui et al., 2001b; Shimaoka et al., 2007). An experimentally 
identified amino acid substitution (K326Q) in the purF gene is reported to offset this 
feedback inhibition by AMP and GMP in E. coli (Zhou et al., 1993) and should be 
incorporated into the corresponding position in the purF gene of C. glutamicum. In order to 
check for evolutionary conserved coding regions, a sequence alignment covering the 
complete amino acid sequence was performed (Zhou et al., 1993). Therefore, six 
organisms exhibiting a broad phylogenetic distinction, including Escherichia coli, 
Corynebacterium glutamicum, Corynebacterium ammoniagenes, Bacillus subtilis, 
Salmonella typhimurium and Saccharomyces cerevisiae, were analyzed. A conserved 
region comprising at least ten amino acids was identified for all organisms including the 
location of the amino acid substitution K326Q in E. coli identified by Zhou et al. (1993) 
The corresponding substitution K348Q in C. glutamicum was inserted into the genomic 
DNA. Verification of the base exchange was carried out by sequencing. 
The amino acid substituent C. glutamicum purFK348Q (purFK348Q) showed balanced 
growth with stable biomass formation and growth rate (Table IV-4). Intracellular purine 
intermediate pool sizes remained almost unchanged for adenosine, guanosine and 
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hypoxanthine (Table IV-3). The most striking changes were observed for intracellular 
inosine concentration which increased 2.9-fold. Compared to the wild type strain, the IMP 
concentration, however, showed only a minor change (10% increase). Intracellular 
concentrations of AMP and its corresponding nucleobase adenine increased by 
approximately 25% each. GMP and guanine pool sizes in C. glutamicum purFK348Q 
increased significantly by 80% and 55%, respectively compared to the wild type, 
indicating a global shift towards the main intermediates GMP, AMP and inosine. Direct 
determination of the in vitro activity of PurF following the method of Matsui et al. (2001a), 
employing HPLC quantitation of substrate (glutamine) and product (glutamate) 
concentrations over time in crude cell extracts, resulted in tremendous background activity, 
not permitting kinetic studies. In addition, heterologous expression using Escherichia coli 
as expression system resulted in enzyme inactivation, probably due to complex 
posttranslational events. Further studies will however focus on the determination of the in 
vitro activity.  
In addition to the deregulation of PurF, further genetic manipulations were aimed at IMP 
degradation, affecting the synthesis of IMP-derived GMP and AMP. The biosynthesis of 
both intermediates was thus shifted from de novo biosynthesis to the purine salvage 
pathway, employing the two enzymes adenosine-phosphoribosyltransferase (APRT) and 
hypoxanthine-guanine-phosphoribosyltransferase (HGPRT) catalyzing the synthesis of 
AMP and GMP/IMP via a condensing reaction of adenine and guanine/hypoxanthine with 
PRPP maintaining a sustained supply of the necessary precursors. These genetic 
manipulations, however, lead to auxotrophies for adenine and/or guanine (Matsui et al., 
2001a; Qian et al., 2006). 
As initial strategy, the single gene deletions of the adenylosuccinate synthetase (purA) 
(catalyzing the conversion of IMP to AMP) and of the IMP-dehydrogenase (guaB2) 
(catalyzing the reaction of IMP to GMP) were analyzed. Due to the generated 
auxotrophies, the medium had to be supplied with adenine and guanine as discussed above 
and resulting phenotypes based on intracellular concentrations of the corresponding purine 
pathway intermediates were analyzed (Table IV-3).  
The metabolic shift from de novo purine biosynthesis to the salvage pathway did not show 
any significant changes in the growth rate of the purA deletion strain. The guaB2 deletion 
strain, however, showed a drastic response after redirecting GMP formation to the salvage 
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pathway: biomass yield was reduced by 25% (0.073 g mol-1glucose) of the wild type yield 
and the specific growth rate even dropped by 30% of the wild type rate, reaching a stable 
rate of 0.32 h-1, thus indicating a restricted compensation efficiency of the salvage pathway 
concerning the GMP supply. Metabolic phenotyping revealed even more distinct 
alterations: most strikingly both deletion mutants were characterized by unbalanced 
intracellular pools sizes, exhibiting transient concentration changes which could not be 
related to biomass formation (Table IV-3). Degradation inefficiency of IMP towards the 
following nucleotides (GMP and AMP) led to maximal intracellular IMP concentrations of 
44 µmol gCDW-1 (ΔpurA) and 37 µmol gCDW-1 (ΔguaB2) corresponding to a 90- and 80-fold 
increase compared to the wild type strain. Hypoxanthine concentrations were affected 
likewise. 
The unbalanced metabolic state observed in C. glutamicum ΔpurA and C. glutamicum 
ΔguaB2, was further investigated in the double deletion mutant C. glutamicum 
ΔpurA ΔguaB2, exhibiting auxotrophies for adenine as well as for guanine. Specific growth 
parameters of the double deletion mutant, i.e. biomass yield (0.075 gCDW mmolglucose-1) and 
specific growth rate (0.317 h-1), were consistent with those obtained for C. glutamicum 
ΔguaB2, indicating a mutual growth-related effect. However, the metabolic fingerprint for 
C. glutamicum ΔpurA ΔguaB2 exhibited remarkable differences (Table IV-3): the 
unbalanced metabolic behavior observed in C. glutamicum ΔpurA and 
C. glutamicum ΔguaB2 was completely reestablished resulting in constant intracellular 
purine intermediate concentrations for all substances quantified. The double deletion 
mutant showed a decreased intracellular IMP pool of 21.9 µmol gCDW-1 compared to the 
single gene deletion mutants which corresponds to a 44-fold increase compared to the wild 
type strain. The IMP reduction was accompanied by a significant increase of the inosine 
concentration (9.7-fold compared to the wild type strain) and especially hypoxanthine 
(290-fold compared to the wild type strain), indicating a metabolic shift from main purine 
intermediates; i.e., the nucleotides, to the corresponding degradation products 
(nucleobases).  
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Extended metabolic manipulations – combination of central pathway and 
branch pathway modifications 
Finally, the combined influence of the genetic modifications described in “Manipulating 
the main carbon flux distributions” and “Targeted perturbations of the purine biosynthetic 
pathway” (see section “Results”) were investigated. The rationally designed mutant 
C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi is characterized by the amino acid 
substitution (purFK348Q), supposed to affect the regulatory key enzyme for the de novo 
synthesis. In addition, the mutant exhibits gene deletions for the initiating reaction of 
glycolysis (pgi) and for the converting reactions leading from IMP to the successive purine 
nucleotides AMP (purA) and GMP (guaB2).  
The biomass yield of 0.076 gCDW mmolglucose-1 for C. glutamicum ΔpurA ΔguaB2 purFK348Q 
Δpgi was consistent with those obtained for C. glutamicum ΔpurA ΔguaB2 and 
C. glutamicum ΔguaB2. Specific growth rate was however reduced to 0.146 h-1. In contrast 
to the two single gene deletion mutants (ΔpurA and ΔguaB2), the previously observed IMP 
decline observed in the double deletion mutant C. glutamicum ΔpurA ΔguaB2 was even 
more pronounced in the mutant containing the four genetic modifications (Table IV-3). In 
conjunction with these findings, an increased IMP degradation towards the corresponding 
nucleoside inosine and nucleobase hypoxanthine was observed.  
 
Quantification of intracellular carbon flux distributions 
Alterations of in vivo carbon flux distributions were investigated in order to assess the 
impact on the purine intermediate profile. The network contained reactions of glycolysis, 
TCA cycle, anaplerosis and PPP. Estimation of intracellular flux distributions was carried 
out based on measurable extracellular rates; i.e., glucose consumption, biomass and by-
product formation as well as the mass isotopomer data obtained from 13C enriched cellular 
protein. Initial values were statistically varied and multiple parameter estimations were 
performed to guarantee finding of the global minimum solution.  
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The metabolic carbon flux distributions determined for the strains C. glutamicum ATCC 
13032 (wild type), C. glutamicum Δpgi, C. glutamicum ΔpurA ΔguaB2 and C. glutamicum 
ΔpurA ΔguaB2 purFK348Q Δpgi are illustrated in Figure IV-2.  
 
Deletion of the pgi gene strongly affected the carbon flux distribution and caused a 
complete carbon redirection towards the PPP. The reflux of ribose 5-phosphate via the 
non-oxidative part of the PPP entering glycolysis was almost tripled. Activity of the TCA 
cycle was only slightly affected, showing a small reduction from 47.3% in the wild type 
strain to 45.7% in the pgi deletion mutant.  
In contrast, the double deletion mutant C. glutamicum ΔpurA ΔguaB2, possessing an intact 
pgi gene, exhibited the lowest flux through the oxidative part of the PPP (29%), which 
almost exclusively accounted for biomass formation. The relative reflux into glycolysis 
was less than 10%. TCA cycle activity was increased to 85%. The strain C. glutamicum 
ΔpurA ΔguaB2 purFK348QΔpgi showed a carbon flux redirection from glycolysis towards 
the PPP (97.8%) caused by the pgi gene deletion. The relative activity of the TCA cycle 
showed a significant decrease of approximately 35% compared to the double deletion 
mutant and dropped from 85% to 55.8%.  
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Figure IV-2. Intracellular carbon flux distributions with corresponding standard deviations of the 
central metabolism of the wild type C. glutamicum ATCC 13032 (in bold) and mutant strains 
C. glutamicum Δpgi, C. glutamicum ΔpurA ΔguaB2 and C. glutamicum ΔpurA ΔguaB2 purFK348Q 
Δpgi (displayed in that order from top to bottom). Net fluxes are given as molar percentage of the 
mean specific glucose uptake rates (4.67 mmol g-1 h-1 for C. glutamicum ATCC 13032; 
4.18 mmol g-1 h-1 for C. glutamicum Δpgi; 4.24 mmol g-1 h-1 for C. glutamicum ΔpurA ΔguaB2; 
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1.92 mmol g-1 h-1 for C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi), which were set to 100%. 
Anabolic fluxes leading towards biomass formation were not displayed for the benefit of lucidity. 
Anabolic demands for auxotrophic mutant strains C. glutamicum ΔpurA ΔguaB2 and 
C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi were corrected for the supplementation of adenine 
and guanine. Abbreviations: G6P, glucose 6-phosphate; P5P, pentose 5-phosphate; F6P, 
fructose 6-phosphate; F16BP, fructose 1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; 
GAP, glyceraldehyde 3-phosphate; 3PG, 3-phosphoglycerate; PEP, phosphoenolpyruvate; Pyr, 
pyruvate; AcCoA, acetyl-CoA; Iso, isocitrate; AKG, α-ketoglutarate; Suc, succinate; OAA, 
oxaloacetate; Mal, malate; Glyex, glycine (extracellular); Treex, trehalose (extracellular). 
 
 
Perturbation-caused alterations of the NADH metabolism 
The inserted genetic changes also altered the redox metabolism, especially regarding the 
NADH/FADH2 (XADH) supply. A surplus was detected in all strains investigated, which 
could be used for ATP generation by oxidative phosphorylation. However, the relative 
NADH production exhibited significant differences among the modified strains (Figure IV-
3): C. glutamicum ATCC 13032 produced a XADH surplus of 369% which decreased to 
346% in the pgi deletion mutant. An increased surplus of 502% was determined for 
C. glutamicum ΔpurA ΔguaB2. This difference can be ascribed to the low activity of the 
PPP (29%) and the contrariwise high TCA cycle activity (85%). In comparison to 
C. glutamicum ΔpurA ΔguaB2, C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi exhibited a 
decreased XADH surplus of 361%. 
 
Chapter IV   -   Let’s take a look inside 
 
90 
 
Figure IV-3. XADH formation for C. glutamicum ATCC 13032, C. glutamicum Δpgi, 
C. glutamicum ΔpurA ΔguaB2 and C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi. Glyceraldehyde 
3-phosphate dehydrogenase (GAP-DH), pyruvate dehydrogenase (Pyr-DH), α-ketoglutarate 
dehydrogenase (AKG-DH) and malate dehydrogenase (MAL-DH) were considered as NADH 
supplying reactions and succinate dehydrogenase (SUC-DH) as FADH2 supplying reaction. 
Anabolically derived NADH was considered with 3.2 mmol gCDW-1 (Becker et al., 2007). 
 
 
The consequences of the unequal NADH/FADH2 supply are discussed in more detail 
below in “Cluster analysis” (see section “Discussion”). 
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Discussion 
 
 
Rerouting metabolic fluxes – contributions of individual pathway branches 
with respect to purine accumulation  
(i) Targeted perturbations in the purine biosynthetic pathway 
Imbalances in free intracellular purine pools are reported to be mutagenic and genotoxic 
(Mathews, 2006; Wheeler et al., 2005). Thus a prerequisite for balanced cellular growth is 
to maintain the intracellular pool sizes, which resulted in efficient regulatory mechanisms 
(Matsui et al., 2001a; Messenger and Zalkin, 1979; Pang et al., 2011; Saxild and Nygaard, 
1991; Shimaoka et al., 2007; Zhou et al., 1994). This pool stability is on the one hand 
sustained by an interaction of de novo purine synthesis and the salvage pathway, ensuring 
a constant supply of purine nucleotides required for cellular growth (Messenger and 
Zalkin, 1979). On the other hand, increasing concentrations perturbing the system can 
easily be broken down via the present degrading and converting reactions.  
In case of the purA gene deletion mutant (C. glutamicum ΔpurA), extracellular 
supplementation with adenine completely restored cellular growth, resulting in comparable 
specific growth rates of the wild type (0.443 h-1) and the C. glutamicum ΔpurA strain 
(0.455 h-1), indicating a thorough compensatory effect by the salvage pathway.  
On the contrary, extracellular guanine complementation was not sufficient to restore wild 
type growth behavior in the guaB2 gene deletion mutant (C. glutamicum ΔguaB2): specific 
growth rate as well as biomass yield were reduced by 25%, each compared to the wild type 
strain (Table IV-4). This can either be explained by insufficient uptake or converting 
systems for guanine. The latter is catalyzed by the salvage pathway. The observed 
phenotypic consequences reemerged in every genotype comprising this genetic 
perturbation (C. glutamicum ΔguaB2 and C. glutamicum ΔpurA ΔguaB2), no matter if 
single or multiple genes were deleted. The attribution of this fundamental salvage branch 
restriction regarding uptake or conversion could not be answered definitely in this study. 
Decreasing intracellular guanine concentrations in C. glutamicum ΔguaB2, however 
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indicate an uptake insufficiency (and not a conversion insufficiency!). Decreasing 
metabolite concentrations are caused by increased consuming reactions (in this case by the 
salvage pathway). 
In contrast, the purA gene deletion mutant C. glutamicum ΔpurA exhibited increasing 
adenine concentrations, supporting a sufficient adenine uptake, even exceeding converting 
reactions by the salvage pathway. This theory is additionally supported by the reduced 
guanine uptake (125 µmol gCDW-1) compared to the adenine uptake (243 µmol gCDW-1), 
indicating basic differences for both intermediates. 
Regarding intracellular pool sizes, the single gene deletion mutants C. glutamicum ΔpurA 
and C. glutamicum ΔguaB2 were found to exhibit the most promising rises in intracellular 
IMP concentration with maximal IMP pool sizes of 44.0 and 37.2 µmol gCDW-1, 
respectively. The associated transient concentration changes however showed no relation 
to biomass formation and resulted in unstable and thus unrepresentative results. This 
phenomenon may at least partially be associated with direct changes in the GMP and AMP 
pool sizes (Table IV-3). These two compounds are reported to act as the most stringent 
regulators for the purine biosynthetic pathway by a feedback-mediated inhibition of the 
PurF enzyme (Messenger and Zalkin, 1979). With both intermediates operating as 
regulators, it is not surprising that the individual gene deletions cause spreading influences 
on the whole branching pathway. 
 
(ii) Targeted perturbation in the central carbon metabolism 
Increasing the precursor supply via the oxidative branch of the PPP seemed to be a 
promising route to boost intracellular purine levels. This strategy has already been 
successfully applied for tryptophan production in E. coli (Mascarenhas et al., 1991) and 
lysine production in C. glutamicum (Becker et al., 2005; Becker et al., 2007), illustrating 
positive correlations between enhanced productivity and increased PPP activities 
(Wittmann and Becker, 2007). 
Thus, the genetic modification (deletion of the pgi gene) was implemented into the 
genome. The resulting effects on the purine intermediate pool sizes (Table IV-3) however, 
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were rather limited compared to those observed for purA and guaB2 gene deletion strains, 
indicating the strong regulation and rigidity of this pathway. 
 
Effects of combined perturbations on intracellular purine pool sizes 
Strains used for industrial manufacturing of purine intermediates are usually characterized 
by an adenine auxotrophy (Demain et al., 1966; Kamada et al., 2001; Matsui et al., 2001a; 
Mori et al., 1997; Qian et al., 2006). This perturbation seems to be fundamental, revealing 
the importance of an IMP conversion block for the accumulation of this intermediate 
metabolite (Villas-Boas et al., 2005). The extracellular supplementation with adenine, 
however, is linked to a repression of transcription initiation (Qian et al., 2006) of genes of 
the pur operone (Qian et al., 2006) via the depletion of PRPP. In order to counterbalance 
this phenomenon, the carbon flux was rerouted by introducing the pgi gene deletion, 
aiming at an increased PRPP supply (Figure IV-2).  
The carbon flux was successfully rerouted. Intracellular purine levels though further 
shifted from nucleotides towards their degradation products, mainly inosine and 
hypoxanthine (Table IV-3). 
 
Cluster analysis 
In order to analyze correlations between the different manipulated pathway branches, 
principal component analysis (PCA) was performed. The result of the cluster analysis is 
illustrated in Figure IV-4. Pareto-scaled concentrations of purine pathway intermediates 
were used for the PCA, resulting in the global purine metabolite phenotype for each 
mutant.  
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Figure IV-4. PCA score plots of principal components 1 and 2 for C. glutamicum ATCC 13032, 
C. glutamicum Δpgi, C. glutamicum purFK348Q, C. glutamicum ΔpurA, C. glutamicum ΔguaB2, 
C. glutamicum ΔpurA ΔguaB2 and C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi. The metabolite 
profiling was performed using cell extracts of exponentially growing cultures (n = 4 for each 
strain). The respective seven strains are shown with corresponding 95% confidence intervals. Data 
were pareto scaled. The gray insert depicts the analysis of C. glutamicum ATCC 13032, 
C. glutamicum Δpgi and C. glutamicum purFK348Q (zoomed from the right lower corner). For 
C. glutamicum ΔpurA and C. glutamicum ΔguaB2, data obtained for phase 2 were considered (see 
Table IV-3).  
 
The first two components contributed to more than 90% of the total variance. As shown in 
the score plot, a distinct separation pattern defining two groups could be derived 
(Figure IV-4). The first group (A.), comprising the wild type strain, the pgi deletion strain 
and the purF substituent, did not show any significant differences concerning intracellular 
purine intermediate pool sizes. As discussed earlier (see “Manipulating the main carbon 
flux distribution” and “Targeted perturbations of the purine biosynthetic pathway” – 
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“Results”), only minor changes with respect to intracellular concentration of purine 
pathway intermediates were caused by these genetic manipulations, which in direct 
comparison to the second group (B.) were quite consistent. The second group (B.), 
however, resulted in a broader clustering pattern comprising intrinsic dissimilarities. As 
shown by loading coefficients (Figure IV-5), the separation was mainly caused by the 
component IMP and its degradation product hypoxanthine, reflecting the observed shift 
from nucleotide accumulation towards increased degradation.  
 
 
 
Figure IV-5. Loading coefficients for the first (A.) and second (B.) principal component obtained 
from multivariate analysis (Figure IV-4). 
 
 
The disruption of critical nodes in the purine pathway itself, i.e. the conversion of IMP to 
AMP and GMP, provided the required fundamental basis for far-reaching effects when 
combined with additional modifications as the pgi gene deletion. 
Solely based on the metabolome data, no clear link between the additional genetic 
manipulation of the pgi deletion and the increased degradation shift could be concluded. 
Therefore, the research was extended by an in-depth fluxome analysis to capture 
integrative effects of fluxome and metabolome. 
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Connectivity of targeted metabolome and fluxome analysis 
In the context of purine accumulation, alterations in the PPP-TCA cycle ratio were of 
special interest, as their relative activities and especially the flux partitioning into these two 
main branches, mainly dictate the XADH (NADH+FADH2) supply and thus ATP 
formation in the respiratory chain (Noguchi et al., 2003). The exclusive metabolization of 
glucose 6-phosphate via the PPP caused a major carbon flux redistribution in 
C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi, having an adverse effect on XADH 
formation compared to C. glutamicum ΔpurA ΔguaB2 (Figure IV-3) and initiating a shift in 
the metabolic profile towards inosine and especially hypoxanthine formation. Since most 
XADH is generated in the TCA cycle, high PPP activities inevitably lead to an increased 
CO2 production via a decarboxylation reaction in the oxidative part of the PPP and thus to 
a reduced carbon availability for other metabolic branches, as seen for C. glutamicum 
ΔpurA ΔguaB2 purFK348Q Δpgi (Figure IV-2). Within the scope of the tightly regulated 
purine biosynthesis, Noguchi et al. (2003) presumed a connection between a declining 
ATP supply and an increasing degrading efficiency within this pathway. The results 
obtained in this study are consistent with those obtained previously (Noguchi et al., 2003). 
This suggests further metabolic engineering targets to increase intracellular IMP levels 
focusing on IMP degrading reactions. 
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Conclusions 
 
 
In the present study, we performed an in-depth metabolic profiling of the purine 
biosynthetic pathway in C. glutamicum. Site-directed perturbations on the genetic level 
with subsequent studies of growth behavior and targeted metabolome analysis revealed a 
tight regulation of the underlying pathway with strong additional effects on the carbon flux 
distributions in the main metabolism as determined for C. glutamicum ΔpurA ΔguaB2 and 
C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi. 
Our results underline the importance of combined analyses employing different 
hierarchical levels such as fluxome and metabolome to reveal trends which indicate active 
regulation mechanisms. The regulatory processes maintaining balanced intracellular 
concentrations have not been fully discovered yet and necessitate further investigation. 
Complex future studies will thus focus on the redox and energy metabolisms, which were 
beyond the scope of the present analyses. In addition, it might be interesting to further 
analyze the metabolic instabilities – detected for C. glutamicum ΔpurA and C. glutamicum 
ΔguaB2. These instabilities were caused by the alteration of the complex regulatory 
structure of this pathway branch, opening up a way for in-depth surveys of this essential 
pathway in prokaryotes as well as in eukaryotes.  
 
In order to achieve an understanding of the global cellular response, individual parts of the 
underlying network, i.e. precursor and cofactor supply, energy and redox metabolism, 
should not be assumed as independent, individual but interconnected units, linked by 
various key metabolites such as ATP or NAD(P)H. 
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Chapter V 
 
Refining and redefining metabolic 
networks 
Restriction of the metabolic flexibility due to pgi gene 
deletion triggers a unique adaptation process in 
C. glutamicum involving increased oxygen uptake 
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Abstract* 
 
 
The flexibility and adaptability of the Gram-positive soil bacterium 
Corynebacterium glutamicum to various environmental as well as genetic perturbations 
provides the basis for the pronounced robustness of this organism. However, if essential 
key genes, as the glucose 6-phosphate isomerase (pgi), are deleted, the metabolic 
flexibility and concomitantly the overall growth performance is tremendously declining, 
ultimately resulting in complete growth stagnation, caused by NADPH imbalances.  
This work describes physiological changes, triggered by pgi deletion in C. glutamicum. 
Thereby analysis of growth behavior, 13C metabolic flux analyses and intracellular 
quantitation of the redox cofactors NADPH and NADP+ were performed. Combining those 
approaches, a unique adaptation process of C. glutamicum upon pgi deletion was 
determined, resulting in increased specific oxygen uptake rates, surpassing the oxygen 
demand for NADH reoxidation in the respiratory chain. This phenomenon exclusively 
occurred in pgi deletion strains used in this work. Findings from 13C metabolic flux 
analysis excluded malic enzyme as the sole reoxidation route for NADPH besides biomass 
formation, which was further confirmed by the deletion of this enzyme 
(C. glutamicum ΔmalE Δpgi). Excessive oxygen not required for NADH reoxidation might 
partly participate in reoxidation of surplus NADPH. 
 
 
 
 
 
* Manuscript in preparation: 
Peifer S, Höfner M, Heinzle E, Schneider K. 
Restriction of the metabolic flexibility due to pgi gene deletion triggers a unique adaptation process in 
C. glutamicum involving increased oxygen uptake. 
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Introduction 
 
 
The carbon contained in metabolized substrates such as glucose gets distributed through 
the entire metabolic network depending on the flux activities of the contributing pathways 
to supply building blocks required for biomass formation. In addition to the supply of 
precursor molecules, redox equivalent requirements – NADH and NADPH – have to be 
covered and evenly balanced (Dominguez et al., 1998), as this would otherwise result in an 
impairment of cellular growth or even in its termination (Nissen et al., 2001).  
The redox equivalents NADH and NADPH, chemically very similar, possess however 
fundamental distinctions within the cellular metabolism: NADH is linked to catabolic 
reactions (Verho et al., 2003) and used in the respiratory chain to meet the anabolic ATP 
demand, while NADPH, in contrast, functions as a reducing equivalent in anabolic 
reactions participating in biomass formation. These two systems – NAD+/NADH and 
NADPH/NADP+ – are thus not in a thermodynamic equilibrium (Fuhrer and Sauer, 2009) 
while the NAD+/NADH ratio exhibits a rather oxidized state and the NADPH/NADP+ ratio 
a rather reduced state. 
During aerobic growth, NADH is generally produced in excess as the net anabolic biomass 
formation additionally generates NADH. This surplus is then used to drive ATP generation 
via the respiratory chain. NADPH, however, is used in anabolic reduction and – if present 
– product formation reactions. A question that has been addressed frequently, is the 
manner in which adequate amounts of NADPH are provided and excessive availability is 
equalized (Fuhrer and Sauer, 2009; Hua et al., 2003). Several mechanisms in different 
organisms have been reported so far, ensuring network-wide balancing of this redox 
equivalent (Fuhrer and Sauer, 2009).  
One mechanism found to be essential in E. coli, is the employment of transhydrogenases, 
generating a biomass-decoupled system to convert NADPH and NADH (Canonaco et al., 
2001; Sauer et al., 2004). This system was found to be active in terms of NADPH 
deficiencies, providing NADPH by the membrane-bound transhydrogenase PntAB, as well 
as oxidizing NADPH in case of overabundances, employing the soluble isoenzyme UdhA 
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(Sauer et al., 2004). Transhydrogenases are not limited to E. coli but mainly studied in this 
organism (Auriol et al., 2011) and were in addition found to be active i.a. in Bacillus 
subtilis and Paracoccus versutus as determined by Fuhrer and Sauer (2009).  
In organisms lacking transhydrogenases, alternative systems evolved, such as for example 
usage of enzymes exhibiting dual cofactor specificities or the existence of different 
isoenzymes with distinct cofactor specificities (Fuhrer and Sauer, 2009) as observed in 
Agrobacterium tumefaciens, Rhodobacter spaeroides, Sinorhizobium meliloti and 
Zymomonas mobilis. One organism neither possessing an active transhydrogenase, 
isoenzymes nor enzymes exhibiting dual cofactor-specificities in terms of NADPH-
dependencies (Kalinowski et al., 2003) is C. glutamicum.  
In this work we addressed the question of alternative NADPH oxidizing systems that could 
balance catabolic NADPH formation and anabolic consumption under excessive NADPH 
generating conditions. We therefore restructured the central metabolism of C. glutamicum 
using rational metabolic engineering, forcing an increased PPP activity via a glucose 6-
phosphate isomerase (pgi) deletion and thus elevated the NADPH generation. In a 
combined analysis, employing 13C metabolic flux analysis, quantification of intracellular 
redox equivalents and off-gas analysis we investigated the metabolic response based on the 
implemented genetic modification.  
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Materials and methods 
 
 
Strains and plasmids 
The wild type strain C. glutamicum ATCC 13032 was purchased from the American Type 
Culture Collection (Manassas, VA, USA) and used as reference strain for further 
modifications. Cloning and plasmid construction was performed employing E. coli DH5α 
as host strain, whereas plasmid amplification and introduction of the coryne-specific 
methylation were carried out in E. coli NM522pTC. In E. coli NM522pTC the pTC plasmid, 
harboring an origin of replication (ori) for E. coli, a tetracycline resistance as selection 
marker and the DNA-methyltransferase gene from C. glutamicum, was co-expressed in 
order to transfer the methylation pattern of C. glutamicum to the integrative plasmids. The 
non-replicating vector used for integrative genetic modifications in C. glutamicum, pClik, 
contained a multiple cloning site (MCS), selection markers for kanamycin (KanR) and sacB 
and an ori for E. coli. The constructed pClik-derivates were used for homologous 
replacement of the native gene sequences with the modified ones. Transformation of 
C. glutamicum and subsequent selection on KanR yielded transformants with genome-
integrated plasmids via single crossover. The second recombination event was depicted by 
the sacB positive selection system on sucrose (Jager et al., 1992). KanR-sensitive and 
sucrose-insensitive clones were tested for the existence of the modified gene sequence via 
PCR and positive clones were additionally sequenced.  
In the present work, perturbations of the pentose phosphate pathway and the malic enzyme 
with regard to general growth behavior and metabolic flexibility were investigated. In 
order to manipulate these metabolic pathways, gene deletions affecting glucose 6-
phosphate isomerase (pgi) and/or malic enzyme (malE) were performed.  
The site-directed mutants and corresponding genetic modifications performed in this study 
are depicted in Table V-1. Primer sequences used for verification are listed in Table V-2. 
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Table V-1. C. glutamicum strains constructed in the present study: Mutant strains of 
C. glutamicum based on the wild type strain (ATCC 13032) were constructed by targeted 
mutagenesis. Plasmid construction and methylation were performed employing E. coli strains. 
 
 strain 
 
genotype 
 
reference 
 
  
C. glutamicum ATCC 13032 
 
wild type 
 
 
American Type Culture 
Collection 
 C. glutamicum Δpgi deletion of the pgi gene This work 
 C. glutamicum ΔmalE deletion of the malE gene This work 
 C. glutamicum ΔmalE Δpgi double deletion of malE and pgi 
genes 
This work 
  
E. coli DH5α 
 
F−endA1, hsdR17(rk−mk+) supE44, 
thi-1λ− recAI gyrA96 relA1 
Φ80ΔlacAm15 
 
(Hanahan, 1983) 
  
E. coli NM522pTC 
 
supE thi-1 Δ(lac-proAB) Δ(mcrB-
hsdSM)5 (rK− mK+) [F′ proAB 
lacIqZΔM15] 
 
Stratagene 
 
 
 
Table V-2. Genotypes and corresponding site-specific primer sequences used for verification (F, 
forward; R, reverse). 
 
 mutant 
genotype 
 
primer 
 
primer sequence 
 
  
Δpgi 
 
Δpgi-F 
Δpgi-R 
 
 
5′-GATCACGCGTATCCCTTCTCCGGCATC-3′ 
5′-GATCTCTAGATCCAGCGACACGAATAATC-3′ 
 ΔmalE ΔmalE-F 
ΔmalE-R 
 
5′-GATCACGCGTTCAGCCCACTGAATCAAC-3′ 
5′-GATCTCTAGAGAATATCTACCACAAGACGC-3′ 
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Recombinant DNA techniques and strain construction 
Oligonucleotide synthesis was performed by Sigma-Aldrich (Steinheim, Germany) and 
DNA sequencing by GATC (Konstanz, Germany). Plasmid construction and DNA 
purification were performed applying standard techniques. Preparation of genomic DNA 
from C. glutamicum was carried out with the MasterPureTM Gram Positive DNA 
Purification Kit (Biozym Scientific GmbH, Germany). PCR reactions were performed in a 
TGradient-Cycler (Whatman – BiometraR, Goettingen, Germany) with Phusion polymerase 
(Biozym, Hessisch Oldendorf, Germany) for insert construction and JumpStart REDTaq 
Ready Mix (Sigma-Aldrich) for strain verification. PCR products were purified using 
NucleoSpin® Extract II Kit (Macherey-Nagel, Düren, Germany) and plasmids using 
HiYield® Plasmid Mini Kit (SLG, Gauting, Germany). Ligation was done with Fast-
LinkTM DNA Ligation Kit (Epicentre Biotechnologies, Madison, WI, USA). FastDigest® 
restriction enzymes were obtained from Fermentas (St. Leon-Rot, Germany) as well as 
10 mM dNTP Mix and 1-kb DNA O’GeneRulerTM. 
For transformation of C. glutamicum, cells were cultivated in BHI++ medium (10 mL in 
100 mL baffled shake flasks) for 12 hours. The main culture in BHI++ medium (80 mL in 
1000 mL baffled shake flasks) was inoculated from the exponentially growing preculture 
to an optical density OD660nm of 0.2. 400 mg isonicotinic acid hydrazide, 2.5 g glycine and 
0.1 mL Tween 80 were dissolved in 20 mL H2O, sterilized by filtration and added to the 
main culture at an OD660nm of 0.6. Cells were harvested by centrifugation (7 min, 4,000 g, 
4°C, Laborfuge 400R, Heraeus, Hanau, Germany) when an OD660nm of 0.8 was reached. 
Cells were washed three times with pre-cooled wash-buffer (10% glycerine, 8 mM tris 
hydrochloride, pH 7.4) and once with 10% glycerine. After the second resuspension in 
6 mL 10% glycerine, 200 µL cells were subsequently used for transformation by 
electroporation as described previously (Tauch et al., 2002; van der Rest et al., 1999).  
 
Transformation of E. coli DH5α and NM522pTC was performed by heat-shock (Inoue et al., 
1990).  
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Chemicals 
Yeast extract, polypeptone, casamino acids, beef extract and brain heart infusion (BHI) 
were purchased from Difco Laboratories (Detroit, USA). 99% enriched glucose, i.e. [1-
13C] and [1,2-13C2], were obtained from Cambridge Isotope Laboratories (Andover, MA, 
USA). All other chemicals and reagents were purchased from Sigma-Aldrich, Merck 
(Darmstadt, Germany), Fluka (Buchs, Switzerland), Roth (Karlsruhe, Germany) and Roche 
Diagnostics (Mannheim, Germany) and were of analytical grade unless stated otherwise. 
 
Media 
The first precultures were grown on complex media containing per liter (pH 6.8): 10.0 g 
glucose, 2.5 g NaCl, 2.0 g urea, 5.0 g yeast extract, 5.0 g beef extract, 5.0 g polypeptone 
and 20.0 g casamino acids. For agar plates, the complex medium was supplemented with 
20.0 g L-1 agar. Second precultures and main cultures were cultivated in minimal medium 
(pH 7.2) containing per liter: 15.0 g glucose, 4.0 g KH2PO4, 16.0 g Na2HPO4, 500 mg 
MgCl2 · 6 H2O, 300 mg 3,4-dihydroxybenzoic acid, 100 mg CaCl2 · 2 H2O, 100 µg 
cyanocobalamin, 750 µg thiamine, 4 µg pyridoxal phosphate, 100 µg biotin, 400 µg 
calcium pantothenate, 2 µg folic acid, 400 µg nicotinic acid, 200 µg 4-aminobenzoic acid, 
400 µg pyridoxine · HCl, 2 mg inositol, 10 mg FeCl2 · 4 H2O, 1 mg ZnCl2, 100 µg CuCl2, 
20 µg NiCl2 · 6 H2O, 20 µg Na2MoO4 · 2 H2O, 500 µg boric acid, 100 µg KI, 100 µg 
CoCl2 · 6 H2O, 10 mg MnCl2 · 4 H2O. For tracer studies, naturally labeled glucose was 
replaced by 99% 13C enriched [1-13C] or [1,2-13C2] glucose for analysis of glucose 6-
phosphate isomerase (pgi) deletion mutants and the volume was adjusted to 5 mL in 50 mL 
baffled shake flasks. 
 
Media applied for transformation experiments of C. glutamicum contained per liter: 37 g 
BHI, 26.4 g (NH4)2SO4 and 40 g glucose for BHI++ and 37 g BHI and 46 g sorbitol for 
BHIS medium.  
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Cultivation conditions 
Cultivations were carried out in baffled shake flasks on an orbital shaker (Multitron 2, 
Infors AG, Bottmingen, Switzerland) at 230 rpm and 30°C. First precultures were grown 
on complex medium (25 mL medium in 250 mL baffled flasks) for 8 h and used for 
inoculation of the second precultures (25 mL medium in 250 mL baffled flasks). Second 
precultures and main cultures were performed in minimal medium. Main cultivations were 
carried out in a 500 mL stirred tank bioreactor (Meredos, Bovenden, Germany) containing 
75 mL minimal medium at 30°C and 1,000 rpm maintaining dissolved oxygen 
concentrations above 40% air saturation throughout the entire cultivation. The gas flow 
was controlled at 1 vvm (vessel volume per minute) by a mass flow controller (WMR 
Compact4, Brooks Instruments, Veenedaal, Netherlands). The composition of aeration and 
exhaust gas was determined by a quadrupole mass spectrometer (Omnistar, Pfeiffer). 
Process variables, i.e. temperature, pH, agitation, dissolved oxygen and gas composition 
were collected and stored using the Lucullus process control system (Lucullus PIMS 2.1, 
Biospectra, Schlieren, Switzerland).  
 
Cell disruption and quantification of enzymatic activities 
Determination of the in vitro enzyme activities was performed in crude cell extracts. 
Therefore cells were cultivated in 25 mL minimal medium in 250 mL baffled shake flasks 
(precultures) which were used for inoculation of the main culture performed in 50 mL 
minimal medium in 500 mL baffled shake flasks. Cells were harvested by centrifugation 
(5 min, 9,800 g, 4°C) during mid-exponential growth phase and washed twice in disruption 
buffer (100 mM Tris/HCl, 10 mM MgCl2, pH 7.5, 4°C). After resuspension in disruption 
buffer and addition of DTT (dithiothreitol) to a final concentration of 0.75 mM, 1 mL cell 
suspension was mixed with 100 mg glass beads (Ø 0.25 mm). Cell disruption was 
performed using a bead mill (Retsch, MM301, Hahn, Germany) at 30 Hz for 5 min (two 
times). Between disruption periods, the cell suspension was cooled on ice for 10 min. Cell 
debris was removed by centrifugation (15 min, 16,000 g, 4°C). The remaining crude cell 
extract was used for determination of the total protein content and enzymatic activities. 
The protein content was determined by the method of Bradford (1976) and the reagent 
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solution from Sigma-Aldrich with bovine serum albumin as external standard. In vitro 
enzymatic activities were determined for the NADP+-dependent malic enzyme (MalE) and 
the first enzyme of the glyoxylate pathway, isocitrate lyase (IsoLy). For reactions based on 
NADPH formation, the molar extinction coefficient of the reduced pyridine-dinucleotide 
(ε340nm = 6.22 mM-1) was used, for those based on phenylhydrazone formation the 
extinction coefficient ε324nm (17.0 mM-1). 
Malic enzyme. The reaction mixture contained 100 mM Tris/HCl (pH 7.8), 200 mM KCl, 
2 mM MgCl2, 1 mM NADP+, 40 mM malate and 50 µL of the crude cell extract. The final 
protein content was between 0.2-0.4 g L-1. Determination of the in vitro malic enzyme 
activity was based on the change of absorption at 340 nm due to NADPH formation.  
Isocitrate lyase. Determination of the in vitro activity of isocitrate lyase in crude cell 
extracts of C. glutamicum was based on the protocol of de Jong-Gubbels et al. (1995) with 
slight modifications. The reaction mixture contained 50 mM MOPS (pH 7.3), 2.5 mM 
MgCl2, 2.5 mM cysteine, 4 mM phenylhydrazine, 2 mM isocitrate and 50 µL of the crude 
cell extract. The final protein concentration was between 0.2-0.4 g L-1. Determination of 
the enzymatic activity was based on the change of absorption at 324 nm due to the 
formation of glyoxylate phenylhydrazone. 
Measurements were started by addition of the substrates, performed at 30°C and monitored 
for 15-30 min. Negative controls were performed without substrate or crude cell extract, 
respectively. All measurements were performed in a total volume of 1 mL and carried out 
in triplicate.  
 
Analytics for extracellular substrate and product analysis 
Cell concentrations were determined by measuring the optical density at 660 nm (OD660nm) 
using a photometer (Marsha Pharmacia Biotech, Freiburg, Germany) and gravimetrically 
correlated to the cell dry weight. Supernatants from the cultivations obtained after 3 min 
centrifugation at 16,000 g were used for quantification of extracellular substrates and 
secreted products. Glucose, α-ketoglutarate and trehalose were quantified in diluted 
supernatants by HPLC (Kontron Instruments, Neufahrn, Germany) using an Aminex HPX-
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87H Bio-Rad column (300 x 7.8 mm; Hercules, USA) at 55°C with a constant flow rate of 
0.8 mL min-1 (7 mM H2SO4 as mobile phase). Quantification of sugars was performed 
using refraction index (RI) detection and UV detection at 218 nm for organic acids. 
Determination of amino acids was performed as described previously (Kromer et al., 
2005). 
 
Analytics for intracellular metabolite quantification 
Due to varying pH stabilities of oxidized and reduced species of pyridine nucleotides, 
different extraction procedures (alkaline and acidic) were applied, resulting in the complete 
degradation of either the oxidized or reduced form. Thus a separate determination allowing 
absolute quantification of both species was provided. 
Extraction of intracellular pyridine nucleotides (NADP+, NADPH) was based on the 
protocol of Franco et al. (1984) and modified as follows: for all extractions, 2 mL samples 
from exponentially growing C. glutamicum cells were drawn in a syringe filled with 2 mL 
of the corresponding extraction solution, preheated to 55°C. For acidic extraction 1 M 
HClO4 was used, for alkaline extraction 1 M KOH (50% ethanol; v:v). Instantaneous 
mixing of sample and extraction solution was ensured by the generated turbulences and 
additionally verified by colored test solutions (bromphenol blue and phenolphthalein). 
Incubation at 55°C was performed for 3 min, followed by addition of 500 µL 0.5 M 
potassium phosphate buffer (pH 7.0) and of adequate volumes of 2 M KOH or 1 M HCl for 
neutralization. After incubation on ice for 10 min, cell debris and insoluble 
macromolecules were removed by centrifugation (10 min, 4°C, 6,000 g).  
Quantification of the extracted pyridine nucleotides was performed employing an 
enzymatic cycling assay according to Bernofsky and Swan (1973) which was slightly 
modified. The reaction mixture contained 120 mM bicine (pH 5.8), 0.4 g L-1 5-
ethylphenazinium ethyl sulfate (PES), 0.125 g L-1 thiazolyl blue (MTT), 375 µM glucose 
6-phosphate, 50 µM MgSO4 · 7 H2O, 1.4 U mL-1 glucose 6-phosphate dehydrogenase and 
150-325 µL mL-1 cell extract.  
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Measurements were started by addition of glucose 6-phosphate dehydrogenase at 30 °C 
and monitored for 60 min at 560 nm (Reader Biorad, model 680XR). Negative controls 
were performed without cell extract. All measurements were carried out in microtiter 
plates in a total volume of 200 µL.  
 
Determination of intracellular pyridine nucleotide concentrations normalized to the cell dry 
weight was achieved by simultaneous determination of the optical density for each 
sampling process. To ensure metabolic steady state and thus stable metabolite 
concentrations over the whole cultivation period, cultivations were performed in duplicate 
and samples were taken for two biomass concentrations, each as duplicate, resulting in 8 
biological samples. Concentrations were determined for two replicates for each sample. 
Calibrations were carried out using separate external standard series for each compound in 
the range from 0.0125 µM to 0.25 µM. 
 
Respiration analysis 
In order to perform an in-depth analysis of the redox metabolism of C. glutamicum, 
including NADH, FADH and NADPH as redox cofactors, a complete cofactor balance was 
set up and compared to the wild type strain as described by Yang et al. (2006). 
Reoxidation of NADH and FADH2 (XADH) was balanced assuming sole reoxidation of 
XADH by oxygen. Thus the amount of XADH to be reoxidized by cellular metabolism is 
restricted by the specific oxygen uptake rate of the microbial culture as follows:  
 
 qO2 – ½ qXADH – ½ qNADPH = 0. 
 
qO2 corresponds to the specific oxygen uptake rate determined using inert gas balancing 
(Heinzle et al., 1990). qXADH, accounting for metabolic fluxes involved in the production of 
XADH (catabolic and anabolic), and qNADPH, accounting for fluxes involved in the 
production and consumption of NADPH (catabolic and anabolic), which can be calculated 
from the metabolic flux distribution determined by 13C MFA as described by Becker et al. 
(2007) and Yang et al. (2006). 
[2]
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The anabolic NADH production of 3.2 mmol NADH per gram biomass was adopted from 
literature for C. glutamicum (Yang et al., 2006), as was the anabolic demand of 15.9 mmol 
NADPH per gram biomass (Yang et al., 2006). 
 
Metabolic network analysis 
The metabolic network of C. glutamicum including all main metabolic pathways utilized 
during growth on glucose comprises i.e. glycolysis, pentose phosphate pathway (PPP), 
tricarboxylic acid (TCA) cycle and anaplerosis. Since usage of [1-13C] labeled glucose is 
insufficient to distinguish between phosphoenolpyruvate and pyruvate as well as 
oxaloacetate and malate pools, these pools were lumped together and only the net 
anaplerotic fluxes were calculated. Glyoxylate pathway was shown to be inactive and was 
therefore neglected. Anabolic pathways towards biomass production and production 
pathways for α-ketoglutarate, trehalose and glycine were incorporated in the metabolic 
network topology. For determination of the metabolic fluxes of mutants comprising the pgi 
deletion [1,2-13C2] labeled glucose was used instead of [1-13C] labeled glucose.  
Calculation of the in vivo metabolic fluxes of the C. glutamicum strains was carried out by 
fitting simulated mass isotopomer distributions to experimentally determined labeling 
patterns of amino acids derived from cellular protein and trehalose secreted during 
cultivation. The calculations were based on the approach of Yang et al. (2008) 
implemented in Matlab (version 2008b, Mathworks Inc., Nattick, USA) using metabolite 
and isotopomer balancing. The hydrolyzed amino acids were analyzed by GC-MS and 
corresponding single mass isotopomer fractions were determined as described previously 
(Kiefer et al., 2004; Wittmann et al., 2004a). The labeling pattern of secreted trehalose was 
determined from supernatants as described by Wittmann et al. (2004b). All samples were 
analyzed in scan mode thereby exluding isobaric interferences between analytes and 
sample components.  
Mass isotopomer fractions of amino acids and trehalose were determined using selective 
ion monitoring (SIM) mode in duplicates. In order to account for naturally occurring 
isotopes in the fragments and derivatization groups, measured GC-MS data were corrected 
(van Winden et al., 2002; Wittmann and Heinzle, 1999) and fitted to the simulated 
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isotopomer distributions. 13C enrichment for amino acids was determined on the basis of 
the [M-57] fragments except for leucine ([M-157]). The mass isotopomer distribution of 
trehalose was analyzed for the m/z 361 fragment consisting of one glucose moiety. 
Anabolic demands for biomass synthesis and extracellular production rates ware 
additionally considered and implemented in the metabolic network. A Monte Carlo 
approach with 100 independent runs was employed for the statistical analysis of metabolic 
flux estimations (Wittmann and Heinzle, 2002). 
  
Refining and redefining metabolic networks   -   Chapter V
 
113 
Results and discussion 
 
 
All strains analyzed in this study were characterized in terms of growth and carbon flux 
distribution, especially emphasizing redox metabolism. The metabolic flux analysis, 
focusing on the central metabolism of C. glutamicum, was performed in order to unravel 
the metabolic consequences of the genetic modifications and to highlight the cellular 
response due to manipulations of the cofactor metabolism of NADPH. All genetic 
modifications were validated on genomic level by PCR as well as on the physiological 
level by measuring enzymatic activities. In the case of the pgi deletion, validation was 
carried out using [1-13C] labeled glucose and comparing the obtained isotopomer 
distribution for alanine. Due to the decarboxylating reaction in the oxidative branch of the 
PPP, the 13C labeled carbon atom of glucose is completely decarboxylated resulting in the 
natural isotopomer distribution of alanine (data not shown). This proves the absence of any 
activity of the glycolysis pathway, 
 
NADPH metabolism in C. glutamicum wild type ATCC 13032 
Using a combination of 13C flux analysis and a metabolomic approach focusing on the 
intracellular redox equivalent concentrations, NADPH metabolism of wild type strain 
C. glutamicum was investigated and compared with the mutant exhibiting the pgi deletion, 
C. glutamicum Δpgi. Since the PPP is considered to operate as the main pathway providing 
NADPH (Lee et al., 2010), modifications targeting this pathway were investigated in great 
detail with respect to NADPH demanding biotechnological product formation (Becker et 
al., 2007; Becker et al., 2011). However, even in case of high NADPH demands, the 
NADPH supply has to be balanced which is further complicated in strains lacking any 
additional NADPH sink. In this case a cellular response has to be triggered that eventually 
balances producing and consuming reactions. This metabolic modulation can generally be 
performed by a number of diverse mechanisms in different organisms, e.g. employing 
transhydrogenases (Sauer et al., 2004), applying unspecific cofactor dependencies of 
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different enzymes (Fuhrer and Sauer, 2009), or activating latent pathways (Fong et al., 
2006; Hua et al., 2003).  
Calculation of NADPH generating fluxes was based on the metabolic flux distributions 
determined for each strain and comprised reactions catalyzed by the glucose 6-phosphate 
dehydrogenase (G6PDH), the 6-phosphogluconate dehydrogenase (6PGDH) and the 
isocitrate dehydrogenase (ICD), where the carbon flux is equivalent to the NADPH 
generation. Calculations of the NADPH consuming fluxes considered the NADPH 
requirements for biomass formation which are linked to the stoichiometry of the 
biosynthetic reactions, the cell composition and the biomass yield. The activity of the 
malic enzyme (MalE), also involved in NADPH metabolism, was considered separately 
since previous studies reported no contribution to NADPH formation in the wild type 
strain (Kromer et al., 2008; Petersen et al., 2000) during growth on glucose. 
Growth parameters are summarized in Table V-3 for the C. glutamicum strains subjected to 
the implemented genetic manipulations.  
In addition, carbon balances were set up and determined to be statistically closed for all 
strains analyzed in this work, ensuring that all main products were considered. 
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Table V-3. Growth parameters (specific growth rates [µ], biomass yields [YX/S], specific uptake 
rates [qS, qO2] and production rates [qCO2]) with corresponding standard deviations and carbon 
balances for the wild type strain (C. glutamicum ATCC 13032) and site-directed mutants 
(C. glutamicum Δpgi, C. glutamicum ΔmalE and C. glutamicum ΔmalE Δpgi) grown on glucose. 
 
 parameter ATCC 13032 Δpgi ΔmalE ΔmalE Δpgi 
 
              
 µ 0.443 ± 0.004 0.376 ± 0.001 0.439 ± 0.002 0.345 ± 0.002 
 
 YX/S 0.095 ± 0.005 0.090 ± 0.002 0.093 ± 0.004 0.082 ± 0.005 
 
 qs 4.67 ± 0.09 4.18 ± 0.02 4.73 ± 0.02 4.21 ± 0.06 
 
 qO2 8.55 ± 0.21 8.71 ± 0.26 10.84 ± 0.32 9.98 ± 0.29 
 
 qCO2 8.85 ± 0.19 9.56 ± 0.12 11.26 ± 0.23 10.41 ± 0.21 
 
 
Carbon  
balance [%] 97.4 ± 1.1 102.0 ± 1.2 104.0 ± 3.5 105.3 ± 3.4 
 
 
data represent mean values obtained from two parallel cultivations with corresponding standard deviations: 
specific growth rates (µ) [h-1]; biomass yields (YX/S) [g mmol-1], specific glucose consumption rates (qS) 
[mmol g-1 h-1], specific oxygen uptake rates (qO2) [mmol g-1 h-1] and specific CO2 production rates (qCO2) 
[mmol g-1 h-1]. 
 
Metabolic flux distributions obtained for the different strains, as well as the corresponding 
NADPH balances are shown in Table V-4 and Figure V-1, respectively.  
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Table V-4. Intracellular carbon flux distributions [%] with corresponding standard deviationsa 
determined for C. glutamicum ATCC 13032, C. glutamicum Δpgi, C. glutamicum ΔmalE and 
C. glutamicum ΔmalE Δpgi. 
 
 flux parameter 
 
ATCC 13032 
 
Δpgi 
 
ΔmalE 
 
ΔmalE Δpgi 
     
 G6P isomerase 52.2 ± 1.3             --  54.6 ± 3.6   --  
 G6P DH 44.9 ± 1.3 97.8 ± 0.1 43.0 ± 3.6 97.7 ± 0.1 
 transketolase 1 12.9 ± 0.4 30.8 ± 0.0 12.6 ± 1.2 30.9 ± 0.0 
 transketolase 2 10.3 ± 0.4 28.4 ± 0.0 10.4 ± 1.2 28.7 ± 0.0 
 aldolase 72.3 ± 0.4 56.4 ± 0.1 75.0 ± 1.1 57.1 ± 0.1 
 G3P DH 153.7 ± 0.4 140.1 ± 0.3 159.3 ± 0.9 141.9 ± 0.4 
 enolase 140.0 ± 0.4 128.7 ± 0.3 147.5 ± 0.8 130.7 ± 0.5 
 pyruvate DH 78.8 ± 0.4 73.8 ± 0.7 95.6 ± 0.8 80.1 ± 1.3 
 citrate synthase 47.3 ± 0.4 45.7 ± 0.9 68.9 ± 1.0 54.1 ± 1.6 
 α-ketoglutarate DH 35.0 ± 0.4 34.6 ± 0.9 58.4 ± 1.1 44.0 ± 1.8 
 pyruvate carboxylaseb 29.0c ± 0.0 25.9d ± 0.2 24.6 ± 0.2 23.9 ± 0.4 
 
data are given as relative fluxes [%] normalized to the specific glucose uptake rates qS (see Table V-3), which 
were set to 100%. 
a  mean values and standard deviations were calculated from 100 independent Monte Carlo runs. 
b  given as net flux through anaplerotic reactions. 
c carboxylating and decarboxylating reactions of the anaplerosis of C. glutamicum ATCC 13032 were 40.1 
± 2.0% and 11.1 ± 2.0%, respectively. 
d carboxylating and decarboxylating reactions of the anaplerosis of C. glutamicum Δpgi were 49.7 ± 3.8% 
and 23.8 ± 3.7%, respectively. 
 
 
The high biomass yield of 0.095 gCDW mmolglucose-1 obtained for the wild type strain caused 
a high NADPH demand for anabolic reactions which was almost identical to combined 
generating reactions of the G6PDH, 6PGDH and ICD (Figure V-1).  
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Figure V-1. NADPH balances for C. glutamicum ATCC 13032, C. glutamicum Δpgi, 
C. glutamicum ΔmalE and C. glutamicum ΔmalE Δpgi comprising NADPH generating reactions of 
the PPP (G6PDH and 6PGDH) and TCA cycle (ICD). Anabolism with a stoichiometric NADPH 
demand of 15.9 mmol gCDW-1 (Yang et al., 2006) was considered as consuming reaction.  
 
Deregulation of the pentose phosphate pathway activity 
As depicted in Table V-4, pgi deletion caused a complete redirection of the carbon flux 
through the oxidative branch of the PPP (97.8%), resulting in a tremendous surplus of 
NADPH (98.1%) exceeding the anabolic capacities (Figure V-1), as was further supported 
by the increasing intracellular NADPH/NADP+ ratio of 4.3 ± 2.8 (wild type 2.8 ± 1.4; 
Table V-5). As an evenly balanced redox metabolism is a prerequisite for balanced growth, 
additional so far unassigned NADPH consuming reactions must be present.  
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Table V-5. Intracellular concentrations [µmol gCDW-1] of NADPH and NADP+ with corresponding 
ratios [-] for C. glutamicum ATCC 13032, C. glutamicum Δpgi, C. glutamicum ΔmalE and 
C. glutamicum ΔmalE Δpgi. 
 
 strain 
NADPH 
concentration 
NADP+ 
concentration 
NADPH/NADP+ 
ratio [-] 
     
 
ATCC 13032 0.324 ± 0.036 0.117 ± 0.057 2.8 ± 1.4 
 
Δpgi 0.437 ± 0.094 0.101 ± 0.063 4.3 ± 2.8 
 
ΔmalE 0.356 ± 0.030 0.100 ± 0.008 3.6 ± 0.4 
 
ΔmalE Δpgi 0.699 ± 0.043 0.041 ± 0.005 17.1 ± 2.4 
 
 
A potential reported candidate for NADPH oxidation is malic enzyme (MalE) operating in 
carboxylating direction (Becker et al., 2007). Though even considering an exclusive 
carboxylating activity solely by MalE – determined by the anaplerotic flux activity derived 
from 13C MFA – the NADPH surplus in C. glutamicum Δpgi (98.1%), could not be 
balanced (Table V-6). In sharp contrast to the transhydrogenase of E. coli, the electron-
transferring capacity of MalE of C. glutamicum is restricted by the corresponding flux 
activity through the carboxylating reaction of the anaplerosis (49.7% maximal activity in 
C. glutamicum Δpgi; Table V-4).  
As MalE however seems to be involved in this NADPH balancing process, it was deleted, 
resulting in a malE deficient strain (C. glutamicum ΔmalE) and a pgi-malE double deletion 
mutant (C. glutamicum ΔmalE Δpgi). The consequences in terms of growth behavior, i.e. 
specific growth rate, were then investigated and the participation of this enzyme in relation 
to the different genetic perturbations was determined. 
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Perturbations of the malic enzyme activity 
Tables V-3 and V-4 depict the growth characteristics and carbon flux distributions 
determined for C. glutamicum ΔmalE. Deletion of malE caused a slight reduction of the 
biomass yield while the growth rate was not affected significantly compared to the wild 
type strain (Table V-3). Figure V-1 illustrates the NADPH supply (154.9 ± 5.2%) and 
demand (148.2 ± 3.2%) with respect to the glucose uptake rate which were evenly 
balanced. The NADPH/NADP+ ratio did not differ significantly in C. glutamicum ΔmalE 
(3.6 ± 0.4) compared to the wild type (2.8 ± 1.4). As malic enzyme was reported to be 
dispensable for growth of C. glutamicum on glucose, exhibiting no observable phenotype 
(Gourdon et al., 2000; Sauer and Eikmanns, 2005), its function was assumed to generate 
NADPH on substrates linked with low PPP activities e.g. lactate (Georgi et al., 2005). This 
hypothesis is consistent with the results obtained in this study.  
 
Combined deletion of pgi and malE genes: probing the network rigidity 
The previously investigated single deletions of malic enzyme and glucose 6-phosphate 
isomerase were combined and the carbon flux distributions as well as the NADPH 
requirements were analyzed. The double deletion mutant C. glutamicum ΔmalE Δpgi was 
constructed, forcing the carbon flux entirely through the oxidative branch of the PPP and 
simultaneously constraining the potential NADPH oxidizing possibilities by deleting the 
malic enzyme. Thus, the central metabolism was restructured towards a linear pathway 
lacking the possibility to adjust the NADPH producing pathways (PPP and TCA). As 
expected, excessive usage of the PPP caused a tremendous NADPH generation of 195.4%, 
clearly exceeding the anabolic demand of 130.4%. The additional NADPH generation by 
the TCA cycle led to a further increase in the NADPH overabundance, resulting in a total 
NADPH supply of 250.0% (Figure V-1). The NADPH/NADP+ ratio increased immensely 
to 17.1 ± 2.4 compared to 2.8 ± 1.4 in the wild type. 
As MalE did not exhibit any detectable activity under in vitro conditions (0.0 ± 0.1 mU 
mgprotein-1) in C. glutamicum ΔmalE Δpgi , this potential NADPH oxidizing system could 
be excluded. Even though an in vitro activity of 133.3 ± 2.2 mU mgprotein-1 was detected in 
C. glutamicum Δpgi, the NADPH surplus in C. glutamicum Δpgi was likewise found to 
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exceed the NADPH oxidizing capacities of MalE. Concluding, no metabolic reoxidation 
mechanism was found to match the NADPH requirements in either C. glutamicum Δpgi or 
C. glutamicum ΔmalE Δpgi. As a NADPH overabundance is deleterious, additional so far 
unconsidered reoxidizing mechanisms have to be present upon pgi deletion. One 
possibility i.e. the NADPH oxidizing capacity of the respiratory chain of C. glutamicum 
(Matsushita et al., 2001) was further investigated. 
 
Investigations of the NADPH reoxidation capacity of C. glutamicum: 
alternative NADPH oxidizing mechanisms 
Over the recent years, the NADPH metabolism of C. glutamicum and especially the 
corresponding balancing capacities were addressed in various works (Becker et al., 2007; 
Kromer et al., 2008; Kromer et al., 2004). An excellent study was published by Becker et 
al. (2007) investigating the problem of a NADPH surplus in genetically modified 
C. glutamicum strains considering the possibility of a NADPH oxidation via the respiratory 
chain. The NADH oxidizing enzyme NADH-ubiquinone-1 oxidoreductase of 
C. glutamicum exhibits an additional NADPH oxidizing function (Matsushita et al., 2001; 
Molenaar et al., 2000) which is linked with the deleterious generation of reactive oxygen 
species (ROS). The oxidation of NADPH via the respiratory chain by molecular oxygen 
would however lead to an increased oxygen consumption eventually surpassing the oxygen 
demand needed for NADH oxidation. The oxygen uptake rate determined for all strains in 
this work matched the required oxygen for complete NADH reoxidation in case of the wild 
type strain and C. glutamicum ΔmalE (Table V-6). 
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Table V-6. CO2 and redox balances for XADH (NADH and FADH2) and NADPH [%] of 
C. glutamicum ATCC 13032, C. glutamicum Δpgi, C. glutamicum ΔmalE and C. glutamicum 
ΔmalE Δpgi with corresponding oxygen consumptions [%]. 
 
  
 
ATCC 13032 
 
Δpgi 
 
ΔmalE 
 
ΔmalE Δpgi 
     
 CO2 productiona           
  gluconate 6PDH 44.9 ± 1.3 97.8 ± 0.1 43.0 ± 3.6 97.7 ± 0.1 
  pyruvate DH 78.8 ± 0.4 73.8 ± 0.7 95.6 ± 0.3 80.1 ± 1.3 
  ICDH 47.3 ± 0.4 45.7 ± 0.9 68.9 ± 1.0 54.1 ± 1.6 
  α-ketoglutarate DH 35.0 ± 0.4 34.6 ± 0.9 58.4 ± 1.1 44.0 ± 1.8 
  anabolismb 10.1 ± 0.4 9.2 ± 0.2 9.5 ± 0.2 8.4 ± 0.1 
 CO2 consumption             
  anaplerosis 29.0 ± 0.0 25.9 ± 0.2 24.6 ± 0.2 23.9 ± 0.4 
 
 
Totalcalc [%]a 
 
187.2 
 
±
 
1.5 
 
235.2 
 
±
 
1.4 
 
250.9 
 
±
 
3.6 
 
260.3 
 
±
 
2.8 
 Totalmeas[%]c 189.5 ± 4.1 228.7 ± 2.9 238.0 ± 4.9 247.2 ± 5.0 
 NADH production             
  G3P DH 153.7 ± 0.4 140.1 ± 0.3 159.3 ± 0.9 141.9 ± 0.4 
  pyruvate DH 78.8 ± 0.4 73.8 ± 0.7 95.6 ± 0.8 80.1 ± 1.3 
  α-ketoglutarate DHd 105.0 ± 1.2 103.8 ± 2.7 175.2 ± 3.3 132.0 ± 5.4 
  anabolism 31.7 ± 0.3 28.8 ± 0.6 29.8 ± 0.6 26.2 ± 1.6 
 Total XADH [%] 
 
369.2 
 
±
 
1.4 
 
346.5 
 
±
 
2.9 
 
459.9 
 
±
 
3.6 
 
380.2 
 
±
 
5.8 
 O2 consumption [%] 
 
183.1 
 
±
 
4.5 
 
208.4 
 
±
 
6.2 
 
229.2 
 
±
 
6.8 
 
237.0 
 
±
 
6.9 
 Redox balance [%] -3.0 ± 9.1 70.3 ± 12.7 -1.5 ± 14.1 93.8 ± 15.0 
 NADPH production             
  G6P DH 44.9 ± 2.6 97.8 ± 0.1 43.0 ± 3.6 97.7 ± 0.1 
  gluconate 6PDH 44.9 ± 2.6 97.8 ± 0.1 43.0 ± 3.6 97.7 ± 0.1 
  ICD 47.3 ± 0.4 45.7 ± 0.8 68.9 ± 1.1 54.1 ± 1.6 
 NADPH consumption             
  anabolism 151.1 ± 8.0 143.1 ± 3.2 148.2 ± 3.2 130.4 ± 8.0 
 Total NADPH [%] -14.0 ± 8.2 98.1 ± 0.9 6.7 ± 7.4 119.2 ± 8.1 
 
a  calculated from carbon flux distributions (Table V-4). 
b anabolism with a stoichiometric CO2 generation of 1.025 mmol gCDW-1 was considered as producing 
reaction (Yang et al., 2005). 
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c total CO2 productions were quantified by off-gas analysis (Table V-3) and normalized to the specific 
glucose consumption rates (Table V-3) which were set to 100%. 
d comprises the combined NADH and FADH2 production by α-ketoglutarate dehydrogenase, succinate 
dehydrogenase and malate dehydrogenase. 
 
 
 
Upon pgi deletion (C. glutamicum Δpgi and C. glutamicum ΔmalE Δpgi) the oxygen 
uptake rates significantly surpassed the demand for XADH reoxidation (Table V-5). 
Further, a physiological phenomenon emerged in those strains comprising the pgi deletion, 
i.e. C. glutamicum Δpgi and C. glutamicum ΔmalE Δpgi, manifesting itself in a reoccurring 
complete growth stagnation of 24 h in synthetic, minimal medium which depicts the severe 
effects of this perturbation. The growth arrest was observed when switching from complex 
medium, used in the first precultures, to minimal medium used in the second precultures. 
After a short growth period (increase of the biomass concentration from 0.04 g L-1 to 
0.08 g L-1), cellular growth completely stopped for approximately 24 h. The reasons for 
this aberrant growth behavior have not been revealed in detail. Due to the cultivation of the 
first precultures on complex medium, carry-over of complex components or intracellular 
metabolite storage might explain the initial (slight) increase of biomass concentration. 
Resumption of growth after approximately 24 h due to contamination was excluded by 
microscopic investigation and plating of the cultivation broth on agar plates. In addition, 
PCR analysis confirmed the presence of the corynespecific pgi deletion and the absence of 
the native wild type pgi sequence. 
 
This reoccurring phenotype suggests a massive adaptation process which finally leads to a 
tolerance for this perturbation. The severity of this genetic manipulation has been 
addressed before for pgi deletion mutants of E. coli (Canonaco et al., 2001; Fischer and 
Sauer, 2003a; Fischer and Sauer, 2003b; Hua et al., 2003; Kabir and Shimizu, 2003; Nor 
'Aini et al., 2006) as well as for C. glutamicum (Blombach et al., 2008; Marx et al., 2003), 
revealing a reduction in growth as a common phenotypical consequence due to the massive 
imbalance concerning NADPH metabolism which is consistent with the results obtained in 
this work. 
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It has to be mentioned that the increased oxygen uptake rates determined for 
C. glutamicum Δpgi and C. glutamicum ΔmalE Δpgi are, however, not implicitly linked 
with a direct oxidation of NADPH in the respiratory chain via molecular oxygen. The 
participation of MalE, assumed to account for the NADPH adjustments in terms of 
NADPH oxidation (Becker et al., 2007), is directly coupled to oxygen consumption, as this 
reaction operates as a transhydrogenase-like cycle, transferring electrons from NADPH 
(catalyzed by MalE) to NADH (catalyzed by malate dehydrogenase). The latter is further 
oxidized in the respiratory chain by molecular oxygen. 
 
The potential oxygen utilization for NADPH reoxidation, accounted for 70.3% in 
C. glutamicum Δpgi and 93.8% in C. glutamicum ΔmalE Δpgi (Table V-6). In 
C. glutamicum Δpgi the increased oxygen consumption, exceeding the XADH demand, 
cannot be distinguished between malic enzyme and the respiratory chain reoxidizing 
NADPH, since both reactions are coupled to oxygen consumption. As oxidation via the 
respiratory chain is reported to be linked with ROS generation (Nantapong et al., 2005), 
reoxidation of NADPH by malic enzyme seems to be most likely in C. glutamicum Δpgi 
concerning the unfavorable ROS generation coupled to NADPH reoxidation via the 
respiratory chain. 
 
Regarding the double deletion mutant (C. glutamicum ΔmalE Δpgi) however a 
participation of the malic enzyme can be excluded and the exceeding oxygen consumption 
might be attributed to a direct participation in reoxidation of NADPH via molecular 
oxygen as no other NADPH-NADH converting systems has been described for 
C. glutamicum to our knowledge. As a NADPH oxidizing capacity of the NADH-
ubiquinone-1 oxidoreductase of C. glutamicum has been reported (Matsushita et al., 2001), 
direct NADPH oxidation via the respiratory chain seems possible. The reported Km and 
Vmax values for NADPH oxidation are approximately 30 times higher (Km;NADPH) 
(Nantapong et al., 2005) and 10 times lower (Vmax;NADPH) (Matsushita et al., 2001). The 
kinetic behavior of the respiratory chain, comprising several interconnected reactants, is 
however very complex (Nicholls and Ferguson, 2002) and direct consequences of 
Chapter V   -   Refining and redefining metabolic networks
 
124 
increased NADPH concentrations can only be assumed. Furthermore, determination of Km 
and Vmax values greatly depend on in vitro conditions of the enzymatic assays.  
It can be noted however, that the intracellular NADPH concentrations were drastically 
increased in C. glutamicum ΔmalE Δpgi, while C. glutamicum Δpgi exhibited only a slight 
increase in the NADPH concentration (Table V-5). As this alteration of intracellular redox 
concentrations was caused by the malE deletion, it seems quite likely that MalE – at least 
partly – contributes to the reoxidation of NADPH in C. glutamicum Δpgi. This reoxidation 
system is deleted in C. glutamicum ΔmalE Δpgi and the direct participation of the 
respiratory chain in NADPH oxidation was thus questioned in this study. In this context 
the drastically increased NADPH concentrations and the reduced NADP+ concentrations in 
C. glutamicum ΔmalE Δpgi might indicate at an increased acceptance of NADPH by the 
NADH-ubiquinone-1 oxidoreductase. The exact elucidation of these interactions was 
however beyond the scope of the present thesis. 
 
The activation of the glyoxylate shunt, as a consequence of pgi deletion in E. coli (Hua et 
al., 2003) bypassing the NADPH generating reaction of ICD reflects another possibility to 
prevent excessive NADPH production. However no activity of the initializing enzyme 
isocitrate lyase was determined and an active participation of this pathway branch was 
therefore excluded. 
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Conclusions 
 
 
In summary, the investigation of the NADPH metabolism in C. glutamicum by 13C 
metabolic flux analysis provided valuable information concerning the flexibility of the 
metabolic network of this organism. One key point, supporting this flexibility, is the 
alternating nature of the metabolic network allowing to compensate various genetic 
manipulations by redirections of carbon fluxes (Becker et al., 2008). However, if this 
flexibility is restricted by a linearization of the network caused by deletion of essential 
genes, e.g. pgi and therefore withdrawing the ability for compensatory adjustment as 
previously suggested (Marx et al., 1999; Wittmann and Heinzle, 2002), the whole system 
has to be reconstructed. In the present work, it seems likely that one of these readjustments 
is the NADPH reoxidation via the respiratory chain. This is however linked to a distinct 
growth perturbation, as expressed by a phase of growth stagnation for 24 h observed for all 
pgi deletion strains which might be provoked only by tremendous stress-induction, as was 
reported previously for an E. coli mutant by Auriol et al. (2011). This genetically modified 
strain forced to produce an exceeding amount of NADPH without the ability to convert 
NADH to NADPH via transhydrogenases, actively modified the enzymatic properties of 
the NADH-ubiquinone-1 oxidoreductase in order to allow NADPH reoxidation via the 
respiratory chain, even linked to direct energy generation. This example additionally 
demonstrates the enormous flexibility and capacity to adapt to (stress-) induced 
perturbations and opens up a way for future in-depth analyses concerning the redox 
metabolism of C. glutamicum. 
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PART II 
 
Phenotype characterization on 
complex medium 
 
 
 
 
 
Analyses performed in previous chapters of Part I revealed the tight regulation of the 
purine intermediate distributions by NADH and ATP supply. In addition, deletion of the 
pgi gene resulted in adverse effects of the overall growth performance due to tremendous 
NADPH overabundances. The NADPH imbalances, representing a common metabolic 
characteristic of pgi deletion strains, were linked to the sole metabolization of glucose via 
the pentose phosphate pathway. 
 
The results obtained from cultivations on complex medium are presented in the following 
chapters of Part II. Thereby, detrimental impacts on growth performance e.g. growth 
stagnation for 24 h were investigated. In addition, the metabolic shift, determined for 
C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi on glucose, was analyzed and related to the 
utilization of complex medium components. These topics are described in: 
 
 Metabolic flux analysis using metabolite balancing with off-gas analysis provides detailed 
information about metabolic dynamics of C. glutamicum grown on complex substrates 
(Chapter VI). 
 Comparative fluxome and dynamic metabolite analysis in a genetically engineered 
C. glutamicum strain cultivated on complex medium (Chapter VII).  
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Chapter VI 
 
Uncovering dynamic structures 
Metabolic flux analysis using metabolite balancing  
with off-gas analysis provides detailed information  
about metabolic dynamics of C. glutamicum  
grown on complex substrates 
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Abstract* 
 
 
Large-scale biotechnological processes often rely on complex substrates complicating in 
vivo metabolic flux quantification due to inherent multi-phase growth and varying 
metabolic activities. We present a metabolite balancing approach relying on metabolite 
balancing with additional constraints such as CO2 production and O2 consumption 
combined with balancing of redox equivalents. Using this scale-independent approach, 
precise determination of the split between glycolysis and pentose phosphate pathway 
during different growth phases on complex substrates was determined which increased 
from 22.8% to 44.6%. In addition, the amino acid content in the media was determined 
concerning free pools and peptide-bound amino acids resulting in completely closed 
carbon balances for each growth phase. Verification of these findings was carried out using 
13C based metabolic flux analysis (on glucose) resulting in comparable flux distributions 
and thereby confirmed the applicability and reproducibility of the extended metabolite 
balancing approach. 
 
 
 
 
 
 
 
 
* Submitted as: 
Peifer S, Lis AV, Heinzle E, Schneider K. 
Metabolic flux analysis using metabolite balancing with off-gas analysis provides detailed information about 
metabolic dynamics of C. glutamicum grown on complex substrates.   
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Introduction 
 
 
Systems biology has evolved towards a field of increasing importance in biological 
sciences (Heinemann and Sauer, 2010; Kohlstedt et al., 2010; Niklas and Heinzle, 2011; 
Otero and Nielsen, 2009) aiming for a comprehensive understanding of the function of 
biological systems. One focus of this research area deals with the study of metabolic 
networks (Klapa et al., 2003; Mahadevan et al., 2002; Papin et al., 2003) and thereby with 
the analysis of in vivo carbon flux distributions. These metabolic distributions represent the 
quantitative and integrative endpoint of the cell physiology (Noh and Wiechert, 2011; 
Sauer, 2006), comprising regulations on the levels of DNA, RNA, proteins and 
metabolites. However, whereas other omic platforms, i.e. genomics, proteomics and 
metabolomics, target the concentration-based determination (Zamboni and Sauer, 2009), 
quantification of carbon fluxes, fluxomics, aims for the disclosure of the time-dependent 
conversion of intracellular metabolites, resulting in a snapshot of the actual physiological 
in vivo state of a biological system, the phenotype.  
The quantification of the in vivo carbon fluxes, the so-called metabolic flux analysis 
(MFA), was applied in different fields of research, focusing on the metabolic engineering 
of pathway fluxes for biotechnology (Blombach et al., 2008; Kohlstedt et al., 2010; 
Wittmann, 2010; Wittmann and Becker, 2007), the discovery of novel pathways (Beste et 
al., 2011; Kromer et al., 2006; Nanchen et al., 2006; Tang et al., 2008), latent pathway 
activations (Fong et al., 2006) and many others (Benyamini et al., 2010; Bonarius et al., 
1996; Bonarius et al., 2001; Niklas et al., 2010; Tang et al., 2008; van Gulik and Heijnen, 
1995; Zamboni and Sauer, 2009). 
 
A direct consequence of the time-dependent flux behavior is the inability to directly 
measure the in vivo carbon flux distributions or their determination from intracellular 
concentrations (Noh and Wiechert, 2011). Thus, in order to derive these fluxes, two major 
approaches have emerged: metabolite balancing and tracer-based flux determination 
employing 13C labeled, stable isotopes (Stephanopoulos, 1998; Stephanopoulos et al., 
1998; Wittmann and de Graaf, 2005).  
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The incorporation of 13C labeled substrates in 13C based MFA, leads to a distinct 
distribution of the labeled carbon atom(s) throughout the entire metabolic network. This 
results in a specific 13C-enrichment found in intracellular free metabolites or 
macromolecules of the cell (isotopic steady state condition) (Marx et al., 1996; Wittmann, 
2007). The specific 13C enrichment is a direct consequence of the cellular metabolism, 
reflecting the activity of metabolic pathways and can thus be used to determine the 
alternative pathway partitioning of carbon fluxes throughout the carbon metabolism. Due 
to considerable improvements and substantial progress in experimental, but especially 
analytical and computational techniques (Bonarius et al., 2001; Klapa et al., 2003; 
Wiechert and de Graaf, 1997; Wiechert et al., 1997; Wittmann, 2007; Wittmann et al., 
2002), nowadays, 13C tracer-based metabolic flux analysis is commonly applied in 
academia as well as in industry. 
 
One of the main disadvantages of isotope-based MFA are the associated high costs for the 
applied 13C labeled compounds (Goudar et al., 2010) calling for small-scale experiments to 
keep the costs in reasonable ranges. However, these conditions may not reflect the actual 
conditions in large-scale industrial processes, since several process parameters, such as 
mixing, are not linearly scaled. In addition, industrial fermentation broths typically 
comprise an enormous fraction of complex components, further restricting the application 
of tracer-based metabolic flux analysis. Of additional relevance is the requirement of a 
metabolic and isotopic steady or pseudo-steady state (Marx et al., 1996; Provost and 
Bastin, 2004; Wiechert, 2001) for stationary MFA with constant intracellular 
concentrations and pathway activities, i.e. balanced growth conditions. However, 
application of complex substrates and the associated adaptation to varying nutritional 
conditions often bears multi-phase growth and thus a dynamic behavior of metabolite 
concentrations and pathway activities, demanding a switch from stationary to in-stationary 
MFA (Noack et al., 2011; Noh and Wiechert, 2011; Wiechert and Noh, 2005). 
 
The second approach, metabolite balancing (Varma and Palsson, 1994), has been 
employed even longer than tracer-based MFA, due to its increased experimental, analytical 
and computational simplicity (Aiba and Matsuoka, 1978; Goudar et al., 2010). The 
mathematical approach is based on balancing intracellular metabolites resulting in a set of 
linearly dependent equations. Determined extracellular and anabolic fluxes, together with 
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the reaction stoichiometry of the metabolic network are used to calculate intracellular 
fluxes. This approach, since it is neither scale-dependent nor relies on labeling data that 
come along with high costs in case of large-scale experiments, is well suited to be applied 
at larger, industrially relevant scales. This method, however, exhibits limitations, since flux 
partitioning in cyclic pathways and reversible reactions cannot be determined without 
further simplification of the network, either by a priori assumption of pathway activities, 
complementation by linear objective functions (Feist and Palsson, 2010; Wiechert, 2001) 
or additional constraints. The latter was mostly achieved by including mass balances of 
cofactors such as ATP or NAD(P)H (Bonarius et al., 1998; Schmidt et al., 1998; van Gulik 
and Heijnen, 1995). Since for some of these cofactors only an approximate balance can be 
estimated, implementation is thus based on certain assumptions, i.e. concerning ATP 
requirements for maintenance processes and the P/O ratio in the respiratory chain. 
  
The metabolite balancing approach in this study only implies the reoxidation of NADH 
and FADH2 by molecular oxygen in order to maintain cellular functionality, as well as 
carbon dioxide production as additional constraints. The associated ATP supply and its 
efficiency are not required and therefore can be resigned. Metabolite dynamics of 
C. glutamicum grown on complex substrates, as used in large-scale industrial processes, 
were investigated applying this metabolite balancing approach in order to gain increased 
knowledge on physiological behavior under these industrially relevant conditions. 
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Materials and methods 
 
 
Microorganism 
The wild type strain C. glutamicum ATCC 13032 was obtained from the American Type 
Culture Collection (Manassas, VA, USA).  
 
Growth media 
The first preculture was grown on complex medium (pH 6.8) containing per liter: 10.0 g 
glucose, 2.5 g NaCl, 2.0 g urea, 5.0 g yeast extract, 5.0 g beef extract, 5.0 g polypeptone 
and 20.0 g casamino acids. For agar plates, the complex medium was supplemented with 
20.0 g L-1 agar. Minimal medium for second precultures and main cultures (pH 7.2) 
contained per liter: 15.0 g glucose, 4.0 g KH2PO4, 16.0 g Na2HPO4, 500 mg 
MgCl2 · 6 H2O, 300 mg 3,4-dihydroxybenzoic acid, 100 mg CaCl2 · 2 H2O, 100 µg 
cyanocobalamin, 750 µg thiamine, 4 µg pyridoxal phosphate, 100 µg biotin, 400 µg 
calcium pantothenate, 2 µg folic acid, 400 µg nicotinic acid, 200 µg 4-aminobenzoic acid, 
400 µg pyridoxine · HCl, 2 mg inositol, 10 mg FeCl2 · 4 H2O, 1 mg ZnCl2, 100 µg CuCl2, 
20 µg NiCl2 · 6 H2O, 20 µg Na2MoO4 · 2 H2O, 500 µg boric acid, 100 µg KI, 100 µg 
CoCl2 · 6 H2O, 10 mg MnCl2 · 4 H2O. For tracer studies, naturally labeled glucose was 
replaced by 99% 13C enriched [1-13C] glucose.  
Second precultures and main cultures on complex media (pH 7.2) contained per liter: 4.0 g 
KH2PO4, 16.0 g K2HPO4, 4.0 g peptone, 20.0 g glucose, 10.0 g MgSO4, 6.0 g urea, 100 mg 
CaCl2 · 2 H2O, 1 mg ZnSO4 · 7 H2O, 20 mg FeSO4, 17 mg MnSO4, 20 mg cysteine, 30 mg 
biotin, 10 mg calcium pantothenate and 5 mg thiamine.  
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Cultivations 
Shake flask cultivations 
Cultivations were carried out on an orbital shaker (Multitron 2, Infors AG, Bottmingen, 
Switzerland) at 230 rpm and 30°C. Precultures on complex medium (25 mL medium in 
250 mL baffled shake flasks) were inoculated with a single colony from an agar plate and 
incubated for 16 h. Cells were harvested by centrifugation (3 min, 6,500 g, 4°C, Laborfuge 
400R, Heraeus, Hanau, Germany), washed twice with sterile 0.9% NaCl and used for the 
inoculation of the second preculture. Second precultures (25 mL medium in 250 mL 
baffled shake flasks) on minimal medium were cultivated for 12 h and on complex medium 
for 8 h. Main cultures on minimal medium were performed in duplicates using 500 mL 
baffled shake flasks with 50 mL medium. Tracer experiments for 13C MFA were carried 
out in 50 mL baffled flasks with 5 mL minimal medium containing 15.0 g L-1 [1-13C] 
glucose. 
 
Bioreactor cultivations 
Cultivations were performed in a 500 mL stirred tank bioreactor (Meredos, Bovenden, 
Germany) in a liquid volume of 75 mL at 30°C and 1,000 rpm. Dissolved oxygen 
concentrations during fermentation were always above 60% air saturation thus avoiding 
oxygen limitation. The airflow was controlled at 1 vvm (vessel volume per minute) by a 
mass flow controller (WMR Compact 4, Brooks Instruments, Veenedaal, Netherlands). 
Composition of air and exhaust gas was quantified using a quadrupole mass spectrometer 
(Omnistar, Inficon, Vaduz, Liechtenstein). All relevant process parameters were collected 
and stored by a process control system (Lucullus PIMS 2.1, Biospectra, Schlieren, 
Switzerland). 
 
Chemicals 
Yeast extract, beef extract, polypeptone and casamino acids were purchased from Difco 
Laboratories (Detroit, USA). [1-13C] glucose (99% enriched) was obtained from 
Cambridge Isotope Laboratories (Andover, Mass., USA). All other chemicals were 
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purchased from Sigma-Aldrich (Steinheim, Germany), Merck (Darmstadt, Germany), 
Fluka (Buchs, Switzerland) or Roth (Karlsruhe, Germany) and were of analytical grade 
unless stated otherwise. 
 
Substrate and product analysis 
Cell concentrations were determined by measurement of optical density at 660 nm 
(OD660nm) using a photometer (Marsha Pharmacia Biotech, Freiburg, Germany) and 
gravimetrically correlated with the cell dry weight. The correlation factors were 
determined as 0.414 gCDW OD660nm-1 for cultivations on minimal medium and 0.419 gCDW 
OD660nm-1 for cultivations on complex medium. 
The concentrations of extracellular substrates and products in cultivation supernatants were 
determined after 3 min centrifugation at 16,000 g. Glucose, α-ketoglutarate and trehalose 
were quantified in diluted supernatants by HPLC (Kontron Instruments, Neufahrn, 
Germany). Separation was performed using an Aminex HPX-87H Bio-Rad column (300 x 
7.8 mm; Hercules, USA) at 55°C with a constant flow rate of 0.8 mL min-1 (7 mM H2SO4 
as mobile phase). Quantification of sugars was carried out using refraction index (RI) 
detection; organic acids were quantified applying UV detection (218 nm). Amino acids 
were quantified as described previously (Kromer et al., 2005). Total amino acid 
concentrations in complex media were determined after acidic hydrolysis of the peptides 
contained in the corresponding supernatants. For this purpose, cultivation supernatants 
were separated from cells by centrifugation (5 min, 16,000 g) and 90 µL were mixed with 
10 µL α-amino-butyrate to a final concentration of 1 mM as internal standard. 
Subsequently 100 µL 12 M HCl were added and incubated for 24 h at 105°C. 
Neutralization was performed by adding adequate amounts of 6 M NaOH and insoluble 
matter was separated by centrifugation (5 min, 7,000 g; Ultrafee-MS filter units, 0.22 µm-
pore-size Durapore membrane; Millipore, Darmstadt, Germany). The remaining clear 
solution was used for quantification of amino acids as described above. To ensure 
complete hydrolysis of peptide-bound amino acids and to determine the degradation 
degree, incubation times were varied between 12 and 24 h. In addition, the amount of HCl 
(12 M) added, was increased from 50% volume fraction up to 200% volume fraction. The 
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effect on the corresponding total amino acid content was determined as described 
previously (Kromer et al., 2005). 
 
Cell disruption and enzymatic determination of the glyoxylate pathway 
activity 
For quantification of the glyoxylate pathway activity of C. glutamicum wild type grown on 
glucose, cells were cultivated in 50 mL minimal medium in 500 mL baffled shake flasks 
(for descriptions see “Shake flask cultivation – Materials and Methods”). Disruption of 
cells was performed as described previously (Becker et al., 2005). Potential activity of the 
glyoxylate shunt was assessed measuring the enzymatic activity of the first enzyme of this 
pathway, isocitrate lyase. The enzymatic assay was performed as described previously by 
de Jong-Gubbels et al. (1995). 
 
Mass spectrometric 13C-labeling analysis 
The labeling patterns of amino acids from cellular protein were analyzed by gas 
chromatography-mass spectrometry (GC-MS) and corresponding single mass isotopomer 
fractions were determined (Kiefer et al., 2004; Wittmann et al., 2004a). Therefore, 1 mg 
cell dry mass was harvested from an exponentially growing culture by centrifugation 
(5 min, 16,000 g) and washed twice with purified water. Cells were then incubated with 
50 µL 6 M HCl at 105°C for 24 h. Subsequently neutralization was performed with 
adequate volumes of 6 M NaOH and insoluble matter was separated by filtration (5 min, 
7,000 g; Ultrafee-MS filter units, 0.22 µm-pore-size Durapore membrane; Millipore, 
Darmstadt, Germany). The remaining clear solution was then lyophilized. Amino acid 
mass isotopomers were analyzed after derivatization using MBDSTFA (N-methyl-N-t-
butyldimethylsilyl-trifluoroacetamide; Macherey-Nagel, Düren Germany) and conversion 
into the corresponding t-butyldimethylsilyl (TBDMS)-derivatives (Wittmann et al., 2002). 
The labeling pattern of secreted trehalose was determined from supernatants. 
Derivatization of trehalose was carried out using BSTFA (N,O-bis-
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(trimethylsilyl)trifluoroacetamide; Macherey-Nagel Düren Germany), resulting in its 
trimethylsilyl-derivate. All samples were first analyzed in scan mode, thereby excluding 
isobaric interferences between analytes and sample components. Mass isotopomer 
fractions of amino acids were determined using selective ion monitoring (SIM) mode in 
duplicates. 13C enrichment was determined on the basis of the [M-57] fragments except for 
leucine ([M-157]). The mass isotopomer distribution of trehalose was analyzed for the m/z 
361 fragment consisting of one glucose moiety. 
 
Biochemical network and biomass requirements 
The metabolic network of C. glutamicum (Figure VI-1) includes all main metabolic 
pathways utilized during growth on glucose, i.e. glycolysis, pentose phosphate pathway 
(PPP), tricarboxylic acid (TCA) cycle and anaplerosis.  
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Figure VI-1. Metabolic network model for isotopomer-based flux estimation and metabolite 
balancing. vi, intracellular fluxes; vBi, anabolic fluxes; abbreviations: G6P, glucose 6-phosphate; 
6PG, 6-phosphogluconate; P5P, pentose 5-phosphate; F6P, fructose 6-phosphate; F16BP, fructose 
1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; GAP, glyceraldehyde 3-phosphate; 3PG, 
3-phosphoglycerate; PEP, phosphoenolpyruvate; Pyr, pyruvate; AcCoA, acetyl-CoA; Cit, citrate; 
AKG, α-ketoglutarate; SucCoA, succinyl-CoA; Suc, succinate; Fum, fumarate; OAA, 
oxaloacetate; Mal, malate; BMi, biomass. 
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Since usage of [1-13C] labeled glucose is insufficient to distinguish between 
phosphoenolpyruvate and pyruvate as well as oxaloacetate and malate pools, these pools 
were lumped and only the net fluxes were calculated. No activity of the glyoxylate shunt 
associated enzyme isocitrate lyase was experimentally detected and was therefore 
neglected. Anabolic pathways towards biomass production and production pathways for α-
ketoglutarate, trehalose and glycine were incorporated in the metabolic network topology. 
For metabolite balancing analysis, decarboxylating and carboxylating reactions located in 
anabolic and catabolic pathways were additionally balanced, as well as NADH and FADH2 
generating and consuming reactions (Table VI-1).  
 
Table VI-1. Molar balance equations for the metabolite balancing model of glucose metabolism 
used for MFA of C. glutamicum wild type strain. 
 
    
1. vG6P: 0 = vinp - v1 - v2 - vB1 
2. vF6P: 0 = v1 - v4 + 0.667v3 - vB2 
3. vP5P: 0 = v2 - v3 - vB3 
4. vGAP: 0 = v4 + 0.333v3 - v5 - vB4 
5. v3PG: 0 = v5 - vB5 - v6 
6. vPEP/Pyr: 0 = v6 - vB6 - v7 - v10 
7. vAcCoA: 0 = v7 - vB7 - v8 
8. vAKG: 0 = v8 - vB8 - v9 
9. vOAA: 0 = v9 + v10 - v8 
10. vCO2: 0 = v2 + v7 + v8 + v9 - v10 - 0.636vB3a - 0.154vB8a + 0.186vB9a  
+ 0.502vB6a - vCO2expb 
11. vXADHc: 0 = v5 + v7 + 3v9 + 0.313vinpd- 2qO2 
 
 
vi intracellular fluxes, vBi anabolic fluxes. 
a stoichiometric coefficients denote the amount of CO2 consumed or released by anabolism accounting for 
the usage of the precursor molecules in different anabolic reactions.  
b  vCO2exp depicts the experimentally determined net CO2 production. 
c  vXADH corresponds to NADH and FADH2 generating reactions.  
d  stoichiometric coefficient denotes the amount of NADH produced by anabolism. 
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Redox balancing 
The amount of XADH (NADH and FADH2) reoxidized by the respiratory chain is:  
 
 vXADH = 2qO2          
 
where qO2 denotes the specific oxygen uptake rate and vXADH the combined specific net 
consumption of NADH and FADH2 in the respiratory chain. Reoxidation of NADPH by 
the respiratory chain was not considered since NADPH – provided by glucose 6-phosphate 
dehydrogenase, 6-phosphogluconate dehydrogenase and isocitrate dehydrogenase – was 
reported to be completely used by anabolic reactions of C. glutamicum wild type (Kromer 
et al., 2008; Chapter V). Thus an active participation of malic enzyme in NADPH 
generation was supposed to be insignificant – under the prevailing conditions – and thus 
negligible. All rates were normalized to the glucose consumption rate. Production of 
XADH (catabolic and anabolic) in the metabolism is given by the reactions defined in 
Figure VI-1: 
 
 vXADH = v5 +v7 + 3v9 + 0.313vinp    
 
The anabolic NADH production of 3.2 mmol NADH per gram biomass, as expressed in 
0.313vinp, was adopted from literature for C. glutamicum (Yang et al., 2006).  
 
Metabolic flux estimation and visualization 
13C metabolic flux analysis 
In vivo metabolic fluxes of the C. glutamicum central carbon metabolism were calculated 
by fitting simulated mass isotopomer distributions to experimentally determined, GC-MS 
derived mass isotopomer fractions of measured amino acid fragments following the 
approach of Yang et al. (2009; 2008) implemented in Matlab (version 2008b, Mathworks 
Inc., Nattick, USA) applying metabolite and isotopomer balancing. Measured GC-MS data 
were corrected for naturally occurring isotopes in the amino acid fragments and 
derivatization reagent respectively (van Winden et al., 2002; Wittmann and Heinzle, 1999). 
[3]
[4]
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In addition extracellular rates and anabolic demands for biomass formation were used for 
flux estimation. Initial free randomized fluxes resulted in comparable metabolic flux 
distributions after optimization indicating the achievement of a global minimum. Statistical 
analysis was carried out using a Monte Carlo approach with 100 independent runs 
(Mollney et al., 1999; Wittmann and Heinzle, 2002; Yang et al., 2008). Fluxes are given 
with corresponding 90% confidence intervals. 
 
Metabolite balancing 
Metabolite balancing was based on extracellular measurable consumption and production 
rates and anabolic demands for biomass formation depicted in the metabolic network of 
Figure VI-1. In addition carbon dioxide production and oxygen consumption were used to 
balance carbon and XADH, allowing the determination of the split between glycolysis and 
pentose phosphate pathway. Flux estimation was carried out using a Monte Carlo approach 
varying extracellular rates within their corresponding standard deviation applying 1000 
independent runs. Metabolic fluxes are given with 90% confidence intervals or with 
corresponding standard deviations. 
Visualization was performed using Omix software (Droste et al., 2011).  
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Results and discussion 
 
 
The information generated by metabolic flux analysis strongly depends on applicability 
and accuracy of the constraints applied (Schmidt et al., 1998). We therefore compared the 
reliability of two different approaches – isotopic tracer-based metabolic flux analysis and 
an extended metabolite balancing approach – in order to overcome limitations associated 
with both approaches. These two approaches were first compared and verified by 
investigating intracellular carbon fluxes during growth on glucose and then the extended 
metabolite balancing approach was applied for growth on complex compounds.  
 
Metabolism of C. glutamicum wild type grown on glucose 
C. glutamicum wild type (ATCC 13032) was grown in duplicate on minimal medium 
applying glucose as sole carbon source. Exponential growth was reached after one 
generation, indicated by constant biomass and by-product yields as well as constant 
glucose consumption and specific growth rate (Table VI-2). 64.3% of the carbon contained 
in glucose was used for biomass production, whereas only 1.5% was directed towards by-
product formation. 
 
Based on kinetic parameters and the stoichiometry of the underlying metabolic network 
(Figure VI-1), isotope tracer experiments allowed for the determination of intracellular in 
vivo carbon fluxes. The determined growth parameters and production rates obtained from 
tracer experiments and from main cultivations of C. glutamicum wild type performed on 
naturally labeled glucose were highly reproducible (Table VI-2) and data from both 
cultivations were used for flux estimation. 
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Table VI-2. Kinetic parameters for C. glutamicum ATCC 13032 grown on minimal medium with 
glucose as sole carbon source obtained from parallel main (naturally labeled glucose) and tracer 
([1-13C] glucose) cultivationsa. 
 
 main cultivations tracer cultivations 
parameter mean  value  
standard 
deviation 
mean  
value  
standard 
deviation 
 
µ 
 
0.443 
 
± 
 
0.004 
 
0.451 
 
± 
 
0.006 
YX/S 0.095 ± 0.005 0.099 ± 0.003 
YGly/S 8.662 ± 0.183 9.192 ± 0.201 
YTre/S 4.767 ± 0.004 5.220 ± 0.012 
YAKG/S 1.995 ± 0.069 1.781 ± 0.089 
qs 4.665 ± 0.090 4.510 ± 0.051 
 
a  specific growth rate µ [h-1], biomass yield YX/S [g mmol-1], yields for glycine YGly/S, trehalose YTre/S and 
α-ketoglutarate YAKG/S [mmol mol-1] and specific glucose consumption rate qs [mmol g-1 h-1]. 
 
Metabolic flux distributions applying 13C MFA 
The isotope labeling approach is based on experimentally determined production and 
consumption rates, the stoichiometry of the underlying network, the anabolic demand for 
biomass production and additionally comprises isotopomer balances and corresponding 
labeling patterns derived from biomass components and secreted products. 
In this study, tracer experiments were carried out using [1-13C] glucose. During mid-
exponential growth phase, the labeling patterns of proteinogenic amino acids derived from 
protein hydrolyzates and of trehalose secreted during the entire cultivation were 
determined at two different time points during cultivation verifying isotopic steady state. 
Stationary 13C metabolic flux analysis was performed using an iterative optimization 
process by minimizing the differences between simulated (Mi, sim) and calculated (Mi, calc) 
labeling patterns (Yang et al., 2009). The obtained fluxes determined for key reactions of 
the metabolism and the corresponding fit of simulated and calculated mass isotopomers are 
summarized in Tables VI-3 and IV-4, respectively. Deviations for each flux, as shown in 
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Table VI-3, correspond to 90% confidence intervals resulting from 100 independent Monte 
Carlo runs.  
 
Table VI-3. In vivo carbon flux distribution and statistical evaluation of central metabolism key 
reactions of the C. glutamicum wild type strain during growth on [1-13C] glucose, obtained by 
tracer-based flux analysis and by the metabolite balancing approach. 
 
 13C MFA metabolite balancing approach 
net flux mean value 90% confidence intervals mean value 
90% confidence 
intervals 
v1 0.522 [0.520 ; 0.524] 0.503 [0.501 ; 0.504] 
v2 0.449 [0.446 ; 0.451] 0.467 [0.465 ; 0.468] 
v3 0.361 [0.360 ; 0.363] 0.353 [0.352 ; 0.355] 
v4 0.723 [0.723 ; 0.724] 0.709 [0.708 ; 0.709] 
v5 1.537 [1.536 ; 1.537] 1.521 [1.521 ; 1.522] 
v6 1.400 [1.399 ; 1.401] 1.384 [1.384 ; 1.385] 
v7 0.788 [0.787 ; 0.789] 0.785 [0.785 ; 0.786] 
v8 0.473 [0.473 ; 0.474] 0.471 [0.471 ; 0.472] 
v9 0.350 [0.350 ; 0.351] 0.348 [0.348 ; 0.348] 
v10 0.290 [0.290 ; 0.290] 0.286 [0.286 ; 0.287] 
vCO2 1.872a [1.869; 1.874] 1.895b [1.894; 1.896] 
vXADH 3.679 [3.678 ; 3.681] 3.662 [3.660; 3.664] 
 
a  calculation of CO2 production was based on the corresponding flux distribution. 
b  CO2 production was experimentally determined. 
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Table VI-4. Relative mass isotopomer fractions of proteinogenic amino acids derived from 
cellular protein and of trehalose secreted during cultivation of C. glutamicum ATCC 13032 on 99% 
[1-13C] glucosea. 
 
 mass isotopomer fraction 
  
metabolite 
 
M0 
 
M1 
 
M2 
 
M3 
 
M4 
 
M5 
 
M6 
 
M7 
 
M8 
 
M9 
ala (m/z  260; c1-c3)          
    calc 0.648 0.337 0.015 0.000       
    exp 0.650 0.335 0.014 0.001       
gly (m/z  246; c1-c2)          
    calc 0.961 0.039 0.000        
    exp 0.961 0.038 0.001        
val (m/z  288; c1-c5)          
    calc 0.529 0.392 0.075 0.004 0.000 0.000     
    exp 0.437 0.432 0.124 0.007 0.000 0.000     
leu (m/z  200; c1-c5)          
    calc 0.314 0.439 0.210 0.037 0.001 0.000     
    exp 0.315 0.425 0.214 0.043 0.002 0.001     
ser (m/z  390; c1-c3)          
    calc 0.656 0.333 0.011 0.000       
    exp 0.655 0.337 0.008 0.000       
thr (m/z  404; c1-c4)          
    calc 0.507 0.400 0.087 0.006 0.000      
    exp 0.505 0.399 0.091 0.004 0.000      
phe (m/z  336; c1-c9)          
    calc 0.345 0.429 0.187 0.035 0.003 0.000 0.000 0.000 0.000 0.000 
    exp 0.341 0.421 0.187 0.034 0.003 0.004 0.002 0.004 0.002 0.002 
asp (m/z  418; c1-c4)          
    calc 0.507 0.400 0.087 0.006 0.000      
    exp 0.504 0.402 0.090 0.004 0.000      
glu (m/z  432; c1-c5)          
    calc 0.377 0.435 0.164 0.023 0.001 0.000     
    exp 0.379 0.427 0.167 0.025 0.001 0.000     
arg (m/z  442; c1-c6)          
    calc 0.298 0.422 0.221 0.053 0.006 0.000 0.000    
    exp 0.314 0.403 0.205 0.050 0.015 0.009 0.004    
tyr (m/z  466; c1-c9)          
    calc 0.345 0.429 0.187 0.035 0.003 0.000 0.000 0.000 0.000 0.000 
    exp 0.339 0.415 0.181 0.034 0.014 0.004 0.003 0.003 0.003 0.004 
tre (m/z  361; c1-c6)          
    calc 0.053 0.886 0.059 0.002 0.000 0.000 0.000    
    exp 0.032 0.886 0.068 0.009 0.004 0.001 0.000    
 
a  GC-MS data experimentally determined (exp) and corresponding calculated values (calc) obtained by an 
interative optimization applying 100 Monte Carlo runs with statistically varying initial values. M0 denotes 
the non-labeled mass isotopomer fraction and Mi the corresponding higher-labeled fractions. 
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An excellent fit between calculated and simulated mass isotopomer ratios was reached, 
indicating the consistency of the underlying metabolic network. Using this approach, 
C. glutamicum wild type revealed a split at the glucose 6-phosphate node of 52.2% and 
44.9% towards glycolysis and PPP, respectively. As indicated by the small confidence 
intervals, this flux partitioning could be determined with excellent precision.  
This approach combining stoichiometric mass balances with isotopomer patterns of central 
metabolites allowed the accurate determination of key fluxes in the central metabolism, 
including the split at the glucose 6-phosphate node as shown in various studies for different 
organisms (Becker et al., 2005; Fuhrer et al., 2005; Goel et al., 1993; Kromer et al., 2008; 
Sauer et al., 2004).  
However, these additional measurements are both analytically and computationally 
challenging and there is no guaranty that the final objective reaches the global minima 
during the iterative optimization process. Furthermore, the tracer experiments are routinely 
carried out in smaller scales that may not be transferrable to large-scale processes due to 
scale-dependent parameters such as mixing and aeration. Thus, in order to reflect industrial 
large-scale processes, scale-independent approaches, like the metabolite balancing 
approach, have to be applied. 
 
Metabolic flux distributions using metabolite balancing 
The metabolite balancing approach based on the metabolic network depicted in Figure VI-
1 contains stoichiometric balances for 13 metabolites, 18 measured fluxes including 
biomass formation and 10 intracellular fluxes to be determined comprising one alternative 
route (glycolysis and PPP). The activities of the alternative fluxes at the glycolysis-PPP 
branch could not be determined without further constraints since the stoichiometry is based 
on linear dependencies and cannot be solved. The statistical evaluation therefore did not 
result in a defined solution but in a solution space for the linear dependent fluxes in 
glycolysis and reactions through the whole metabolic network. The only determinable flux 
not depending on varying input fluxes obtained from Monte Carlo simulations was the 
anabolic flux v10, connecting the pools of PEP/Pyr and OAA/Mal. This non-dependency is 
based on the function to replenish the TCA cycle compensating for the draining reactions 
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vB8 and vB9 leaving the TCA cycle towards biomass formation. Thus, the activity of the 
anaplerotic flux v10 is solely determined by the anabolic demand of the cells. Flux 
determination resulted in tremendous deviations of the estimated fluxes. In addition 
obtained fluxes partly exhibited physiologically non-feasible values in terms of 
thermodynamics, as indicated by negative fluxes for the oxidative branch of the PPP (v2) 
(data not shown). 
In order to overcome this problem, the metabolic network has either to be further 
simplified, i.e. the flux through the oxidative branch of the PPP has to be assumed to be 
accountable solely for precursor supply and the non-oxidative branch has to be neglected, 
specific fluxes have to be assumed a priori or additional constraints or objective functions 
have to be implemented (Niklas and Heinzle, 2011). Since simplification or a priori 
assumption of flux activities are seldom physiologically justified (Schmidt et al., 1998), 
several reports aimed towards the establishment and validation of additional constraints, 
like the balance of metabolites involved in energy and redox metabolism (ATP, NADPH 
and NADH). Incorporation of balances for such metabolites, however, emerged being 
difficult, as for ATP neither requirements for maintenance or futile cycles nor the 
efficiency of the respiratory chain generating ATP from NADH, expressed as the P/O 
ratio, can be determined directly. As for the case of NADPH, all reactions involved in 
generation and consumptions and especially their feasible direction, evoked by the 
physiological state, have to be accounted for. 
In C. glutamicum four strictly NADP+-dependent enzymes are supplying NADPH for 
anabolism i.e. glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase 
(PPP), isocitrate dehydrogenase (TCA cycle) and malic enzyme (MalE, anaplerotic node) 
(Eikmanns et al., 1995; Gourdon et al., 2000; Marx et al., 1996; Sugimoto and Shiio, 
1987a; Sugimoto and Shiio, 1987b; Wittmann and de Graaf, 2005). The participation of 
MalE however, was reported to be insignificant for the wild type strain of C. glutamicum 
during growth on glucose (Kromer et al., 2008; Chapter V). Furthermore, no 
transhydrogenase activity interconverting NADH and NADPH is reported for 
C. glutamicum (Dominguez et al., 1998), allowing a separate consideration of NADH and 
NADPH pools and corresponding reducing and oxidizing reactions. 
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To elude these uncertainties, we extended the stoichiometric approach by the directly 
measurable parameters, carbon dioxide production rate (qCO2) and oxygen consumption 
rate (qO2), both determined by exhaust gas analysis. The latter was further coupled to the 
oxidation of XADH in the respiratory chain, expressed by equation 3 [3], implying that 
consumed oxygen is used for the oxidation of reduced equivalents NADH and FADH2. 
The advantage relying solely on XADH for balancing is to circumvent uncertainties 
associated with ATP balancing (such as futile cycles, hydrolysis and unknown efficiencies 
of the ATP synthases namely the P/O ratios in the respiratory chain). Consideration of the 
net CO2 efflux allowed the combined determination of the fluxes v2, v7, v8 and v10. In 
combination with the qO2-XADH constraint, the glucose 6-phosphate partitioning could be 
estimated, resulting in a precise determination of all linear dependent fluxes (Figure VI-2). 
Furthermore, calculated flux activities solely exhibit physiologically feasible values 
(Figure VI-2). 
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Figure VI-2. Correlation of flux activities and precision of flux estimations, showing obtained 
values for 1000 Monte Carlo simulations with varying initial values. Fluxes (vi) of glycolysis (i=4, 
5) and PPP (i=2, 3) and anaplerosis (i=10) are related to the initiating step of glycolysis (v1). 
Values are displayed as relative values (in %) normalized to the glucose uptake rate, which was set 
to 100%. Determination of flux distributions was performed with balancing of XADH (Table VI-
1). Flux calculations were carried out without thermodynamic restrictions, allowing physiologically 
non-feasible values to be calculated. 
 
 
The implementation of the CO2 and XADH balances introduces two additional constraints 
that were further analyzed and physiologically validated in direct comparison with the 
tracer-based flux determination in minimal medium. As depicted in Table VI-3, pathway 
activities estimated by the two different approaches resulted in almost identical flux 
distribution patterns, revealing the reliability and applicability of the extended metabolite 
balancing approach. Importantly, this approach can only be applied, when separation of 
NADPH and NADH is provided, as is not the case for organisms capable of NADPH-
NADH interconversion by transhydrogenases as described for Paracoccus versutus, 
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Bacillus subtilis and Escherichia coli (Fuhrer and Sauer, 2009). In this context, 
participation of MalE, transferring electrons from NADH to NADPH, has to be ensured to 
be not active or insignificant, as was reported to be the case for C. glutamicum wild type 
strain (Kromer et al., 2008; Chapter V).  
 
Metabolic flux analysis for industrial large-scale processes 
Cultivation profile of C. glutamicum on complex medium 
Industrial manufacturing of biotechnological products is mainly performed as scale-up 
process applying complex fermentation broths as substrates for the production process. 
Due to the complex nature of the substrate and changing environmental conditions, 
microbiological growth seldom features a single-phased growth behavior, resulting in 
substantial increased experimental and analytical demands for in-depth analysis.  
In this study, fluxome analysis of C. glutamicum in a complex medium mimicking 
industrial fermentation conditions was performed applying the aforementioned extended 
metabolite balancing approach. The cultivation profile of C. glutamicum ATCC 13032 on 
complex medium is depicted in Figure VI-3. Consumption and production of amino acids 
(free and peptide-bound) were quantified and monitored over the complete cultivation 
period and are illustrated in Figure VI-4.  
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Figure VI-3. Profile of the batch fermentation of C. glutamicum ATCC 13032 on complex media, 
resulting in multi-phase growth behavior. Asterisks mark the growth phases, which were further 
analyzed by MFA. (A.) Growth profile, showing biomass production [gCDW L-1] and glucose 
consumption [mM]. (B.) CO2 production rate [CPR; mmol L-1 h-1] and O2 uptake rate [OUR; 
mmol L-1 h-1]. All data are shown with respect to the observed growth phases. 
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Figure VI-4. Time course of amino acid concentrations [µmol L-1] of C. glutamicum ATCC 13032 
during growth on complex medium in relation to biomass concentration [g L1-]: free amino acids 
(open circles), peptide-bound amino acids (open squares) and hydrolyzates (both combined; full 
squares) of cultivation supernatants. Dashed lines mark different growth phases.  
 
The resulting amino acid consumptions and glycine production with respect to biomass 
formation were determined for each growth phase and are summarized in Table VI-5. 
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were varied (see “Substrate and product analysis – Materials and Methods”). Neither 
increasing degradation times nor increasing volumes of 12 M HCl showed any effect on 
the concentration of released free amino acids.  
 
Table VI-5. Amino acid consumption and production values [µmol gCDW-1], obtained for 
C. glutamicum ATCC 13032 grown in 75 ml complex medium for growth phases I and IIa,b. 
 
amino acid phase I phase II 
alanine (Ala) 216.7 60.0 
arginine (Arg) 193.2 -- 
aspartate/asparagine (Asx) 259.9 -- 
glutamate/glutamine (Glx) 369.2 -- 
glycine (Gly) 147.6 52.1c 
histidine (His) 51.7 -- 
isoleucine (Ile) 156.6 -- 
leucine (Leu) 213.8 -- 
lysine (Lys) 137.4 33.0 
methionine (Met)d 62.1 -- 
phenylalanine (Phe) 57.4 -- 
serine (Ser) 438.9 -- 
threonine (Thr) 238.1 -- 
tryptophan (Trp)d 18.6 -- 
tyrosine (Tyr) 62.8 -- 
 
a  values are obtained from hydrolyzates of the cultivation supernatants and represent the net consumptions 
of peptides and free amino acids. 
b  for phase III no substrate consumption was detected. 
c  glycine secretion in terms of free amino acids for growth phase II. 
d for methionine and tryptophan, values were obtained exclusively from free amino acids due to 
instabilities during acid hydrolysis (for reference see Figure VI-4). 
 
Quantification of methionine and tryptophan was carried out only for free amino acids due 
to instabilities of these two compounds during acidic hydrolysis. Furthermore, quantitative 
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determination of asparagine and aspartate as well as of glutamine and glutamate was 
performed for the combined pools of these compounds. 
 
During 11 h of cultivation, 10 g L-1 biomass were produced and 100 mM glucose were 
consumed. Considering growth parameters like specific growth rate, biomass yield and 
substrate consumption rates, the cultivation profile was divided into three major growth 
phases. For the first 8-9 h exponential growth was observed, characterizing the first two 
phases. In contrast, the third phase exhibited a decrease in OD660nm, entire depletion of the 
main carbon source glucose and further lacked any amino acid consumption, indicating the 
death phase. The shift between these phases is indicated by dashed lines.  
During phase I, the specific growth rate was found to be at maximum with 0.508 h-1, 
corresponding to a doubling time of less than 90 min. Biomass production was covered 
mainly by glucose uptake, though a substantial part of the needed carbon was provided by 
peptide-bound as well as free amino acids available in the complex medium (Figure VI-4 
and Table VI-5). 28% of the produced biomass during this period were covered by 
assimilated amino acids leaving a biomass-glucose yield of 0.079 gCDW mmolglucose-1 
derived solely from glucose. The carbon contained in glucose was thus converted to 
biomass and carbon dioxide with 54.0% and 48.9%, respectively (Table VI-6). During this 
phase all amino acid consumptions except for serine were lower than the amount required 
for biomass formation (Wittmann and Heinzle, 2008).  
 
Serine uptake was determined with a constant yield of 438.9 µmol gCDW-1, exceeding the 
required demand of 225 µmol gCDW-1 by almost 100%. As consequence, amino acid uptake 
for all amino acids except for serine was assumed to be directly incorporated into cellular 
protein, whereas the consumed surplus of serine is most likely converted to pyruvate via 
serine dehydratase as described by Netzer et al. (2004b).  
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Table VI-6. Carbon balances for the first two growth phases of C. glutamicum ATCC 13032 
grown in 75 mL complex mediuma. 
 
 consumed carbon 
sources 
 produced carbon                      
sources 
phase I 
 
glucose 
 
13.7  
C-mmol
 
 
biomassc 
(CDW) 
 
7.4  
C-mmol 
 
(= 0.54  
C-molCDW C-molglu) 
 
serineb 
 
0.2  
C-mmol
 
 
CO2 
 
6.7  
C-mmol 
 
(= 0.49  
C-molCO2 C-molglu) 
      
balance 13.9  C-mmol   
14.1  
C-mmol  
phase II 
 
glucose 
 
31.5 
C-mmol
 
 
biomassc 
(CDW) 
 
19.8 
C-mmol 
 
(= 0.63 
C-molCDW C-molglu) 
   
 
CO2 
 
11.7 
C-mmol 
 
(= 0.37 
C-molCO2 C-molglu) 
   
 
glycine 
 
0.1  
C-mmol 
 
      
balance 31.5  C-mmol   
31.6  
C-mmol  
 
a  for the third phase, no carbon balance was established, since neither carbon consumption nor production 
were detected, thus indicating the death phase. 
b for serine balance, only the metabolized fraction (213.9 µmol gCDW-1) and not the total fraction (438.9 
µmol gCDW-1) was considered. 
c for biomass balance, only fractions derived from glucose were considered: for phase I 72% of the 
corresponding CDW were derived from glucose (28% from peptides and amino acids); for phase II only 
1% of the CDW was derived from peptides and amino acids. 
 
 
The second growth phase was initialized by the depletion of the free amino acid pools, 
except for alanine and lysine which were further consumed during the second growth 
phase. During this period, the specific growth rate decreased to 0.431 h-1, which is 
consistent with growth on minimal medium containing glucose as sole carbon source 
(Table VI-2). Amino acid consumption (alanine and lysine during the second growth 
phase; Figure VI-4), drastically dropped and accounted for only 1% of the synthesized 
biomass during this phase. In addition, a constant glycine secretion of 58.2 µmol gCDW-1 
was observed. In this phase the nitrogen demand was covered by supplemented urea. The 
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carbon contained in glucose (70 mM) was converted to biomass (62.9%), CO2 (37.1%) and 
glycine (0.2%) (Table VI-6). The increased biomass yield of 0.093 gCDW per mmol glucose 
thereby depicted the altered carbon usage from an amino acid/glucose-co-consumption in 
phase I (0.079 gCDW mmolglucose-1) to glucose metabolization during phase II (0.093 gCDW 
mmolglucose-1): in phase II glucose was used for biomass formation by converting 62.9% of 
the contained carbon into cellular components, whereas during phase I solely 54.0% of the 
glucose derived carbon were converted into biomass and almost 50% were lost as CO2 
(Table VI-6). Except for glycine no further by-product secretion was observed.  
The results of the fermentation were further analyzed by metabolic flux analysis applying 
the metabolite balancing approach, thereby enabling a separate determination of the in vivo 
carbon fluxes for the two observed growth phases. The underlying metabolite model from 
Figure VI-1 was extended by uptake reactions for all amino acids determined and serine 
metabolization. The anabolic demand for NADH as described in the literature for sole 
glucose consumption (Yang et al., 2006) was adjusted accordingly. Carbon balances were 
set up for each growth phase and are listed in Table VI-6. Inclusion of CO2 production 
yielded closed carbon balances indicating that all relevant substrates and products 
concerning all growth phases had been taken into account. 
 
Fluxome profile of C. glutamicum, observed for different growth phases 
Carbon flux distributions and corresponding standard deviations were estimated and are 
summarized in Figures VI-5 and VI-6. All fluxes could be determined with excellent 
precision including flux partitioning at the glucose 6-phosphate node.  
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Figure VI-5. In vivo carbon flux distribution of the central metabolism of C. glutamicum ATCC 
13032 during growth on complex media, resulting in multi-phase growth behavior: Phase I. Fluxes 
are standardized to the specific glucose uptake rate (phase I qS = 4.70 mmol g-1 h-1) which was set 
to 100%. PEP and Pyr, as well as Mal and OAA are lumped together. Net fluxes are displayed with 
corresponding standard deviations. 
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Figure VI-6. In vivo carbon flux distribution of the central metabolism of C. glutamicum ATCC 
13032 during growth on complex media, resulting in multi-phase growth behavior: Phase II. Fluxes 
are standardized to the specific glucose uptake rate (phase II qS = 5.46 mmol g-1 h-1), which was set 
to 100%. PEP and Pyr, as well as Mal and OAA are lumped together. Net fluxes are displayed with 
corresponding standard deviations. 
 
BMP5P
extracellular
intracellular
BMG6P
BM3PG
BMPEP/Pyr
BMAcCoA
BMOAA
BMAKG
Ala 
Lys
Lys
BMGAP
Gly
100.0
44.6 ± 3.2
53.6 ± 3.1
0.5 ± 0.0
0.9 ± 0.0
15.3 ± 0.10.3 ± 0.0
Glucose
G6P
F6P
F16BP
DHAP
GAP
3PG
PEP/Pyr
AcCoA
P5P
Gly
BMF6P
Fum
Suc
OAA/Mal Cit
AKG
73.5 ± 1.0
34.0 ± 3.2
157.0 ± 1.0
144.5 ± 1.0
88.5 ± 0.9
58.9 ± 0.81
47.6 ± 0.9
26.7 ± 0.4
1.2 ± 0.0
2.9 ± 0.0
1.9 ± 0.0 10.7 ± 0.1
12.0 ± 0.1
29.4 ± 0.2
29.5 ± 0.1
11.4 ± 0.1
0.5 ± 0.0
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The flux partitioning at the branch point between glycolysis and PPP is of special interest 
as it allows assessing the amount of NADPH delivered by the oxidative branch of the PPP 
as well as the accompanying carbon loss and the precursor supply via this pathway. PPP 
activity during the first phase was drastically reduced compared to the second phase, 
indicating the reduced demand of NADPH for anabolic reactions due to the considerable 
amino acid consumption. Thus less carbon had to be dedicated for biomass production and 
NADPH supply and could therefore be channeled through the pathways generating energy 
in terms of NADH and eventually ATP. This reduced requirement of consumed glucose for 
precursor supply was also reflected in a high TCA activity of over 80%. During the second 
growth phase the PPP activity was increased according to the increased anabolic demand 
of glucose as precursor supplier and the enhanced requirements for NADPH for biomass 
production, deduced from the main usage of glucose as sole carbon source. TCA activity 
dropped to only 59%, which could be caused by the increased requirement of the biomass 
precursors acetyl-CoA, pyruvate and phosphoenolpyruvate.  
 
Metabolic flux partitioning at the glucose 6-phosphate node during the second growth 
phase on complex substrate was identical to that obtained from 13C MFA on glucose as 
sole carbon source. Since glucose was also the sole carbon source during the second 
growth phase on complex medium one would expect a similar flux distribution as it was 
the case in the 13C MFA experiment. A further validation of the applicability of this 
approach was performed, analyzing the NADPH consuming and producing reactions, 
based on the estimated fluxes depicted in Figures VI-5 and VI-6. The anabolic NADHP 
demand of 15.9 mmol NADPH per gram biomass during sole glucose consumption (Yang 
et al., 2006) was corrected for both growth phases considering the consumption of amino 
acids and their direct incorporation into biomass. For the first growth phase, a NADPH 
generation of 131.0% (related to the glucose uptake rate) and a NADPH demand of 
127.0% were determined, indicating a closed NADPH balance for this phase. Due to the 
reduced amino acid uptake in the second growth, the anabolic demand of NADPH was 
increased and calculated with 146.0%. The NADPH supply was determined to account for 
148.1% likewise matching the requirements. 
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In summary, both growth phases exhibited closed carbon as well as NADPH balances, 
ensuring a correct determination of the intracellular in vivo carbon flux distributions under 
dynamic metabolite conditions using balance equations listed in Table VI-1. Thus, the 
supposed non-participation of the malic enzyme during glucose sustained growth (Kromer 
et al., 2008; Chapter V) was validated.  
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Conclusions 
 
 
The metabolite balancing approach was seen to be best suited for fluxome estimation on 
complex medium for multiple reasons. First, growth-phase dependent changes in the 
fluxome are challenging for stationary 13C-MFA, since it is based on an isotopic steady 
state in the main biomass components like the cellular protein. However, during dynamic 
changes isotopic steady state may not be reached in cellular protein. Thus, the only 
labeling-based alternative would be a dynamic labeling approach, employing free 
intracellular metabolites for determination of the corresponding labeling patterns. This 
approach also requires the determination of intracellular metabolite concentrations that are 
often difficult to accomplish (Bolten et al., 2007; Wittmann et al., 2004c). Furthermore 
potential protein degradation (turnover), resulting in the release of labeled amino acids 
representative for a previous phase, could corrupt the results. Even if all experimental 
problems are solved, such a dynamic labeling approach is experimentally, analytically and 
also computationally demanding.  
Another reason for applying metabolite balancing is the scale-independency of this 
approach. A tracer-based analysis is always scale-dependent as information obtained from 
small-scale tracer cultivations that are required due to their inherent cost for labeled 
substrates have to be transferred to large-scale fermentations. Only gas chromatography 
combustion isotope ratio mass spectrometry (GC-C-IRMS) can solve the cost issue of 13C 
labeled substrates to a certain extent (Heinzle et al., 2008; Yuan et al., 2010).  
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Abstract* 
 
 
In the following research, important insights into the metabolizing pathways and especially 
into the cellular adaptation capability of C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi 
were revealed. In small-scale fermentation with peptone-supplemented medium, the 
utilization of complex medium components were analyzed. The supplementation with 
peptone was applied to prevent glucose metabolism specific limitations of this 
C. glutamicum mutant determined for cultivations on minimal medium strain due to the pgi 
deletion (Chapters IV and V). The utilization of complex medium components was found 
to delay the pgi specific phenomenon i.e. the reductive burden due to excess NADPH 
delivery and the associated growth stagnation. Furthermore, peptone-supported growth 
resulted in an increased NADH and ATP supply. This promoted enhanced intracellular 
IMP concentrations of 40.66 µmol gCDW-1 (12.88 µmol gCDW-1 on minimal medium with 
glucose as sole carbon source; Chapter IV). The change of the carbon and precursor 
sources – from considerable peptide/amino acid supported growth (45.8% peptone derived 
biomass formation and metabolization of aspartate/asparagine, glutamate/glutamine and 
serine) to mainly glucose supported growth – however led to a progression of the NADPH 
surplus and the initiation of a growth stagnation period. 
 
 
 
 
 
 
* Manuscript in preparation: 
Peifer S, Lis AV, Heinzle E, Schneider K. 
Comparative fluxome and dynamic metabolite analysis in a genetically engineered C. glutamicum strain 
cultivated on complex medium.   
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Introduction 
 
 
In the field of the biotechnological industry, Corynebacterium glutamicum and related 
species provide an excellent production platform for food and feed additives, 
pharmaceuticals, fine chemicals, polymers and bio-based fuels (Becker and Wittmann, 
2012). Rational strain optimization employing metabolic engineering strongly contributed 
to further broaden the product portfolio of this organism (Becker and Wittmann, 2012). In 
this study the potential of this organism for biotechnological production of the flavor-
enhancing compound IMP was investigated. Various parameters and key points – 
supplying, regulating or constraining the purine biosynthesis capability – have been 
investigated in previous studies (Chapters IV and V) and were included in an approach 
focusing on intracellular IMP accumulation. In the course of these works, some of the 
parameters proofed to be detrimental for cellular growth, as was determined for the pgi 
deletion (Chapter V). In addition, redirection of the metabolic carbon fluxes caused by an 
entry block into glycolysis and aiming at an increased precursor supply of ribose 5-
phosphate led to a metabolic shift of the intracellular distribution of the purine 
intermediates, favoring the accumulation of the corresponding degradation products – 
especially hypoxanthine – at the expense of IMP (Chapter IV). This metabolic shift was 
reported to be influenced mainly by a decreasing ATP supply via oxidative 
phosphorylation (Noguchi et al., 2003) which was consistent with the results obtained and 
discussed in Chapter IV. The decreased ATP delivery was caused by a diminished 
generation of NADH due to the forced metabolization of the sole carbon source glucose 
through the pentose phosphate pathway and the associated decarboxylating reaction of the 
6-phosphogluconate dehydrogenase. In addition to the carbon loss due to the release of one 
molecule CO2 per mol glucose 6-phosphate entering the oxidative branch of the PPP as 
initiating step of the metabolization, the redirection through the PPP was accompanied by a 
rigorous overabundance of NADPH (unbalanced supply and demand), resulting in a 
growth arrest for 24 h (Chapter V). This particular growth behavior developed after 
switching from complex medium to minimal medium employing glucose as sole carbon 
source and proofed to be detrimental with regard to the specific growth rate. 
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However, these two burdens are clearly linked to the utilization of glucose as carbon 
source and its sole metabolization via the oxidative branch of the PPP upon pgi deletion. 
As industrial biotechnological fermentation processes are seldom based on minimal 
medium containing expensive or purified compounds, the utilization of complex and low 
priced substances, e.g. peptone, and associated consequences on the intracellular purine 
accumulation should be investigated in this study. Thereby the main focus was put on the 
NADH generation using the provided complex substances in comparison to the usage of 
glucose as sole carbon source. In addition, the disturbance of the growth performance by 
excessive NADPH supply, determined on glucose sustained growth, was analyzed likewise 
and the impact on the purine concentrations was investigated. 
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Materials and methods 
 
 
Bacterial strains 
In the present study, the wild type strain of Corynebacterium glutamicum (ATCC 13032) 
and the site-directed mutant C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi were 
investigated. The wild type strain (C. glutamicum ATCC 13032) was purchased from the 
American Type Culture Collection (Manassas, VA, USA) and the site-directed mutant was 
constructed as described previously (Chapter IV).  
 
Media and growth conditions 
Precultures were carried out on an orbital shaker (Multitron 2, Infors AG, Bottmingen, 
Switzerland) at 230 rpm and 30°C. First precultures were performed on complex medium 
(pH 6.8) in baffled shake flasks (25 mL medium in 250 mL baffled shake flasks) 
containing per liter: 10.0 g glucose, 2.5 g NaCl, 2.0 g urea, 5.0 g yeast extract, 5.0 g beef 
extract, 5.0 g polypeptone and 20.0 g casamino acids. For agar plates, the complex medium 
was supplemented with 20.0 g L-1 agar. Second precultures (50 mL medium in 500 mL 
baffled shake flasks) and main cultures on complex media (pH 7.2) contained per liter: 
4.0 g KH2PO4, 16.0 g K2HPO4, 4.0 g peptone, 20.0 g glucose, 10.0 g MgSO4, 6.0 g urea, 
100 mg CaCl2 · 2 H2O, 1 mg ZnSO4 · 7 H2O, 20 mg FeSO4, 17 mg MnSO4, 20 mg 
cysteine, 30 mg biotin, 10 mg calcium pantothenate and 5 mg thiamine. For cultivation of 
the site-derived mutant C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi exhibiting deletions 
of adenylosuccinate synthetase (purA) and IMP dehydrogenase (guaB2), the medium was 
additionally supplemented with 200 mg L-1 adenine sulfate and 80 mg L-1 guanine 
hydrochloride, due to auxotrophy-derived requirements (Chapter IV). 
Main cultivations were performed in a stirred tank bioreactor (500 mL, Meredos, 
Bovenden, Germany) in a volume of 75 mL at 30°C and 1,000 rpm. Dissolved oxygen 
concentrations during fermentation were always above 60% air saturation thus avoiding 
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oxygen limitation. The airflow was controlled at 1 vvm (vessel volume per minute) by a 
mass flow controller (WMR Compact 4, Brooks Instruments, Veenedaal, Netherlands) and 
composition of air and exhaust gas was quantified using a quadrupole mass spectrometer 
(Omnistar, Inficon, Vaduz, Liechtenstein). Process parameters were collected and stored 
by a process control system (Lucullus PIMS 2.1, Biospectra, Schlieren, Switzerland). 
 
Chemicals 
Yeast extract, polypeptone, casamino acids and beef extract were obtained from Difco 
Laboratories (Detroit, USA). All other chemicals and reagents were purchased from 
Sigma-Aldrich (Steinheim, Germany), Merck (Darmstadt, Germany), Fluka (Buchs, 
Switzerland), Roth (Karlsruhe, Germany) and Roche Diagnostics (Mannheim, Germany) 
and were of analytical grade unless stated otherwise. 
 
Extracellular substrate and product analysis 
Biomass concentrations were determined by measuring the optical density of the culture at 
660 nm (OD660nm) using a photometer (Marsha Pharmacia Biotech, Freiburg, Germany) 
which was gravimetrically correlated with the cell dry weight. Extracellular substrates and 
secreted products were analyzed after 3 min centrifugation at 16,000 g. Quantification of 
glucose was performed in diluted supernatants by HPLC (Kontron Instruments, Neufahrn, 
Germany) by RI detection as described previously (Chapter VI). Total amino acid 
concentrations in complex media were determined after acidic hydrolysis of the peptides 
contained in the corresponding supernatants as described previously (Kromer et al., 2005; 
Chapter VI). Extracellular concentrations of adenine and guanine were quantified by 
HPLC (Agilent 1290 Infinity, Agilent Technologies, Waldbronn, Germany) as described 
previously (Chapter IV).  
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Intracellular metabolite analysis 
Extraction and quantification of intracellular purine intermediates by LC-ESI-MS/MS was 
performed as described previously (Peifer et al., 2012; Chapter III).  
 
Determination of the in vitro malic enzyme activity 
Determination of in vitro malic enzyme activity was performed in crude cell extracts. 
Cultivations and cell disruption were performed as described previously (Chapter V). The 
specific activity was determined using the molar extinction coefficient of NADPH (ε340nm = 
6.22 mM-1) and the corresponding protein content contained in the crude cell extracts. The 
final protein concentration was between 0.2-0.4 g L-1. The reaction mixture contained 
100 mM Tris/HCl (pH 7.8), 200 mM KCl, 2 mM MgCl2, 1 mM NADP+, 40 mM malate 
and 50 µL of the crude cell extract. Determination of the in vitro malic enzyme activity 
was based on the change of absorption at 340 nm due to NADPH formation. The protein 
content was determined by the method of Bradford (1976) and the reagent solution from 
Sigma-Aldrich with bovine serum albumin as external standard. 
Measurements were started by addition of the substrates, performed at 30°C and monitored 
for 15-30 min. Negative controls were performed without substrate or crude cell extract, 
respectively. All measurements were done in a total volume of 1 mL and carried out in 
triplicate.  
 
Fluxome analysis 
Carbon flux distribution of C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi was determined 
by a metabolite balancing approach. Briefly, extracellular measurable rates (glucose 
consumption, biomass formation, amino acid and peptide consumption and amino acid 
secretion) and anabolic demand for biomass formation were used to determine the 
metabolic fluxes of a simplified model containing reactions of glycolysis/gluconeogenesis, 
TCA cycle, PPP and anaplerotic carboxylation (as combined fluxes of the anaplerosis). 
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Statistical evaluation was carried out using a Monte Carlo approach applying 1000 
independent runs (for detailed description see Chapter VI). 
Visualization was performed using Omix software (Droste et al., 2011). 
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Results and discussion 
 
 
In the present study, the availability of compounds – peptides and free amino acids – 
derived from peptone as complex medium supplement, their utilization and corresponding 
influences on the intracellular distribution and accumulation of the purine biosynthetic 
pathway intermediates in C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi were analyzed. 
Utilization of those complex components, which can directly serve as precursors for 
protein formation, led to a direct reduction of the ATP demand for protein synthesis. The 
overall ATP availability – as a key parameter for the purine distribution to be optimized in 
this study – was thus improved. In addition, the amount of carbon drained from the main 
pathways and spend for protein synthesis was diminished, resulting in comparatively 
increased fluxes (normalized to the glucose consumption rate) of the different pathway 
branches. The connection between the postulated increased flux activities and the cofactor 
delivery, i.e. NADH and ATP, was investigated and discussed below. 
 
Dynamics of intracellular purine pathway metabolites during multi-phase 
growth 
As described in Chapter VI, the wild type strain of C. glutamicum grown on complex 
medium exhibited exponential growth during the whole cultivation period, although two 
distinct growth phases were detected switching from amino acid and peptide supported 
growth (phase I) to primary glucose consumption (phase II) (for a detailed description see 
Chapter VI). The concentrations of the main purine intermediates were determined for the 
second growth phase and compared to those obtained during growth on minimal medium 
(Chapter IV). As illustrated in Table VII-1, the distribution of the purine intermediates on 
complex medium was similar to those obtained during growth on minimal medium. The 
concentration of AMP was found to be decreased and the concentration of GMP to be 
increased, however no significant intracellular accumulation of IMP or hypoxanthine were 
detected for both cases. The determination was likewise performed for the site-directed 
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mutant C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi for the first and additionally the third 
growth phase.  
 
Table VII-1. Concentrations of purine intermediates [µmol gCDW-1] in C. glutamicum wild type 
(ATCC 13032) and C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi, determined during growth on 
minimal medium (MM) and complex medium (CM). 
 
 concentrations [µmol gCDW-1] 
 
compound 
 
ATCC 13032 
 
ΔpurA ΔguaB2 purFK348Q Δpgi  
 
 
 
MMa 
 
CM 
 
MM 
 
CMb 
 
AMP 
 
8.13 
 
± 
 
0.50 
 
6.57 
 
±
 
0.94 
 
3.57 
 
±
 
0.20 
 
5.83 
(4.18) 
 
± 
 
0.04 
(0.37) 
 
GMP 
 
2.63 
 
± 
 
0.16 
 
5.04 
 
±
 
0.33 
 
0.51 
 
±
 
0.03 
 
1.30 
c 
 
± 
 
0.02 
 
 
IMP 
 
0.49 
 
± 
 
0.06 
 
0.38 
 
±
 
0.04 
 
12.88 
 
±
 
0.74 
 
40.66 
(11.86) 
 
± 
 
0.53 
(1.49) 
 
hypoxanthine 
 
0.28 
 
± 
 
0.03 
 
0.10 
 
±
 
0.03 
 
101.53 
 
±
 
1.09 
 
7.57 
(7.31) 
 
± 
 
0.95 
(0.55) 
             
 
a  data on minimal medium were taken from Chapter IV. 
b concentrations for C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi on complex medium were determined 
for the first (top) and third growth phase (in brackets, bottom) as depicted with asterisks in Figure VII-1. 
c below detection limit. 
 
 
The genetically engineered strain C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi exhibited a 
significantly different growth behavior compared to the wild type, which was reflected in 
four distinct growth phases (Figure VII-1). For neither strain grown on complex medium, 
any nucleosides were detected, which even on minimal medium solely exhibited small 
concentrations (Table VII-1). During the whole cultivation no secretion of purine 
compounds into the extracellular environment was observed and solely the intracellular 
concentrations were determined.  
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Figure VII-1. Batch fermentation profile of C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi on 
complex medium, resulting in multi-phase growth. Asterisks mark the corresponding growth 
phases further investigated. (A.) Growth profile with biomass production [gCDW L-1], glucose 
consumption [mM], lysine production [mM] and pH. (B.) CO2 production rate [CPR; mmol L-1 h-1] 
and O2 uptake rate [OUR; mmol L-1 h-1]. All data are shown with respect to observed growth 
phases. 
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In direct comparison to the wild type strain, the distribution of the detected purine 
compounds differed significantly. The IMP concentration of C. glutamicum ΔpurA ΔguaB2 
purFK348Q Δpgi significantly exceeded the wild type level in phase I (amino acid- and 
peptide-supported growth) (Table VII-1). The IMP concentration (40.66 µmol gCDW-1) 
even surpassed the concentration determined during growth on minimal medium 
significantly (12.88 µmol gCDW-1). In addition, AMP and GMP concentrations were 
drastically reduced compared to the wild type, which is consistent with results obtained in 
Chapter IV from growth experiments on minimal medium. The shift towards glucose-
supported growth, however, led to a decrease of the intracellular IMP pool by 70% to a 
final concentration of 11.86 µmol gCDW-1 which is in excellent agreement with the 
concentration determined for growth on glucose as sole carbon source in minimal medium 
(Chapter IV – Table IV-1). 
 
One of the major objectives of this study was the investigation of C. glutamicum ΔpurA 
ΔguaB2 purFK348Q Δpgi cultivated on peptone-supplemented medium. Thereby, the 
quantitation of purine intermediates and their intracellular distribution was put into focus.  
Up to this point it can be concluded that the supplementation with peptides and free amino 
acids positively influenced the distribution of the purine metabolites. Especially the 
accumulation of the monophosphorylated nucleotide IMP was increased. Former results 
(Chapter IV) indicated a decrease of the IMP concentration due to a diminished ATP 
supply upon pgi deletion in combination with the deletion of IMP depleting reactions 
(purA and guaB2). The increased IMP concentration (40.66 µmol gCDW-1) determined in 
this study, might indicate that the adverse effect of the pgi deletion on the purine 
distribution was compensated to a certain extend. Due to the fact that the former decline 
was supposed to be caused by a decreased activity of NADH generating reactions, the 
phase-dependent metabolic growth behavior and the distribution of the underlying carbon 
fluxes on complex medium were determined.  
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Metabolization of alternating carbon sources  
Most strikingly, the so far observed unique adaptation process concerning a complete 
growth stagnation caused by the disruption of the pgi gene (Chapter V), was completely 
absent during cultivation on complex medium for the period investigated and illustrated in 
Figure VII-1 and was thus determined to be directly linked to sole glucose consumption. In 
this context, the degree of amino acid/peptide utilization was determined and its impact on 
the flux distribution was investigated. 
In accordance with the results obtained for the amino acid consumption of C. glutamicum 
wild type (Chapter VI) the site-directed mutant C. glutamicum ΔpurA ΔguaB2 purFK348Q 
Δpgi exhibited constant amino acid uptake rates for growth phases I, II and III. In contrast 
to the wild type growth behavior, the majority of the amino acid uptakes of C. glutamicum 
ΔpurA ΔguaB2 purFK348Q Δpgi however exceeded the anabolic demand, i.e. determined for 
alanine, arginine, aspartate/asparagine, glutamate/glutamine, lysine, serine and threonine 
(Table VII-2). For C. glutamicum ATCC 13032 (wild type) solely serine consumption 
exceeded the anabolic demand (Chapter VI – Table VI-5). During the second and third 
growth phases of C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi, the amino acid 
consumption declined significantly (Table VII-2), exceeding the anabolic demand solely in 
the case of alanine during the second growth phase (consumption: 665 µmol gCDW-1; 
anabolic demand: 606 µmol gCDW-1).  
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Table VII-2. Amino acid consumption and production values [µmol gCDW-1], obtained for 
C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi grown in 75 ml complex medium for growth phases 
I, II and IIIa. 
 
amino acid anabolic demandb phase I phase II phase III 
alanine (Ala) 606 665 665 --c 
arginine (Arg) 189 315 155 155 
aspartate/asparagine (Asx) 399 1045 -- -- 
glutamate/glutamine (Glx) 806 1426 -- -- 
glycine (Gly) 361 281 -- -- 
histidine (His) 71 66 66 66 
isoleucine (Ile) 202 163 163 115 
leucine (Leu) 440 402 402 226 
lysine (Lys) 202 313 -- 132d 
methionine (Met)e 146 41 41 -- 
phenylalanine (Phe) 133 133 133 133 
serine (Ser) 225 989 -- -- 
threonine (Thr) 275 530 -- -- 
tryptophan (Trp)e 54 29 -- -- 
tyrosine (Tyr) 81 75 75 -- 
 
a values are obtained from hydrolyzates of the cultivation supernatants and represent the net consumptions 
of peptides and free amino acids. 
b data for anabolic demand were taken from Wittmann and Heinzle (2008). 
c – indicates uptake <1 µmol gCDW-1. 
d  lysine secretion in terms of free amino acids for growth phase III. 
e for methionine and tryoptophan, values were obtained exclusively from free amino acids due to 
instabilities during acid hydrolysis. 
data for C. glutamicum wild type strain on complex medium are depicted in Chapter VI – Table VI-5. 
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The amino acids taken up exceeding the anabolic demand, i.e. alanine, arginine, 
aspartate/asparagine, glutamate/glutamine, lysine, serine and threonine, are either stored – 
leading towards increasing intracellular pool sizes – or used as additional carbon sources 
and hence are metabolized. In order to determine their corresponding pool sizes, the fast 
filtration method for the quantitative determination of free intracellular amino acids in 
C. glutamicum, described by Wittmann et al. (2004c) was applied. The presence of the 
complex supplement peptone in the medium however precluded an accurate quantification 
as complex medium components seemed to attach to the cells thus disturbing the precise 
quantification of intracellular amino acid pools. Therefore, a carbon balance was set up and 
a possible metabolization of those amino acids was evaluated (Table VII-3).  
 
Table VII-3. Carbon balance for the first growth phase of C. glutamicum ΔpurA ΔguaB2 
purFK348Q Δpgi grown in 75 mL complex medium. 
 
consumed carbon sources  produced carbon sources 
 
glucose 
 
2.31 C-mmol  
 
biomass 
(CDW) 
 
2.97 C-mmol 
 
amino acidsa 
 
2.12 C-mmol 
(1.95 C-mmol) 
 
  CO2 
 
1.31 C-mmol 
     
 
Totalb 
 
4.43 C-mmol 
(4.26 C-mmol) 
 
   4.28 C-mmol 
 
a. consumption of amino acids was determined comprising all amino acids detected (including those 
exceeding the anabolic demand): numbers on top; and in addition comprising amino acid below or with 
balanced anabolic demand (Gly, His, Ile, Leu, Met, Phe, Trp and Tyr) and those reported to be 
metabolizable (excluding surpluses of Arg, Lys and Thr): numbers in brackets. 
b carbon balance considering different amino acid utilization. 
 
This evaluation was based on the assumption that an increase in amino acid pools sizes 
inevitably leads to a reduced carbon supply as these compounds are not metabolized and 
not used as carbon sources. Table VII-3 illustrates the results obtained in case of 
exhaustive metabolization (upper numbers) and for the case of a possible storage by 
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increasing pool sizes (lower numbers). As is clearly indicated in Table VII-3, a thorough 
metabolization comprising all amino acids detected would lead to an imbalance of 
consumed and produced carbon sources with a consumption surplus. This is further 
supported by the fact that the genome of C. glutamicum does not comprise gene sequences 
for the metabolization of arginine, lysine and threonine/isoleucine (Kalinowski et al., 2003) 
and is thus not able to utilize these compounds as carbon sources. Therefore the surplus of 
those amino acids that cannot be metabolized and that are exceeding the anabolic demand 
was assumed to be stored thus increasing the corresponding intracellular pools. The 
estimation of metabolic fluxes during phase I solely accounted for the metabolized carbon 
sources, i.e. glucose, alanine, aspartate/arginine, glutamate/glutamine and serine.  
The second growth phase of C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi exhibited 
constantly decreasing specific CO2 production rates while an increasing biomass formation 
was observed (Figure VII-1), clearly indicating a metabolic adaptation process involving 
inconstant consumption and production rates. As depicted in Table VII-2, the amino acid 
consumption profile significantly changed from phase I to phase III, switching from an 
amino acid-supported growth during phase I (45.8% peptone-derived biomass formation), 
to mainly glucose-supported growth. During phase III, CO2 production increased 
proportional to biomass concentration (Figure VII-1). Most interestingly biomass 
formation as well as glucose consumption during phase III showed a linear 
production/consumption behavior (Figure VII-2) characterized by constant rates (qCDW = 
0.203 g L-1 h-1, qGlu = 0.308 mmol L-1 h-1; Figure VII-2A.) and thus a constant biomass 
yield (YX/S = 0.064 gCDW mmolglu; Figure VII-2B.).  
 
Bringing the facts together   -   Chapter VII
 
179 
 
Figure VII-2. Linear biomass formation [gCDW L-1] and glucose consumption [mM] (A.) and 
biomass yield [gCDW mmolglu-1] (B.) during the third growth phase of C. glutamicum ΔpurA ΔguaB2 
purFK348Q Δpgi on complex medium over time. 
 
 
It has to be noted however, that the linear growth is directly linked to a constantly 
decreasing specific growth rate, as the average period for duplication is constantly 
increasing. The decreasing specific growth rate might be caused by several parameters: one 
possibility is the insufficient availability of an essential compound e.g. limited carbon 
sources, medium supplements or insufficient oxygen supply. These possible limitations 
however can be excluded as neither carbon sources nor supplements were limiting and the 
dissolved oxygen concentration was above 60% throughout the entire cultivation. Another 
growth-inhibiting parameter is the accumulation of harmful secretion products normally 
observed as initiation of cell lysis and the death phase. This was observed for the 
cultivation of the wild type strain of C. glutamicum as a reduction of the final biomass 
concentration (Chapter VI – Figure VI-4). However, for C. glutamicum ΔpurA ΔguaB2 
purFK348Q Δpgi no reduction in biomass concentration was detected (Figure VII-1). The 
cultivation time was thus prolonged up to 80 h and the growth behavior was monitored 
(Figure VII-3). 
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Figure VII-3. Batch fermentation profile of C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi on 
complex medium, resulting in multi-phase growth. (A.) Growth profile with biomass production 
[gCDW L-1] and glucose consumption [mM] taken from Figure VII-1; (B.). Period of growth arrest 
without biomass formation and potential adaptation phase resulting in growth recovery.  
 
The growth stagnation, starting after 45 h was found to persist for another 20 h. The 
glucose consumption, however, further decreased (slightly) which became even more 
pronounced after 65 h with a simultaneous increase of the biomass concentration 
(Figure VII-3B.). Due to the almost exhaustive utilization of glucose, the growth behavior 
was solely monitored until that point of the cultivation. Resumption of growth after 65 h 
due to contamination was excluded by microscopic investigation and plating on agar 
plates. 
In summary, it seems quite likely that the growth stagnation observed during this 
cultivation did not depict the death phase but a temporary growth arrest, found to be a 
mutual characteristic for pgi deletion strains of C. glutamicum grown on glucose as sole 
carbon source as shown in previous studies (Chapter V). This is further supported by the 
fact that no substrate or supplement limitations were detected, that glucose was 
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continuously depleted and that the growth stagnation was first initialized by a substrate 
change, i.e. from amino acid to glucose consumption. 
Considering these facts, it seems quite likely that the growth stagnation, determined for all 
pgi deletion strains, was not circumvented by the addition of complex medium 
components, i.e. peptone, but solely delayed. In order to verify these findings, cultivation 
conditions should be modified, e.g. increasing the glucose concentrations or decreasing the 
peptone concentrations and thus provoking an earlier shift towards the growth stagnation 
period, which could be further analyzed in more detail. Besides, it would be beneficial to 
determine whether an additional glucose supplementation during the growth stagnation, 
e.g. as glucose pulse, would prolong and sustain cellular growth after the stagnation period.  
 
The consequences of the substrate switch – from amino acid-supported growth during 
phase I to mainly glucose consumption during phase III – on the redox metabolism 
(NADH/NADPH) were analyzed in detail and possible connections to the initiation of the 
growth stagnation were suggested. The reduced NADPH demand for protein due to the 
usage of amino acids from the medium and the consequences for the NADH generation 
were considered in the following. 
 
Metabolic flux distribution in C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi 
during phase I 
The distribution of intracellular carbon fluxes of C. glutamicum ΔpurA ΔguaB2 purFK348Q 
Δpgi was determined for the first growth phase. Due to the metabolic adjustments during 
phase II and the linear growth behavior in phase III, these two phases were not considered 
for flux estimation. The consequences of the drastically reduced amino acid consumption 
in phase III were however related to the overall growth behavior and the consequences are 
discussed in the overall context (see “Metabolic activity and NADPH metabolism during 
phase III – Results and Discussion”). 
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Figure VII-4. In vivo carbon flux distribution of the central metabolism of C. glutamicum ΔpurA 
ΔguaB2 purFK348Q Δpgi during growth on complex media (phase I). Fluxes are standardized to the 
specific glucose uptake rate (qS = 0.97 mmol g-1 h-1) which was set to 100%. PEP and Pyr, as well 
as Mal and OAA are lumped together. Net fluxes are depicted with corresponding standard 
deviations derived from 1000 Monte Carlo simulations. Intracellular accumulation of arginine, 
lysine and threonine/isoleucine is illustrated with estimated flux activities normalized to the 
glucose uptake rate (for explanations see Table VII-3 and text). 
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The pgi deletion led to a redirection of the carbon flux and an exclusive metabolization of 
glucose via the oxidative branch of the PPP (Figure VII-4). This was directly linked to a 
tremendous increase of NADPH formation and carbon release in terms of CO2 due to the 
decarboxylating reaction in the PPP.  
The increased CO2 formation as well as the enhanced NADPH generation, exhibited both 
adverse effects: first affecting the NADH supply as the ratio of PPP and TCA cycle 
dictates the potential for an efficient NADH supply mainly provided in the TCA cycle 
(Marx et al., 1999; Noguchi et al., 2003); and secondly affecting the growth performance 
due to an NADPH overabundance and the associated reductive burden. Both points will be 
discussed in detail, especially focusing on the consequences for the overall growth 
performance and the intracellular distribution of purine pathway intermediates. 
The increase of the PPP activity led to a substantial CO2 production and an initial carbon 
loss of 17% of the consumed glucose in the first metabolizing pathway (PPP). In addition, 
the comparatively high biomass yield of 0.19 g mmol-1 on complex medium 
(0.076 g mmol-1 on minimal medium; Chapter IV) required large amounts of precursors. 
This anabolic demand, however, was covered to a significant extent by the amino acid 
consumption (Table VII-2) and 45.8% of the composed biomass were synthesized from 
these compounds. Furthermore, the enormous uptake of serine, glutamate/glutamine, 
aspartate/asparagine and – to a lesser extent – alanine led to a carbon replenishment in the 
lower glycolysis and the TCA cycle (Figure VII-4). Due to the increased uptake especially 
of glutamate, an increase of the TCA cycle activity to 66%, leading from α-ketoglutarate to 
succinyl-CoA, and an even further increase due to the aspartate metabolization to 72.3%, 
leading from fumarate to malate were determined. Considering these findings, the peptone-
supplemented metabolic activity provided an overall XADH supply of 472.8% compared 
to 387.1% generated during growth on glucose as sole carbon source (Figure VII-5 and 
Chapter IV). As the generated XADH can be directly used to generate ATP via the 
respiratory chain, the total ATP supply can be assumed to be significantly improved during 
growth on peptone-supplemented media (at least for the first growth phase).  
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Figure VII-5. XADH supply for C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi. Glyceraldehyde 
3-phosphate dehydrogenase (GAP-DH), pyruvate dehydrogenase (Pyr-DH), α-ketoglutarate 
dehydrogenase (AKG-DH) and malate dehydrogenase (MAL-DH) were considered as NADH 
supplying reactions and succinate dehydrogenase (SUC-DH) as FADH2 supplying reaction. In 
addition, metabolization of excessive Asx (Table VII-2 and Figure VII-4) to fumarate, resulting in 
an increased flux towards malate, was considered. Anabolic derived NADH was corrected for 
reduced amino acid synthesis due to amino acid consumption (Table VII-2) and considered with 
1.7 mmol gCDW-1 for growth on peptone supplemented medium and 3.2 mmol gCDW-1 for growth on 
minimal medium (Yang et al., 2006). 
a data for cultivation on minimal medium were taken from Chapter IV. 
 
The second consequence of the pgi deletion was the excessive NADPH generation, mainly 
caused by the tremendous PPP activity of 96.1%. For the first growth phase the produced 
NADPH was determined to account for 263.6%, delivered by the activities of glucose 6-
phosphate dehydrogenase, 6-phosphogluconate dehydrogenase and isocitrate 
dehydrogenase (Figure VII-4). Due to the pronounced amino acid uptake, the anabolic 
demand of NADPH was reduced from 15.9 mmol per gram biomass (Yang et al., 2006) to 
8.0 mmol per gram biomass, accounting for a total NADPH demand of 152.0%. Thus, 
generated and consumed NADPH could not be balanced and caused an apparent NADPH 
surplus of 111.6%. A potential participation of the malic enzyme (MalE) operating in 
carboxylating direction and thereby reoxidizing excessive NADPH was then considered. 
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The possible role of MalE in pgi deletion strains of C. glutamicum has already been 
discussed in Chapter V and was determined to be linked with increased oxygen uptake 
rates, exceeding the requirements for NADH oxidation. The active participation of this 
enzyme would lead to an additional flux towards malate, and thus inevitably from malate 
to oxaloacetate transferring the electrons from NADPH (reoxidized by MalE) to NADH 
(generated by malate dehydrogenase). The increased NADH generation would however 
require an elevated O2 consumption to oxidize NADH (Chapter V). In order to assess a 
potential MalE participation, the oxygen consumption rate – normalized to the glucose 
uptake rate – was determined and the maximal capacity for NADH reoxidation was 
calculated. The oxygen consumption rate during phase I accounted for 292.7%, comprising 
an oxidation potential – in terms of NADH reoxidation – of 585.5%, exceeding the 
aforementioned NADH generation of 472.8% (Figure VII-5) by 112.7%. As the NADPH 
overabundance was determined to constitute 111.6%, the increased oxygen consumption 
could compensate the overproduction of NADPH. It should be mentioned that due to the 
metabolite balancing approach solely the net-reaction of the anaplerotic decarboxylation 
and carboxylation could be determined and the participation of MalE and its operating 
direction can only be speculated about. The verification was thus extended and the in vitro 
enzyme activity of MalE was investigated. With a specific activity of 122 U mgprotein-1, the 
in vitro activity of this enzyme allowed a maximal conversion of 3.7 mmol gCDW h-1 
(381.4% normalized to the specific glucose uptake rate of 0.97 mmol gCDW h-1) and thus 
significantly surpassed the potentially required 111.6%. A participation of MalE in 
NADPH reoxidation therefore seems quite likely. 
 
Metabolic activity and NADPH metabolism during phase III  
The third growth phase is characterized by linear growth (Figure VII-2), with a constant 
biomass formation rate (0.203 g L-1 h-1) and glucose consumption rate (3.08 mmol L-1 h-1) 
and a biomass yield of 0.064 g mmol-1. The overall metabolic performance and the 
consequences of the altered biomass formation and amino acid consumption were 
qualitatively assessed and compared to the first growth phase. 
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The biomass yield (YX/S;PIII = 0.06 g mmol-1) was significantly reduced compared to phase 
I (YX/S;PI = 0.19 g mmol-1) as was the amino acid uptake (Table VII-2). These two 
alterations should lead to a further increase of the NADPH generation: first, due to the 
relatively decreased biomass yield, the NADPH consumption for biomass formation will 
decrease likewise as the NADPH demand is directly linked to the biomass formation; in 
addition, the lowered biomass yield will cause a reduction in the anabolic precursor 
demand, inevitably increasing the relative glucose metabolization expressed in relatively 
increased flux activities. As the generation of NADPH is provided by those reactions, the 
NADPH supply is supposed to increase proportionally. Thus, the metabolic adjustment – 
from peptone-supported growth to mainly glucose-supported growth – and the observed 
decline of the biomass yield seem to further increase the NADPH supply while reducing 
the NADPH demand which leads to an even more pronounced NADPH surplus and a 
reductive burden. In this context, the phase III-specific initiation of the lysine secretion 
(Figure VII-1) might additionally indicate an overloading in the NADPH supply, as the 
synthesis of this amino acid provides another NADPH oxidizing reaction with a capacity 
of 0.5 mmol NADPH gCDW-1. In the context of the supposedly tremendous NADPH 
overabundance, the comparatively minor NADPH oxidizing capacity of lysine secretion 
(<1% mMLys mMGlu-1) does not really balance NADPH, but may be regarded as an 
additional indication for a reductive – and in this case even growth-deleterious – burden. 
As phase III was now assessed to not represent a balanced or constant metabolic state, the 
quantified purine intermediate concentrations for that phase (Table VII-1) cannot be 
regarded as representative values for the whole phase period, but only as time- and 
especially (metabolic) state-dependent. Even so, a clear trend, leading from increased 
(40.66 µmol gCDW-1) to decreased (11.83 µmol gCDW-1) intracellular IMP concentrations 
was determined and in addition linked to the metabolic consequences provoked by the pgi 
deletion. 
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Reflections 
 
 
The overall objective of the research presented in this study addressed the in-depth analysis 
of the purine biosynthetic pathway of the Gram-positive soil bacterium Corynebacterium 
glutamicum. Several experimental platforms have been employed, targeting a 
comprehensive investigation of the underlying system. In order to increase the existing 
knowledge about the essential pathway of the purine biosynthesis, it is of utmost 
importance to establish the foundations of systems-level understanding and to identify 
system structures, e.g. interacting parameters, and to comprehend and reconstruct dynamic 
structures. Furthermore, system redesign, e.g. modification and construction, allows the 
identification of basic principles and regulatory concepts, and helps uncovering cellular 
responses in terms of when and how readjustments of metabolic activity are initiated.  
In Chapter I, a general introduction into the field of systems biotechnology is presented 
and in addition the possibilities of targeted strain manipulation e.g. of C. glutamicum as 
model organism within this field, are addressed. Fundamental principles about this 
organism, its metabolic physiology as well as the analytical techniques – targeted 
metabolite profiling employing LC-ESI-MS/MS and metabolic flux analysis – and strain 
construction principles are summarized in Chapter II.  
In Chapter III, an analytical method for intracellular purine intermediate quantitation in 
Corynebacteria was implemented and validated. Thereby, a suitable extraction procedure 
for Gram-positive bacteria was especially investigated, that could be directly coupled to a 
precise and accurate quantitation by LC-ESI-MS/MS. 
Following a targeted metabolic engineering approach, site-directed mutant strains of 
C. glutamicum were created: the initial wild type properties were altered, leading to a 
degradation-deactivated, supposedly feedback-released and precursor-improved purine 
pathway. To this end several key factors have been identified which positively influence 
the deregulation towards increased intracellular IMP levels (Chapter IV) e.g. the deletion 
of the degrading reactions towards AMP and GMP. Simultaneously, detrimental factors 
have been exposed, i.e. excessively increased PPP activity – targeting an improved 
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precursor availability – on glucose as sole carbon source (Chapters IV and V). The 
deletion of the key enzyme glucose 6-phosphate isomerase caused a tremendous reduction 
of the intracellular IMP concentrations in combination with a metabolic shift, favorising 
the intracellular accumulation of the degradation product hypoxanthine (Chapter IV). 
Furthermore, growth-deleterious impacts were determined, which – due to NADPH 
imbalances – led to a complete growth stagnation of the pgi deletion strains for 24 h 
(Chapter V).  
This phenomenon was further addressed in Part II applying small-scale fermentations 
with a broadened substrate spectrum. In Chapter VI, a suitable method for the 
determination of intracellular carbon fluxes on complex substrates was implemented. 
Combining a metabolite balancing approach with off-gas analysis allowed for the 
quantitation of intracellular fluxes during multi-phase growth. This approach was further 
validated in direct comparison with 13C MFA on minimal medium with glucose as sole 
carbon source. Applying this method, multi-phase growth of the wild type strain of 
C. glutamicum (Chapter VI) and the site-directed mutant strain C. glutamicum ΔpurA 
ΔguaB2 purFK348Q Δpgi were analyzed in great detail, also determining intracellular pool 
sized of purine intermediates (Chapter VII). In the last chapter of Part II (Chapter VII), 
the individual aspects, presented and discussed in previous chapters are recapitulated and 
the tight interconnection of these aspects is highlighted. As a direct consequence, the 
reductive burden in terms of excessive NADPH – leading to the inability to further sustain 
cellular growth – and the purine intermediate distribution were significantly improved, but 
not prevented completely. 
  
The different steps and factors were presented and discussed thoroughly in the previous 
chapters, conclusions were drawn and future objectives and recommendations have been 
proposed. The last chapter of this thesis is dedicated to additional aspects and observations 
made but not presented in the previous chapters as well as challenges not approached 
directly in the scope of this thesis. 
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Future directions 
 
 
Investigation of the redox metabolism in C. glutamicum:  
an extended approach 
 
 
Background 
One parameter that has been intensely studied in this thesis was the situation of excessive 
NADPH production, resulting in an imbalance between supply and demand. The direct 
cause of this phenomenon and the corresponding consequences have been examined and 
discussed in detail in Chapter V. Even though a unique adaptation process was discovered 
and related to the site-directed genetic perturbation of the initiating step of the glycolysis, 
i.e. the disruption of the pgi gene, a significant amount of NADPH still needing to be 
reoxidized, remained unassigned. The issue about additional oxidizing capacities was not 
entirely resolved and will now be addressed in this context.  
 
Network remodeling using in silico predictions 
Metabolization of carbon sources such as glucose leads to the distribution of substrate-
derived carbon throughout the entire metabolic network, delivering precursor molecules 
and redox equivalents. Metabolization thereby generates products either more reduced or 
oxidized compared to the substrate(s) taken up by the cells. Either way, the sum of all 
feasible pathways must be redox neutral, meaning that NADH as well as NADPH balances 
have to be closed (Nielsen et al., 2003). This was the case for all strains analyzed in this 
thesis except for the pgi deletion strains, exhibiting an unassigned NADPH surplus. 
However, to assure unimpaired cellular growth, additional, so far unconsidered, reduced 
products must be accumulated or secreted or the reductive state of present products must 
be higher than supposed, e.g. the biomass. As carbon balances were closed and the flux 
estimations yielded accurate results, the possibility of additional reduced products can be 
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excluded, pointing at an underestimation of the NADPH demand in terms of a changed 
reductive state of presently synthesized compounds. Thus the determined products must 
exhibit a higher degree of reduction as was assumed for setting up the redox balances.  
Since the by-products are characterized by a distinct degree of reduction precisely 
calculable, the only product potentially comprising a higher degree of reduction is the 
biomass. In turn, the reductive state of the cell dry weight is purported by relative content 
of the different contributing macromolecules, i.e. lipids, carbohydrates, proteins, DNA, 
RNA and inorganic compounds. In conclusion, changes of the intracellular 
macromolecular composition of the cell inevitably lead to readjustments of NADPH and 
NADH delivery and demand, possibly balancing the redox metabolism in pgi deletion 
strains. As especially lipid and protein contents dictate the anabolic demand of NADPH, 
these two fractions were varied in percentage and the consequences for the NADPH 
demand were analyzed. In order to establish redox balances for these hypothetically 
modified conditions, the individual precursor demands were adapted and in silico flux 
distributions, contributing to the NADH and NADPH supply, were calculated.  
 
Under simplified assumption two scenarios were investigated, the first (Scenario A) 
reflecting increasing lipid content, and the second (Scenario B), reflecting increasing 
protein content. In order to highlight trends in metabolic adjustments and redox equivalent 
deliveries, broad ranges were simulated comprising increased as well as decreased 
fractions of lipids and proteins compared to the wild type biomass composition 
(Figure VIII-1).  
The composition of the cell dry weight was adopted from Kjeldsen and Nielsen (2009) and 
the precursor demands were modified accordingly as illustrated in Figure VIII-2.  
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Figure VIII-1. In silico varied biomass compositions of C. glutamicum, comprising increasing 
lipid (A.) and protein contents (B.). Relative fractions were adjusted accordingly, except for DNA 
content which was assumed to be constant with one DNA molecule per cell exhibiting 1% by 
weight (for references see “Supplementary material – Outlook”). 
a,b  initial biomass compositions adopted from Kjeldsen and Nielsen (2009) for scenario A (modified lipid 
content) and scenario B (modified protein content), respectively. 
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Figure VIII-2. Variation-caused alterations of precursor distribution in C. glutamicum, for 
increasing lipid (A.) and protein contents (B.). Calculation of precursor fractions were based on the 
in silico cell dry weight remodeling illustrated in Figure VIII-1. Most influenced precursor species 
are highlighted in dark grey.  
a,b  initial precursor distributions for scenario A (modified lipid content) and scenario B (modified protein 
content), respectively (adopted from Wittmann and Heinzle (2008)). 
 
Modifications of biomass composition (Figure VIII-1) were reflected in increasing 
demands of the main precursor for lipid biosynthesis acetyl-CoA (Scenario A; Figure VIII-
2A) and in increasing demands of especially phosphoenolpyruvate and pyruvate (PEP/Pyr) 
as major building blocks for protein biosynthesis (Scenario B; Figure VIII-2B). In 
consequence, anabolic effluxes of precursors located upstream and downstream of acetyl-
CoA and PEP/Pyr were significantly reduced. Impacts on intracellular carbon fluxes were 
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analyzed by 13C MFA employing strain specific parameters (biomass yield, by-product 
formations and labeling data derived from Chapters IV and V) and modified precursor 
demands (Figure VIII-2).  
 
 
 
Figure VIII-3. In silico predictions of metabolic flux activities based on strain specific 
parameters (YX/S, YP/S, MDVs) and modified biomass compositions for increasing lipid content 
(A.) and increasing protein content (B.). Relative flux changes are shown in turquoise (attenuation) 
and purple (amplification) comprising altered biomass compositions depicted in Figure VIII-2 (five 
different compositions for each scenario, from left – lowest lipid/protein content –, to right – 
highest lipid/protein content). The unmodified (native) biomass composition-related flux 
distribution (relative changes equal to zero) is shown for each scenario in dark grey (A.: second 
from left; B.: third from left; for references see Figures VIII-1 and VIII-2 and “Supplementary 
material – Outlook”). 
 
 
The resulting predictions of metabolic flux activities are illustrated in Figure VIII-3 for 
scenario A (increasing lipid content) and scenario B (increasing protein content). It has to 
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be mentioned however, that these estimations represent simplified in silico predictions and 
have to be validated, requiring an explicit determination of the actual biomass composition. 
 
Variations of the macromolecule content featured significant, content-specific alterations 
possessing the major modification sites at the acetyl-CoA- and PEP/Pyr-nodes for 
increasing lipid and protein contents, respectively.  
 
Scenario A 
With acetyl-CoA representing the main precursor for lipid synthesis, pronounced carbon 
withdrawal was observed at this metabolic node assuming an increased lipid fraction in the 
biomass compositions. Consequently, while increasing lipid content, glycolysis – from 
glycose 6-phosphate to acetyl-CoA – was increased likewise as the relative anabolic 
precursor demands, except for acetyl-CoA, were reduced (Figure VIII-2). Oxidative and 
reversible PPP branches were not affected significantly. Most distinct shifts of the 
metabolic activities were observed for those reactions directly leading towards or from 
acetyl-CoA, namely pyruvate dehydrogenase and citrate synthase (Figure VIII-3), marking 
acetyl-CoA as the major precursor for lipid biosynthesis.  
 
Scenario B 
Variations of the protein content revealed a similar trend exhibiting amplified activities 
upstream of the PEP/Pyr-node and attenuated ones downstream. However, relative flux 
changes were as pronounced as in scenario A. This is on one side caused by the fact that 
protein synthesis drains carbon at multiple points within the metabolic network; PEP and 
pyruvate thereby solely depicting the major contributors while other metabolic pathway 
branches provide additional precursor, e.g. α-ketoglutarate (AKG) and oxaloacetate (OAA) 
from the TCA cycle. The second point is the difference between absolute contents: while 
lipids account for 13% of the cell dry weight, proteins account for 52% (Figure VIII-1). 
Chapter VIII   -   Outlook 
 
196 
Similar absolute variations, e.g. 12% increase in scenario A and 13% in scenario B, lead to 
tremendous effects in relative percentages leading to an increase of approximately 100% in 
lipids but only 25% in proteins. In summary, variations of the protein content caused a 
rather global network adjustment while variation of the lipid content resulted in a more 
pronounced and primarily punctual modulation. 
In addition to remodeling metabolic fluxes, the alteration of the biomass composition 
drastically altered the reduction degree of the biomass, meaning that the anabolic demands 
of NADPH and the anabolic synthesis of NADH are depending on these compositions. 
Stoichiometric demands for both redox equivalents were calculated for each case and are 
depicted in Table VIII-1. 
 
As illustrated in Table VIII-1, modifications of the lipid content caused a significant 
increase in the anabolic NADPH demand, whereas an identical increase in the protein 
fraction – 26% (scenario A) and 25% (scenario B) absolute increase – resulted in a 
significantly lower NADPH demand. In addition, anabolic supply of NADH decreased to 
2.7 mmol gCDW-1 in scenario A, but was almost unaffected by changing relative protein 
contents in scenario B.  
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Table VIII-1. Stoichiometric demands for NADPH and generation of NADH [mmol gCDW-1] 
determined from modified biomass compositions, i.e. lipid and protein contentsa. 
 
 
 
biomass 
contents [%]
 
NADPH 
[mmol gCDW-1] 
 
NADH 
[mmol gCDW-1] 
Sc
en
ar
io
 A
: 
in
cr
ea
sin
g 
lip
id
  
co
nt
en
t 
7 15.0 3.3 
13b 15.9 3.2 
20 17.1 3.0 
25 17.9 2.9 
33 19.2 2.7 
max.  
differencec 26 4.2 0.6 
Sc
en
ar
io
 B
: 
in
cr
ea
sin
g 
pr
ot
ei
n 
co
nt
en
t 
40 14.8 3.1 
45 15.3 3.1 
52b 15.9 3.2 
60 16.7 3.2 
65 17.1 3.2 
max.  
differencec 25 2.3 0.1 
 
a  calculations based on the theoretical scenarios illustrated in Figures VIII-1 and VIII-2. 
b  initial values for lipid and protein contents, respectively. 
c  in absolute terms. 
 
The complete redox balances were then established (Tables VIII-2 and VIII-3) including 
the experimentally determined specific oxygen consumption rate and biomass yield as 
strain-specific, unchanged variables (Chapter V). 
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Table VIII-2. Predictions for XADH and NADPH redox balances [%] for (in silico) increasing 
lipid content (scenario A) with experimentally determined oxygen consumption [%] (in vivo). 
 
 
lipid content [%]a 
 
7 
 
13b 
 
20 
 
25 
 
33 
NADPH production      
 G6P DH 97.6 97.8 97.9 97.9 98.0 
 6PG DH 97.6 97.8 97.9 97.9 98.0 
 isocitrate DH 48.8 45.7 42.1 39.0 33.7 
 244.0 241.3 237.9 234.8 229.7 
NADPH consumption      
 anabolism 135.0 143.1 153.9 161.1 172.8 
Total [%] 109.0 98.2 84.0 73.7 56.9 
XADH production      
 G3P DH 139.2 140.1 141.4 142.0 143.3 
 pyruvate DH 69.0 73.8 79.6 83.4 89.6 
 α-ketoglutarate DHc 111.0 103.8 96.0 88.5 75.3 
 anabolism 29.7 28.8 27.0 26.1 24.3 
Total [%] 348.9 346.5 344.0 340.0 332.5 
O2 consumption [%]                                               208.4 
Redox balance [%] -41.1 -27.9 -11.2 3.1 27.4 
 
a  expressed as percent of the cell dry weight. 
b initial values for lipid content (wild type). 
c comprises combined NADH and FADH2 production by α-ketoglutarate dehydrogenase, succinate 
dehydrogenase and malate dehydrogenase. 
 
 
 
Exclusive variation of lipid content allowed an evenly closed redox balance solely after 
increasing the corresponding fraction up to 25% of the biomass (Table VIII-2). Due to the 
tremendous withdrawal of acetyl-CoA, the activity of the TCA cycle dropped significantly, 
causing an overall reduction in the supply of NADPH. The increased degree of reduction 
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of the cell dry weight (Table VIII-1), however, led to an increased anabolic demand for 
NADPH (30% increase). Despite increasing activities of the glycolysis (Figure VIII-3), the 
net XADH supply decreased, mainly caused by the diminished activity of the TCA cycle. 
It is however doubtful, whether an increase of the lipid content to 25% reflects a 
physiologically feasible condition. 
 
Table VIII-3. Predictions for XADH and NADPH redox balances [%] for (in silico) increasing 
protein content (scenario B) with experimentally determined oxygen consumption [%] (in vivo). 
 
 
protein content [%]a 
 
40 
 
45 
 
52b 
 
60 
 
65 
NADPH production      
 G6P DH 97.3 97.4 97.8 98.1 98.2 
 6PG DH 97.3 97.4 97.8 98.1 98.2 
 isocitrate DH 47.4 46.4 45.7 44.7 44.0 
 242.0 241.2 241.3 240.9 240.4 
NADPH consumption      
 anabolism 133.2 137.7 143.1 150.3 153.9 
Total [%] 108.8 103.5 98.2 90.6 86.5 
XADH production      
 G3P DH 136.5 137.9 140.1 142.6 144.2 
 pyruvate DH 80.8 77.7 73.8 69.3 66.4 
 α-ketoglutarate DHc 116.1 110.1 103.8 96.6 91.5 
 anabolism 27.9 27.9 28.8 28.8 28.8 
Total [%] 361.3 353.6 346.5 337.3 330.9 
O2 consumption [%]                                                208.4 
Redox balance [%] -53.3 -40.3 -27.9 -11.1 -0.6 
 
a  expressed as percent of the cell dry weight. 
b initial values for protein content (wild type). 
c comprises combined NADH and FADH2 production by α-ketoglutarate dehydrogenase, succinate 
dehydrogenase and malate dehydrogenase. 
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Increase of the protein content also led to an even-balanced redox metabolism which was 
achieved with an assumed protein content of 65%. Separate investigations of the XADH 
and NADPH metabolism, however, revealed significant differences between scenario A 
and scenario B: in scenario A, redox balancing was mainly achieved by decreasing 
NADPH surpluses (relative reduction of 50%), in scenario B by a decreasing XADH 
allocation, highlighting different adjustment processes for both scenarios. It is, however, 
questionable too, whether a protein augmentation to 65% of the total cell dry weight, 
represents an in vivo feasible situation.  
In summary, both scenarios – theoretically - allowed even-balanced redox supply and 
demand. The changes permitting these adjustments might however reflect extreme non-
physiological solutions due to the distinct requirements compared to the reported biomass 
composition (Figure VIII-4). 
 
 
Figure VIII-4. In silico alterations of the biomass composition with even-balanced redox 
metabolism (scenario A: 25% lipid fraction (IV); scenario B: 65% protein fraction (V); derived 
from Tables VIII-2 and VIII-3) in comparison with the reported, initial biomass composition 
derived from Wittmann and Heinzle (2008). 
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Concluding, a combination of scenario A and B with a slightly increased lipid fraction 
(15%) and an increased protein fraction (58%) were investigated (Scenario C; Figure VIII-
5), combining the differential balancing mechanisms determined for scenario A and B.  
 
 
Figure VIII-5. In silico alterations of biomass compositions, comprising a lipid fraction of 15% 
and a protein fraction of 58% (scenario C) in comparison with the initial biomass composition 
derived from Wittmann and Heinzle (2008). 
 
 
As depicted in Figure VIII-5, the overall composition changes were less pronounced as 
those highlighted in Figure VIII-4, more likely representing physiologically feasible 
conditions. The protein content was solely increased by 6% (absolute) and the lipid content 
by 2% (absolute). Most importantly, the composition presumed for scenario C generated an 
even-balanced redox metabolism: the stoichiometric NADPH demand was increased to 
17.4 mmol gCDW-1 and the stoichiometric NADH supply was slightly decreased to 3.1 
mmol gCDW-1. Thus, the NADPH supply accounted for 238.9%, the anabolic consumption 
for 156.6%, while the XADH production dropped to 335.5%. In total, the reduced redox 
equivalents accounted for 417.8% needing to be oxidized. Considering the unchanged 
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specific oxygen consumption with 208.4% (Chapter V), which comprised an oxidation 
potential for 416.8% of reduced redox equivalents, the redox balance was closed with -1%. 
It has to be mentioned, that this scenario just represents one of many possibilities and 
actual in vivo variations of the biomass composition might turn out to be far more complex 
than considered in this chapter. The predictions demonstrated and discussed here were 
meant to allow first estimations about composition-dependent balancing mechanisms and 
to evaluate their range of influence and general feasibility.  
In summary, variations of biomass compositions might partly be involved in balancing 
supply and demand of redox equivalents, resulting in evened redox balances inevitable for 
balanced cellular growth. Furthermore, the magnitude of the reductive state – the degree of 
reduction – cannot be deduced solely from in silico calculation but has to be determined 
experimentally, providing the basis for detailed analyses such as the establishment of redox 
balances.  
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An additional target towards increasing productivity: 
secretory processes 
 
 
Background 
Besides increasing knowledge and understanding of the essential pathway of the purine 
biosynthesis, part of this thesis focused on the intracellular accumulation of flavor-
enhancing compounds. The last section of this chapter intends to further broaden the 
knowledge about targeted intracellular accumulation of the phosphorylated purine 
nucleotide, IMP. 
In the general introduction key targets – identified and analyzed in this study – are 
summarized, focusing on precursor availability, deleting depleting reactions and 
neutralizing feedback inhibition. These parameters represented crucial hurdles to be 
overcome in order to increase intracellular metabolite concentration. 
The bacterial cell, however, is a complex system comprising evolutionary developed 
definite and optimized regulation mechanisms that are (sometimes) not known or 
understood in great detail. One mechanism – addressed in Chapter IV – is the distinct 
inhibition by feedback regulation of the amidophosphoribosyltranferase (PurF) preventing 
unnecessary metabolite synthesis, i.e. any kind of intracellular concentration increase that 
cannot be used to improve cellular growth behavior (Marx et al., 1999). With increasing 
intracellular metabolite concentrations, the corresponding feedback inhibitions become 
even more pronounced, eventually blocking the afferent pathway branch (Figure VIII-6A). 
In consequence, either all inhibitory processes have to be tackled, the causative compounds 
have to be removed from the system or their corresponding pool sizes have to be kept at a 
non-inhibitory level (Figure VIII-6B). 
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Figure VIII-6. Increasing feedback inhibition of an intracellular metabolite (purple), caused by 
rising intracellular pool sizes (A.). Unchanged feedback inhibition, maintained by a constant – low 
– intracellular metabolite pool size (purple; B.) due to improved secretory processes. 
 
Principle of secretion 
The principle of metabolite export as maximizing productivity process has been 
investigated and proven to be successful for the excretion of amino acids (Bellmann et al., 
2001; Dassler et al., 2000; Diesveld et al., 2009; Doroshenko et al., 2007; Kennerknecht et 
al., 2002; Livshits et al., 2003; Vrljic et al., 1999; Zakataeva et al., 1999), indicating that 
export facilitation might also beneficially affect the productivity for nucleotides (Livshits 
et al., 2003). While many systems have been identified for various substances in bacteria 
(Eggeling and Sahm, 2003; Jack et al., 2001; Zakataeva et al., 2007), efflux systems for 
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purine nucleotides and derivatives have only been rarely studied (Kakehi et al., 2007; 
Zakataeva et al., 2007) up to date. The hydrophilic nature of phosphorylated nucleotides 
thereby precludes any diffusion through the cell membrane working as a permeability 
barrier – except for small molecules like gases and water or apolar substances like glycerol 
(Dassler et al., 2000; Gronskiy et al., 2005). Translocation of polar substances, e.g. 
nucleotides, therefore depends on active transport mechanisms (Kramer, 1994).  
 
Mechanisms for IMP secretion in Corynebacteria 
The study of the purine biosynthetic pathway and associated efflux systems is not only of 
fundamental but also of industrial interest as those compounds exhibit several properties 
making them promising candidates for biotechnological production. Over the last decades, 
especially one Corynebacterium species – Corynebacterium ammoniagenes – was 
successfully employed for the biotechnological production of purine nucleotides and their 
derivatives, exhibiting substantial potential for their secretion.  
These production strains, derived and optimized by classical breeding, i.e. random 
mutagenesis and selection processes, featured a mutual characteristic: their increased 
capability for the translocation of phosphorylated (polar) nucleotides from the cell interior 
into extracellular environment. Although the genetic backgrounds allowing these transport 
mechanisms were not known – and still aren’t – the existing potential for nucleotide 
secretion led to a wide application range of this bacterial species for the biotechnological 
production. In contrast, the well studied close relative, Corynebacterium glutamicum, 
exhibiting an immense industrial importance (Burkovski, 2008) but missing comparable 
secretory capabilities for purine nucleotides, did not find successful application for the 
industrial production of purine compounds.  
A direct comparison regarding the ability for intracellular accumulation of the flavor-
enhancing substance IMP in Corynebacterium glutamicum – performed in this thesis – and 
a high-scale production strain of Corynebacterium ammoniagenes – adopted from Teshiba 
and Furuya (1983) – clearly demonstrates comparable capacities (Figure VIII-7). While the 
investigation of the purine biosynthesis in C. glutamicum, carried out in this work, did not 
include any working points for improving secretory mechanisms, the industrial 
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applications of C. ammoniagenes for purine accumulation, seem to be based – at least 
partly – on these secretory properties: the intracellular IMP concentrations, determined for 
both species, exhibited similar maximum concentrations, possibly indicating an upper limit 
for intracellular pool sizes and the need for pool size reduction, either by secretion – 
observed in C. ammoniagenes – or by degradation – as shown in C. glutamicum (for 
reference see Chapter IV). 
 
 
 
Figure VIII-7. Correlation between intracellular IMP accumulation [µmol gCDW-1] and 
extracellular IMP secretion [g L-1] on minimal medium and complex media.  
Abbreviations: I. – V.: results obtained during growth on minimal medium (for reference see 
Chapter IV): I., C. glutamicum wild type (ATCC 13032); II., C. glutamicum Δpgi; III., 
C. glutamicum purFK348Q; IV., C. glutamicum ΔpurA ΔguaB2; V., C. glutamicum ΔpurA ΔguaB2 
purFK348Q Δpgi. VI. – VII.: results obtained during growth on complex media (for reference see 
Chapter VII and Teshiba and Furuya (1983), respectively): VI., C. glutamicum ΔpurA ΔguaB2 
purFK348Q Δpgi, VII.: C. ammoniagenes KY13369. A., processes not optimized for IMP secretion. 
B., process optimized for IMP secretion. 
a data for C. ammoniagenes KY13369 were taken from Teshiba and Furuya (1983) and represent 
maximum values for intracellular as well as extracellular IMP concentration.  
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In conclusion, the increase of the intracellular IMP concentration in C. glutamicum, 
targeted and investigated as a part of this work (Chapter IV) completely excluded any 
extracellular secretion. Targeting different working points within the metabolic network 
(Chapter IV) and implementing different strategies concerning varying cultivation 
conditions (Chapters VI and VII), allowed an iterative optimization process also disclosing 
basic regulatory fundamentals (Chapter IV) and crucial points for genetic modifications 
(Chapter V). 
Based on the information gained in this study, it seems quite likely that a further significant 
increase of IMP productivity can only be achieved by including – so far not considered – 
secretory processes. 
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Supplementary material 
 
Chapters IV and V 
Stoichiometric networks for 13C metabolic flux analysis (MFA) 
 
 
 
 
Figure S-1.  Metabolic network of the central carbon metabolism of 
Corynebacterium glutamicum used for 13C-MFA of C. glutamicum ATCC 13032, C. glutamicum 
ΔpurA ΔguaB2 and C. glutamicum ΔmalE. The network contains mass balances for 15 metabolites 
linked by 15 intracellular fluxes (vi; vir), 4 extracellular fluxes (vinp; vext i) and 10 anabolic fluxes 
(vBi). 
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Molar balance equations for metabolites illustrated in Figure S-1 are defined as follows: 
 
vG6P: 0 = (vinp + v1r) - (v1 +v7 + vB1 + ½vext1) 
vF6P: 0 = (v1 + v9 + v10) - (v1r + v2 + v9r + v10r + vB2) 
vDHAP: 0 = (v2) - (v3) 
vGAP: 0 = (v2 + v3 + v8 + v9r + v10) - (v4 + v8r + v9 + v10r + vB5)  
v3PG: 0 = (v4) - (v5 + v16 + vB6) 
vPEP/Pyr: 0 = (v5 + v15r) - (v6 + vB7) 
vP5P: 0 = (v7 + 2v8r + v10r) - (2v8 + v10 + vB3) 
vE4P: 0 = (v9 + v10r) - (v9r + v10 + vB4) 
vS7P: 0 = (v8 + v9r) - (v8r + v9) 
vAcCoA: 0 = (v6) - (v11 + vB8) 
vIso: 0 = (v11) - (v12)
vAKG: 0 = (v12) - (v13 + vB9 + vext3)
vSuc: 0 = (v13 + v14r) - (v14) 
vOAA/Mal: 0 = (v14 + v15) - (v11 + v14r + v15r + vB10) 
vGly,int: 0 = (v16) - (vext2) 
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Figure S-2.  Metabolic network of the central carbon metabolism of Corynebacterium 
glutamicum used for 13C-MFA of C. glutamicum Δpgi, C. glutamicum ΔpurA ΔguaB2 purFK348Q 
Δpgi and C. glutamicum ΔmalE Δpgi. The network contains mass balances for 15 metabolites 
linked by 14 intracellular fluxes (vi; vir), 4 extracellular fluxes (vinp; vext i) and 10 anabolic fluxes 
(vBi). 
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Molar balance equations for metabolites illustrated in Figure S-2 are defined as follows: 
 
vG6P: 0 = (vinp) - (v6 +vB1 + ½vext1) 
vF6P: 0 = (v8 + v9) - (v1 + v8r + v9r + vB2) 
vDHAP: 0 = (v1) - (v2) 
vGAP: 0 = (v2 + v3 + v7 + v8r + v9) - (v3 + v7r + v8 + v9r + vB5)  
v3PG: 0 = (v3) - (v4 + v15 + vB6) 
vPEP/Pyr: 0 = (v4 + v14r) - (v5 + vB7) 
vP5P: 0 = (v6 + 2v7r + v9r) - (2v7 + v9 + vB3) 
vE4P: 0 = (v8 + v9r) - (v8r + v9 + vB4) 
vS7P: 0 = (v7 + v8r) - (v7r + v8) 
vAcCoA: 0 = (v5) - (v10 + vB8) 
vIso: 0 = (v10) - (v11)
vAKG: 0 = (v11) - (v12 + vB9 + vext3)
vSuc: 0 = (v12 + v13r) - (v13) 
vOAA/Mal: 0 = (v13 + v14) - (v10 + v13r + v14r + vB10) 
vGly,int: 0 = (v15) - (vext2) 
 
 
 
 
 
 
 
Mass isotopomer distributions 
 
The corresponding flux activities and standard deviations determined for C. glutamicum 
ATCC 13032, C. glutamicum Δpgi, C. glutamicum ΔpurA ΔguaB2 and C. glutamicum 
ΔpurA ΔguaB2 purFK348Q Δpgi are listed in Chapter IV, and for C. glutamicum ΔmalE and 
C. glutamicum ΔmalE Δpgi in Chapter V. 
 
Comparison of experimentally determined and calculated mass isotopomer distributions of 
C. glutamicum ATCC 13032 is depicted in Chapter VI. 
 
Computational modeling and mathematical optimization were performed by a Monte Carlo 
approach as described by Yang et al., (2008). 
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Table S-1. Relative mass isotopomer fractions of proteinogenic amino acids derived from cellular 
protein and of trehalose secreted during cultivation of C. glutamicum ΔpurA ΔguaB2 on 99% [1-
13C] glucosea. 
 
 mass isotopomer fraction 
  
metabolite 
 
M0 
 
M1 
 
M2 
 
M3 
 
M4 
 
M5 
 
M6 
 
M7 
 
M8 
 
M9 
ala (m/z  260; c1-c3)          
    calc 0.604 0.365 0.030 0.001       
    exp 0.622 0.364 0.013 0.000       
gly (m/z  246; c1-c2)          
    calc 0.948 0.051 0.001        
    exp 0.948 0.047 0.005        
val (m/z  288; c1-c5)          
    calc 0.479 0.411 0.101 0.009 0.000 0.000     
    exp 0.397 0.449 0.144 0.008 0.001 0.001     
leu (m/z  200; c1-c5)          
    calc 0.273 0.435 0.240 0.050 0.003 0.000     
    exp 0.273 0.429 0.243 0.052 0.002 0.001     
ser (m/z  390; c1-c3)          
    calc 0.624 0.356 0.019 0.000       
    exp 0.629 0.363 0.008 0.000       
thr (m/z  404; c1-c4)          
    calc 0.462 0.415 0.112 0.011 0.000      
    exp 0.465 0.423 0.106 0.006 0.000      
phe (m/z  336; c1-c9)          
    calc 0.300 0.422 0.216 0.053 0.008 0.001 0.000 0.000 0.000 0.000 
    exp 0.308 0.430 0.209 0.041 0.004 0.003 0.001 0.003 0.001 0.001 
asp (m/z  418; c1-c4)          
    calc 0.462 0.415 0.112 0.011 0.000      
    exp 0.465 0.423 0.106 0.006 0.000      
glu (m/z  432; c1-c5)          
    calc 0.332 0.438 0.194 0.033 0.002 0.000     
    exp 0.329 0.441 0.198 0.031 0.001 0.000     
tyr (m/z  466; c1-c9)          
    calc 0.300 0.422 0.216 0.053 0.008 0.001 0.000 0.000 0.000 0.000 
    exp 0.306 0.428 0.209 0.041 0.006 0.002 0.002 0.002 0.002 0.002 
tre (m/z  361; c1-c6)          
    calc 0.017 0.928 0.053 0.002 0.000 0.000 0.000    
    exp 0.026 0.928 0.030 0.001 0.007 0.005 0.003    
 
a  GC-MS data experimentally determined (exp) and corresponding calculated values (calc) obtained by an 
interative optimization applying 100 Monte Carlo runs with statistically varying initial values. M0 denotes 
the non-labeled mass isotopomer fraction and Mi the corresponding higher-labeled fractions. 
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Table S-2. Relative mass isotopomer fractions of proteinogenic amino acids derived from cellular 
protein and of trehalose secreted during cultivation of C. glutamicum ΔmalE on 99% [1-13C] 
glucosea. 
 
 mass isotopomer fraction 
  
metabolite 
 
M0 
 
M1 
 
M2 
 
M3 
 
M4 
 
M5 
 
M6 
 
M7 
 
M8 
 
M9 
ala (m/z  260; c1-c3)          
    calc 0.653 0.332 0.014 0.000       
    exp 0.657 0.332 0.011 0.000       
gly (m/z  246; c1-c2)          
    calc 0.962 0.037 0.000        
    exp 0.963 0.037 0.000        
val (m/z  288; c1-c5)          
    calc 0.535 0.388 0.073 0.004 0.000 0.000     
    exp 0.445 0.431 0.116 0.005 0.001 0.001     
leu (m/z  200; c1-c5)          
    calc 0.317 0.438 0.207 0.036 0.001 0.000     
    exp 0.319 0.433 0.208 0.037 0.002 0.001     
ser (m/z  390; c1-c3)          
    calc 0.662 0.328 0.010 0.000       
    exp 0.662 0.332 0.006 0.000       
thr (m/z  404; c1-c4)          
    calc 0.495 0.399 0.097 0.009 0.000      
    exp 0.498 0.409 0.089 0.003 0.000      
phe (m/z  336; c1-c9)          
    calc 0.353 0.428 0.182 0.034 0.003 0.000 0.000 0.000 0.000 0.000 
    exp 0.348 0.420 0.179 0.033 0.004 0.005 0.002 0.005 0.002 0.002 
asp (m/z  418; c1-c4)          
    calc 0.495 0.399 0.097 0.009 0.000      
    exp 0.497 0.409 0.090 0.003 0.000      
glu (m/z  432; c1-c5)          
    calc 0.372 0.431 0.169 0.026 0.002 0.000     
    exp 0.370 0.432 0.173 0.023 0.000 0.000     
tyr (m/z  466; c1-c9)          
    calc 0.353 0.428 0.182 0.034 0.003 0.000 0.000 0.000 0.000 0.000 
    exp 0.349 0.420 0.179 0.032 0.008 0.003 0.002 0.002 0.002 0.003 
tre (m/z  361; c1-c6)          
    calc 0.021 0.926 0.052 0.001 0.000 0.000 0.000    
    exp 0.026 0.926 0.032 0.002 0.006 0.005 0.003    
 
a  GC-MS data experimentally determined (exp) and corresponding calculated values (calc) obtained by an 
interative optimization applying 100 Monte Carlo runs with statistically varying initial values. M0 denotes 
the non-labeled mass isotopomer fraction and Mi the corresponding higher-labeled fractions. 
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Table S-3. Relative mass isotopomer fractions of proteinogenic amino acids derived from cellular 
protein and of trehalose secreted during cultivation of C. glutamicum Δpgi on 99% [1,2-13C2] 
glucosea. 
 
 mass isotopomer fraction 
  
metabolite 
 
M0 
 
M1 
 
M2 
 
M3 
 
M4 
 
M5 
 
M6 
 
M7 
 
M8 
 
M9 
ala (m/z  260; c1-c3)          
    calc 0.597 0.217 0.182 0.004       
    exp 0.601 0.213 0.183 0.003       
gly (m/z  246; c1-c2)          
    calc 0.788 0.206 0.006        
    exp 0.785 0.209 0.005        
val (m/z  288; c1-c5)          
    calc 0.419 0.325 0.196 0.058 0.003 0.000     
    exp 0.372 0.356 0.198 0.072 0.002 0.000     
leu (m/z  200; c1-c5)          
    calc 0.244 0.431 0.262 0.060 0.003 0.000     
    exp 0.241 0.422 0.267 0.064 0.004 0.001     
ser (m/z  390; c1-c3)          
    calc 0.609 0.199 0.188 0.004       
    exp 0.589 0.238 0.170 0.003       
thr (m/z  404; c1-c4)          
    calc 0.341 0.417 0.184 0.056 0.001      
    exp 0.347 0.412 0.182 0.057 0.001      
phe (m/z  336; c1-c9)          
    calc 0.164 0.278 0.262 0.179 0.083 0.028 0.006 0.000 0.000 0.000 
    exp 0.160 0.274 0.264 0.181 0.083 0.028 0.006 0.001 0.001 0.001 
asp (m/z  418; c1-c4)          
    calc 0.341 0.417 0.184 0.056 0.001      
    exp 0.344 0.412 0.186 0.059 0.000      
glu (m/z  432; c1-c5)          
    calc 0.243 0.426 0.264 0.063 0.004 0.000     
    exp 0.247 0.423 0.265 0.062 0.002 0.000     
tyr (m/z  466; c1-c9)          
    calc 0.164 0.278 0.262 0.179 0.083 0.028 0.006 0.000 0.000 0.000 
    exp 0.161 0.276 0.264 0.180 0.082 0.028 0.006 0.001 0.001 0.001 
tre (m/z  361; c1-c6)          
    calc 0.000 0.0019 0.940 0.041 0.001 0.000 0.000    
    exp 0.006 0.006 0.943 0.041 0.002 0.001 0.001    
 
 
a  GC-MS data experimentally determined (exp) and corresponding calculated values (calc) obtained by an 
interative optimization applying 100 Monte Carlo runs with statistically varying initial values. M0 denotes 
the non-labeled mass isotopomer fraction and Mi the corresponding higher-labeled fractions. 
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Table S-4. Relative mass isotopomer fractions of proteinogenic amino acids derived from cellular 
protein and of trehalose secreted during cultivation of C. glutamicum ΔmalE Δpgi on 99% [1,2-
13C2] glucosea. 
 
 mass isotopomer fraction 
  
metabolite 
 
M0 
 
M1 
 
M2 
 
M3 
 
M4 
 
M5 
 
M6 
 
M7 
 
M8 
 
M9 
ala (m/z  260; c1-c3)          
    calc 0.604 0.208 0.185 0.004       
    exp 0.608 0.209 0.180 0.002       
gly (m/z  246; c1-c2)          
    calc 0.790 0.204 0.006        
    exp 0.788 0.207 0.005        
val (m/z  288; c1-c5)          
    calc 0.425 0.320 0.195 0.058 0.003 0.000     
    exp 0.379 0.355 0.194 0.070 0.002 0.000     
leu (m/z  200; c1-c5)          
    calc 0.240 0.432 0.265 0.060 0.003 0.000     
    exp 0.244 0.429 0.264 0.060 0.003 0.000     
ser (m/z  390; c1-c3)          
    calc 0.608 0.202 0.186 0.004       
    exp 0.592 0.235 0.171 0.003       
thr (m/z  404; c1-c4)          
    calc 0.355 0.416 0.186 0.041 0.001      
    exp 0.355 0.409 0.179 0.057 0.001      
phe (m/z  336; c1-c9)          
    calc 0.151 0.274 0.264 0.186 0.088 0.030 0.007 0.000 0.000 0.000 
    exp 0.159 0.272 0.263 0.181 0.083 0.029 0.007 0.002 0.001 0.001 
asp (m/z  418; c1-c4)          
    calc 0.355 0.416 0.186 0.041 0.001      
    exp 0.351 0.410 0.183 0.055 0.000      
glu (m/z  432; c1-c5)          
    calc 0.255 0.429 0.254 0.059 0.004 0.000     
    exp 0.255 0.429 0.256 0.057 0.001 0.000     
tyr (m/z  466; c1-c9)          
    calc 0.151 0.274 0.264 0.186 0.088 0.030 0.007 0.000 0.000 0.000 
    exp 0.156 0.269 0.259 0.185 0.087 0.030 0.007 0.003 0.002 0.002 
tre (m/z  361; c1-c6)          
    calc 0.000 0.019 0.940 0.041 0.001 0.000 0.000    
    exp 0.041 0.023 0.885 0.034 0.007 0.004 0.006    
 
a  GC-MS data experimentally determined (exp) and corresponding calculated values (calc) obtained by an 
interative optimization applying 100 Monte Carlo runs with statistically varying initial values. M0 denotes 
the non-labeled mass isotopomer fraction and Mi the corresponding higher-labeled fractions. 
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Table S-5. Relative mass isotopomer fractions of proteinogenic amino acids derived from cellular 
protein and of trehalose secreted during cultivation of C. glutamicum ΔpurA ΔguaB2 purFK348Q 
Δpgi on 99% [1,2-13C2] glucosea. 
 
 mass isotopomer fraction 
  
metabolite 
 
M0 
 
M1 
 
M2 
 
M3 
 
M4 
 
M5 
 
M6 
 
M7 
 
M8 
 
M9 
ala (m/z  260; c1-c3)          
    calc 0.583 0.218 0.194 0.005       
    exp 0.584 0.216 0.197 0.000       
gly (m/z  246; c1-c2)          
    calc 0.757 0.237 0.006        
    exp 0.726 0.255 0.019        
val (m/z  288; c1-c5)          
    calc 0.402 0.326 0.205 0.064 0.003 0.000     
    exp 0.353 0.350 0.210 0.081 0.006 0.000     
leu (m/z  200; c1-c5)          
    calc 0.257 0.431 0.252 0.057 0.003 0.000     
    exp 0.237 0.415 0.271 0.069 0.007 0.001     
ser (m/z  390; c1-c3)          
    calc 0.608 0.182 0.206 0.004       
    exp 0.593 0.226 0.179 0.002       
thr (m/z  404; c1-c4)          
    calc 0.360 0.398 0.188 0.053 0.001      
    exp 0.366 0.395 0.187 0.050 0.001      
phe (m/z  336; c1-c9)          
    calc 0.283 0.318 0.234 0.119 0.035 0.010 0.002 0.000 0.000 0.000 
    exp 0.250 0.293 0.241 0.139 0.052 0.017 0.004 0.002 0.001 0.001 
asp (m/z  418; c1-c4)          
    calc 0.360 0.398 0.188 0.053 0.001      
    exp 0.363 0.398 0.187 0.050 0.001      
glu (m/z  432; c1-c5)          
    calc 0.273 0.418 0.245 0.061 0.004 0.000     
    exp 0.253 0.419 0.258 0.064 0.005 0.001     
tyr (m/z  466; c1-c9)          
    calc 0.283 0.318 0.234 0.119 0.035 0.010 0.002 0.000 0.000 0.000 
    exp 0.246 0.294 0.242 0.140 0.052 0.018 0.004 0.002 0.001 0.001 
tre (m/z  361; c1-c6)          
    calc 0.000 0.019 0.940 0.041 0.001 0.000 0.000    
    exp 0.041 0.039 0.870 0.034 0.007 0.004 0.006    
 
a  GC-MS data experimentally determined (exp) and corresponding calculated values (calc) obtained by an 
interative optimization applying 100 Monte Carlo runs with statistically varying initial values. M0 denotes 
the non-labeled mass isotopomer fraction and Mi the corresponding higher-labeled fractions. 
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Plasmid charts 
 
 
 
 
         
Figure S-3. Structure of the integrative plasmid pClik int sacB used for the introduction of stable 
modification into the genome of Corynebacterium glutamicum via homologous recombination. 
 
                                   
Figure S-4. Structure of the pTC plasmid, used for transfer of the corynespecific methylation 
pattern to the integrative pClik-derivates. 
 
 
pClik integrativ sacB
4323 bp
sacB downstreambereich
sacB (Bacillus subtilis)
Kan R
Ori -EC (pMB)
Promotor sacB Mlu I (31)
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sacB (Bacill btilis)
Promot r sacB
KanR
pClik integrative sacB
pTC
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cglM - locus
TetR - gene
p15A ori
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Outlook 
 
Table S-6. In silico alterations of biomass composition of C. glutamicuma. 
 
  biomass fractions 
   
  ash carbohydrates lipids DNA RNA proteins 
        
Alteration of lipid fraction 
 A.I. 10.7 20.3 7.0 1.0 5.3 55.7 
 A.II.b 10.0 19.0 13.0 1.0 5.0 52.0 
 A.III. 9.2 17.4 20.0 1.0 4.6 47.8 
 A.IV. 8.5 16.4 25.0 1.0 4.3 44.8 
 A.V. 7.6 14.5 33.3 1.0 3.8 39.8 
Alteration of protein fraction 
 B.I. 12.6 23.8 16.3 1.0 6.3 40.0 
 B.II. 11.5 21.9 14.9 1.0 5.7 45.0 
 B.III.b 10.0 19.0 13.0 1.0 5.0 52.0 
 B.IV. 8.3 15.7 10.8 1.0 4.2 60.0 
 B.V. 7.2 13.8 9.4 1.0 3.6 65.0 
Scenario C 
  7.7 14.5 15.0 1.0 3.8 58.0 
 
a relative fractions and abbreviations are highlighted in Figures VIII-1, VIII-4 and VIII-5. 
b initial biomass composition adopted from Kjeldsen and Nielsen (2009). 
 
 
 
 
 
Supplementary material
 
236 
Table S-7. Intracellular carbon flux distributions (in silico) with corresponding standard 
deviations determined for varying lipid content of C. glutamicum Δpgia. 
 
 
lipid content [%] 
 
7 
 
(A.I.) 
 
13b 
 
(A.II.) 
 
20 
 
(A.III.) 
 
25 
 
(A.IV.) 
 
33 
 
(A.V.) 
Flux parameter      
 
      
 G6P DH 97.6 ± 0.1 97.8 ± 0.1 97.9 ± 0.1 97.9 ± 0.3 98.0 ± 0.1 
 transketolase 1 30.7 ± 0.0 30.8 ± 0.0 30.9 ± 0.0 31.0 ± 0.1 31.2 ± 0.0 
 transketolase 2 28.1 ± 0.1 28.4 ± 0.0 28.8 ± 0.0 29.0 ± 0.1 29.4 ± 0.0 
 aldolase 55.8 ± 0.1 56.4 ± 0.1 57.2 ± 0.1 57.6 ± 0.2 58.5 ± 0.1 
 G3P DH 139.2 ± 0.3 140.1 ± 0.3 141.4 ± 0.3 142.0 ± 0.4 143.3 ± 0.2 
 enolase 127.6 ± 0.3 128.7 ± 0.3 130.1 ± 0.3 130.8 ± 0.5 132.3 ± 0.3 
 pyruvate DH 69.0 ± 0.6 73.8 ± 0.7 79.6 ± 0.5 83.4 ± 0.7 89.6 ± 0.6 
 citrate synthase 48.8 ± 0.6 45.7 ± 0.9 42.1 ± 0.7 39.0 ± 1.0 33.7 ± 0.9 
 α-ketoglutarate DH 37.0 ± 0.7 34.6 ± 0.9 32.0 ± 0.8 29.5 ± 1.1 25.1 ± 1.0 
 pyruvate carboxylase
c 27.2 ± 0.1 25.9 ± 0.2 23.9 ± 0.1 22.5 ± 0.2 20.2 ± 0.1 
 
data are given as relative fluxes [%] normalized to the specific glucose uptake rate qS = 4.18 mmol gCDW-1 h-1 
(see Table V-3), which was set to 100%. 
a mean values and standard deviations were calculated from 100 independent Monte Carlo runs. 
b initial values for lipid content (wild type). 
c given as net flux through anaplerotic reactions. 
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Table S-8. Intracellular carbon flux distributions (in silico) with corresponding standard 
deviations determined for varying protein content of C. glutamicum Δpgia. 
 
 
protein content [%] 
 
40 
 
(B.I.) 
 
45 
 
(B.II.) 
 
52b 
 
(B.III.) 
 
60 
 
(B.IV.) 
 
65 
 
(B.V.) 
Flux parameter      
 
      
 G6P DH 97.3 ± 0.0 97.4 ± 0.2 97.8 ± 0.1 98.1 ± 0.1 98.2 ± 0.1 
 transketolase 1 30.0 ± 0.0 30.3 ± 0.1 30.8 ± 0.0 31.3 ± 0.0 31.6 ± 0.0 
 transketolase 2 28.2 ± 0.0 28.3 ± 0.1 28.4 ± 0.0 28.5 ± 0.0 28.6 ± 0.0 
 aldolase 54.8 ± 0.0 55.5 ± 0.2 56.4 ± 0.1 57.5 ± 0.1 58.2 ± 0.1 
 G3P DH 136.5 ± 0.1 137.9 ± 0.5 140.1 ± 0.3 142.6 ± 0.2 144.2 ± 0.2 
 enolase 125.1 ± 0.1 126.5 ± 0.6 128.7 ± 0.3 131.1 ± 0.3 132.6 ± 0.3 
 pyruvate DH 80.8 ± 0.2 77.7 ± 1.0 73.8 ± 0.7 69.3 ± 0.6 66.4 ± 0.5 
 citrate synthase 47.4 ± 0.3 46.4 ± 1.3 45.7 ± 0.9 44.7 ± 0.7 44.0 ± 0.6 
 α-ketoglutarate DH 38.7 ± 0.3 36.7 ± 1.4 34.6 ± 0.9 32.2 ± 0.7 30.5 ± 0.7 
 pyruvate carboxylase
c 21.4 ± 0.0 23.3 ± 0.2 25.9 ± 0.2 28.9 ± 0.1 30.8 ± 0.1 
 
data are given as relative fluxes [%] normalized to the specific glucose uptake rate qS = 4.18 mmol gCDW-1 h-1 
(see Table V-3), which was set to 100%. 
a  mean values and standard deviations were calculated from 100 independent Monte Carlo runs. 
b initial values for protein content (wild type). 
c  given as net flux through anaplerotic reactions. 
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Table S-9. Intracellular carbon flux distribution (in silico) with corresponding standard deviations 
determined for initial biomass composition of C. glutamicum Δpgi and for Scenario C. 
 
 
flux parameter 
 
initial biomass 
composition 
 
scenario C 
 
   
 G6P DH 97.8 ± 0.1 98.2 ± 0.1 
 transketolase 1 30.8 ± 0.0 31.4 ± 0.0 
 transketolase 2 28.4 ± 0.0 28.8 ± 0.0 
 aldolase 56.4 ± 0.1 58.1 ± 0.1 
 G3P DH 140.1 ± 0.3 143.7 ± 0.2 
 enolase 128.7 ± 0.3 132.3 ± 0.2 
 pyruvate DH 73.8 ± 0.7 72.7 ± 0.6 
 citrate synthase 45.7 ± 0.9 42.5 ± 0.7 
 α-ketoglutarate DH 34.6 ± 0.9 30.4 ± 0.8 
 pyruvate carboxylase
a 25.9 ± 0.2 27.9 ± 0.2 
 
data are given as relative fluxes [%] normalized to the specific glucose uptake rate qS = 4.18 mmol gCDW-1 h-1 
(see Table V-3), which was set to 100%. Mean values and standard deviations were calculated from 100 
independent Monte Carlo runs. 
a  given as net flux through anaplerotic reactions. 
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Table S-10. Relative flux changes of in silico predicted metabolic fluxes based on strain specific 
parameters (YX/S, YP/S, MDVs) and modified biomass compositions for increasing lipid content as 
depicted in Figure VIII-4. 
 
 
lipid content [%]a 
 
7 
 
(A.I.) 
 
13b 
 
(A.II.) 
 
20 
 
(A.III.) 
 
25 
 
(A.IV.) 
 
33 
 
(A.V.) 
flux parameter      
 
      
 G6P DH -0.20 - 0.10 0.10 0.20 
 transketolase 1 -0.33 - 0.32 0.65 1.29 
 transketolase 2 -1.06 - 1.40 2.09 3.46 
 aldolase -1.07 - 1.41 2.11 3.66 
 G3P DH -0.64 - 0.92 1.35 2.26 
 enolase -0.86 - 1.08 1.62 2.76 
 pyruvate DH -6.73 - 7.57 12.23 19.40 
 citrate synthase 6.56 - -8.21 -15.85 -30.46 
 α-ketoglutarate DH 6.71 - -7.81 -15.95 -32.10 
 
data are given as relative changes (logarithmized and expressed in percent) in relation to fluxes determined 
for the initial biomass composition (A.II.)  
a  lipid contents are given as relative biomass fraction [%]. 
b
  initial biomass composition served as reference (- indicates: flux changes are equal to zero). 
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Table S-11. Relative flux changes of in silico predicted metabolic flux activities based on strain 
specific parameters (YX/S, YP/S, MDVs) and modified biomass compositions for increasing protein 
contents as depicted in Figure VIII-4. 
 
 
protein content [%]a 
 
40 
 
(B.I.) 
 
45 
 
(B.II.) 
 
52b 
 
(B.III.) 
 
60 
 
(B.IV.) 
 
65 
 
(B.V.) 
flux parameter      
 
      
 G6P DH -0.51 -0.41 - 0.31 0.41 
 transketolase 1 -2.63 -1.64 - 1.61 2.56 
 transketolase 2 -.071 -0.35 - 0.35 0.70 
 aldolase -2.88 -1.61 - 1.93 3.14 
 G3P DH -2.60 -1.58 - 1.77 2.88 
 enolase -2.84 -1.72 - 1.85 2.99 
 pyruvate DH 9.06 5.15 - -6.29 -10.57 
 citrate synthase 3.65 1.52 - -2.21 -3.79 
 α-ketoglutarate DH 11.20 5.89 - -7.19 -12.61 
 
data are given as relative changes (logarithmized and expressed in percent) in relation to fluxes determined 
for the initial biomass composition (B.III.). 
a  protein contents are given as relative biomass fraction [%]. 
b
  initial biomass composition served as reference (-indicates: flux changes are equal to zero). 
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